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Abstract
In muscle and adipose tissue insulin promotes glucose uptake by stimulating the 
translocation of the glucose transporter GLUT4 from an intracellular location to the plasma 
membrane. This exocytic delivery of GLUT4 to the plasma membrane is fundamental for 
the maintenance of blood glucose homeostasis. Individuals with insulin resistance or type 
II diabetes exhibit a blunted ability of insulin to stimulate GLUT4 translocation, and, as a 
result, a decreased rate of insulin stimulated glucose transport. To design effective 
therapies we require a clear understanding of the molecular basis of intracellular GLUT4 
trafficking.
Recent studies support a model in which the intracellular GLUT4 itinerary involves two 
intracellular cycles. In the basal state, GLUT4 recycles between the PM and endosomes in 
the fast recycling endosomal system. However, unique sequences within GLUT4 cause a 
large population to be sorted away hom the endosomal system, into a slowly recycling 
intracellular pathway between endosomes and the TGN. This pathway involves the soiling 
of GLUT4 into unique storage vesicles, (GLUT4 storage vesicles, GSVs) which are 
mobilised in response to insulin, and are responsible for the majority of GLUT4 that is 
delivered to the cell surface in response to insulin. The intracellular sorting of GLUT4 is 
therefore essential to direct GLUT4 into the insulin-responsive compartment and to 
effectively sequester GLUT4 ûom the cell surface in the basal state. However, the 
molecules responsible for regulating this intracellular sorting pathway remain largely 
unknown.
Previous studies have implicated the TGN localised t-SNARE, STX16, in GLUT4 
trafficking in 3T3-L1 adipocytes. STX16 is a phosphoprotein in these cells and 
phosphorylation is decreased in response to acute insulin stimulation. This study aimed to 
elucidate the role, if any, of STX16 in GLUT4 trafficking, and to deteimine whether 
phosphorylation was responsible for the regulation of this process.
In this study, experiments to identify the exact site of insulin-regulated phosphorylation 
were carried out in HEK 293 cells and suggest that STX16 phosphoiylation may be 
specific to adipocytes. Immunoprécipitation studies revealed the existence of a STX16 
containing SNARE complex in 3T3-L1 adipocytes with the t-SNAREs STX6 and Vtila; 
however, this SNARE complex does not appear to be regulated by insulin. These studies 
also suggest that STX16 does not bind to its cognate SM protein, mVps45, when part of 
this SNARE complex, either in the presence or absence of insulin.
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Recombinant adenoviruses were generated to express wild-type STX16 and STX16 
mutants in 3T3-L1 adipocytes to assess their effects on glucose transport. Expression of 
these STX16 mutants proved problematic due to a property inherent in STX16, which 
requires stabilisation by its cognate SM protein, mVps45. It appears that STX16 expressed 
in excess of mVps45 is subject to proteasomal degradation, since expression could be 
dramatically increased when proteasome function was inhibited.
One mutant, STXlbcyt, constituted the dominant negative cytosolic domain of STX16 and 
was expressed in adipocytes to perturb endogenous STX16 function. Expression of 
STXlôcyt significantly slowed the endocytic retrieval of GLUT4 following insulin- 
withdrawal. In contrast, expression of STXlôcyt had no effect on the secretion of an 
adipocyte-derived adipokine, ACRP30. In a complementary approach, endogenous STX16 
was knocked down by > 90 % using a specific Morpholino Anti sense Oligonucleotide. 
3T3-L1 adipocytes depleted of STX16 in this way showed a significant decrease in insulin- 
stimulated glucose transport. This corresponded with ~ 30 % decrease in cellular GLUT4 
levels. These data were rationalised within a model in which STX16 functions to sequester 
GLUT4 from the PM in the basal state in a step which involves the intracellular sorting of 
GLUT4 fiom the fast cycling endosomal system into the slowly recycling intracellular pool 
of which GSVs are part. In cells depleted of STX16, this pathway is blocked and GLUT4 
appears to be directed into a degradative pathway.
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1. Introduction
1.1. Type II Diabetes
Type II diabetes is now one of the main threats to human health in the 21®' century, with an
explosive increase in the worldwide occurrence of this heterogeneous disorder in the past 
two decades (reviewed in Zimmet et ah, 2001). An estimated 6 % of the adult population 
in the Western world is affected and the number of people affected worldwide is 
anticipated to increase by 6 % per annum, potentially reaching a total of 200 -300 million 
cases in 2010 (Amos et ah, 1997; Kopelman and Hitman, 1998).
The type II diabetes epidemic is taking place both in developed and developing nations and 
is particularly pronounced in certain ethnic groups, for example in Pacific and Indian 
Ocean island populations, groups in India and Australian Aboriginal communities (Zimmet 
et ah, 2001). Originally a disease associated with onset in later life, type II diabetes has 
now been reported in children and adolescents in various countries, including the UK 
(Zimmet et ah, 2001). The main reasons for the epidemic proportions of the disorder are 
believed to be the prevalence of a sedentary lifestyle, and in particular, obesity (Zimmet et 
ah, 2001).
Type II diabetes is characterised by insulin resistance and / or abnormal insulin secretion, 
either of which may predominate. Insulin resistance is characterised by dysfiinctional 
glucose uptake into muscle and adipose tissue, in conjunction with an oversupply of 
glucose from the liver, which results in high circulating plasma glucose levels. This leads 
to many of the complications associated with type II diabetes including blindness, renal 
failure, nerve damage and limb amputation (Brownlee, 2001), with atherosclerotic 
cardiovascular disease being responsible for 80 % of diabetic mortality (MoHer, 2001).
Glucose uptake into muscle and adipose tissues is facilitated by the glucose transporter, 
GLUT4 (Section 1.2.1) (Bryant et ah, 2002; Watson et ah, 2004). As dysfunctional glucose 
uptake into these tissues contributes to insulin resistance and the onset of type II diabetes, a 
clear understanding of the molecular basis of intracellular GLUT4 trafficking is required to 
design effective therapies (Bryant et ah, 2002; Watson et ah, 2004).
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1.2. Facultative glucose transporters
Glucose is a primary source of energy for eukaryotic cells. Glucose is distributed 
throughout the various tissues of the body in mammals by a family of glucose transporters, 
called GLUTs, of which there are 12 known members (reviewed in Gould and Bell, 1990; 
Mueckler, 1994; Olson and Pessin, 1996). These members differ in their tissue distribution 
and kinetic properties, as well as in their intracellular localisation.
GLUTs are integral membrane proteins, and when present at the cell surface, act as shuttles 
to allow glucose to cross the plasma membrane (PM). GLUT proteins share a similar 
topology with 12 transmembrane helices, which foim an aqueous pore that allows glucose 
to diffuse down its concentration gradient in a non-energy dependent process (Gould and 
Bell, 1990; Mueckler, 1994). Thus the rate of glucose entry into a cell is dependent of the 
quantity of glucose transporters present at the eell surface.
Many mammalian tissues, such as the brain, have a constitutively high glucose requirement 
and as such possess transporters that are constitutively targeted to the cell surface, for 
example GLUTs 1-3 (Olson and Pessin, 1996). By contrast, certain tissues require a 
regulated glucose transport system, as in the case of GLUT4 facilitated glucose uptake into 
muscle and fat cells (Bryant et ah, 2002; Watson et ah, 2004).
1.2.1.GLUT4
Muscle and adipose tissues have evolved a highly regulated glucose transport system, 
which allows the rate of glucose uptake to increase in these tissues by 10-40 fold within 
minutes of exposure to a particular stimulus (reviewed in Shepherd and Kalin, 1999). This 
system is essential for the maintenance of blood glucose homeostasis during exercise, 
when the metabolic demands of the skeletal muscle can increase more than 100-fold, and 
during the absorptive period (after a meal), when insulin stimulation increases the uptake 
of glucose into muscle and adipose tissue for subsequent storage as glycogen and 
triglycerides.
The glucose transporter responsible for the insulin-stimulated transport of glucose into 
muscle and fat cells is GLUT4, which is expressed in high levels in only white and brown 
adipocytes and in cardiac and skeletal myocytes (Bryant et ah, 2002; Olson and Pessin, 
1996; Watson et ah, 2004). Unlike other members of the facilitative glucose transporter 
family, GLUT4 is almost completely intracellularly localised in the basal state. In response
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to insulin, GLUT4 is mobilised (translocated) to the PM, allowing an increase in the rate of 
glucose entry (Bryant et al., 2002; Watson et al., 2004). Dysfunctional glucose uptake into 
muscle and fat cells contributes to the onset of type II diabetes.
Figure 1.1 shows adipocytes immuno-stained for GLUT4, indicating its intracellular 
location in basal cells and its subsequent movement to the cell surface in response to 
insulin. The mechanism by which this translocation occurs will be described in detail in 
Section 1.7.
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Figure 1.1 GLUT4 in 3T3-L1 adipocytes (taken from Bryant et al., 2002)
Confocal image of 3T3-L1 adipocytes incubated either with (right panel) or without 
(left panel) 100 nM insulin for 15 mins. The location of GLUT4 in these cells is shown 
using an antibody that specifically recognises GLUT4 and a secondary antibody 
conjugated to Alexa-488 (green). In the basal state, GLUT4 is localised mainly to 
intracellular vesicles, whereas upon insulin stimulation it is delivered to the PM.
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1.3. Insulin
1.3.1. Function of insulin
In normal individuals, plasma glucose is maintained in a naiTOW range between 4 and 7 
mM during periods of feeding and fasting by a balance between glucose absorption from 
the intestine, production by the liver, and uptake and metabolism by peripheral tissues. As 
well as increasing glucose uptake in muscle and adipose tissue, insulin inhibits hepatic 
glucose production, thus acting as the primary regulator of blood glucose homeostasis 
(reviewed in Saltiel and Kahn, 2001). In addition, insulin stimulates cell growth and 
differentiation, and promotes the storage of substrates in fat, liver and muscle by 
stimulating lipogenesis, glycogen and protein synthesis, and inliibiting lipolysis, 
glycogenolysis and protein breakdown. Insulin resistance or deficiency results in profound 
dysregulation of these processes, and produces elevations in fasting and postprandial 
glucose and lipid levels (Saltiel and Kahn, 2001).
1.3.2Jnsulin signalling
Insulin responsive cells, such as muscle and fat cells, express a cell-surface receptor to 
which the hormone can bind. Upon insulin binding, a confonnational change is induced in 
the receptor, leading to activation of its tyrosine-kinase domain and the phosphorylation of 
several proximal substrates, translating the signal into an intracellular cascade responsible 
for the many cellular effects of insulin (reviewed in Saltiel and Kalin).
Activation of the insulin receptor results in the tyrosine phosphorylation of members of the 
insulin-receptor-substrate (1RS) family (IRS-1 and IRS-2 in muscle and fat cells), which 
recruit effector molecules, such as the lipid kinase phosphatidylinositol 3-kinase (PI3K), to 
the PM. A signalling pathway involving PI3K has been implicated in GLUT4 trafficking 
(Bryant et al., 2002; Saltiel and Kalin, 2001; Tengliolm and Meyer, 2002). There is 
considerable evidence to suggest that the Class la  PI3K might have an important role in 
insulin-stimulated GLUT4 translocation (Bryant et ah, 2002; Saltiel and Kahn, 2001). 
Insulin signalling will be discussed further in Section 3.1.2.2 (Chapter 3).
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1.3.3Jnsulin resistance
As mentioned previously, one of the main pathophysiological defects in type II diabetes is 
insulin resistance, a decrease in cellular responses to insulin. This insulin resistance is 
characterised by defects at many levels, for example, decreases in receptor concentration 
and kinase activity, the concentration and phosphoiylation of IRS-1 and -2, PI(3)K 
activity, GLUT4 and the activity of intracellular enzymes (Pessin and Saltiel, 2000). This 
decreased insulin sensitivity includes a reduction in insulin-stimulated glucose uptake into 
fat and muscle cells, due to a defect in the ability of insulin to stimulate GLUT4 
translocation to the PM in these cells. In adipocytes, decreased insulin sensitivity is caused 
additionally by decreased GLUT4 expression (Minokoshi et ah, 2003; Shepherd and Kahn, 
1999), an effect that is not observed in muscle. Indeed, GLUT4 protein and mRNA levels 
are decreased in adipocytes in most cases of insulin resistance, including that present in 
human obesity and type II diabetes (Shepherd and Kahn, 1999).
1.3A. The importance of adipose tissue
Adipose tissue accounts for only a small fraction of glucose disposal after a meal, with the 
majority of glucose taken up by muscle (Minokoshi et al., 2003). On this basis, it would 
not be expected that diminished glucose uptake into adipocytes would have a significant 
impact on glucose homeostasis. However, whereas mice with a knockout of the insulin 
receptor in muscle have normal glucose tolerance (Bruning et al., 1998), those with 
adipose specific ablation of GLUT4 have impaired glucose tolerance, which appears to be 
due to insulin resistance being induced in muscle and liver (Abel et ah, 2001). Further 
experimental evidence has now demonstrated conclusively that decreased GLUT4 
expression in adipocytes decreases insulin sensitivity in muscle and liver, resulting in a 
change in glucose homeostasis (Minokoshi et al., 2003).
1.3.5. Secretion from adipocytes
Excess adipose tissue in obesity and lack of adipose tissue in lipodystrophic states are 
associated with insulin resistance and type II diabetes mellitus in human and animal studies 
(Ganda, 2000; Kahn and Flier, 2000), demonstrating that adipose tissue is crucial in 
regulating metabolism beyond its ability to take up glucose. Until recently, adipose tissue 
was commonly viewed exclusively as a depot for lipids. However, adipocytes are now 
viewed as highly active cells with potent autocrine, paracrine and endocrine functions.
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which play active roles in nonnal metabolic homeostasis and in the development of disease 
(Mora and Pessin, 2002).
1.4. Intracellular protein trafficking
1.4.1. introduction
Eukaryotic cells have been endowed with extensive internal membranes that enclose 
specific compartments, or organelles, each of which plays a unique role in the gi'owth and 
metabolism of the cell. As such, each organelle contains a collection of specific enzymes 
that catalyse necessary chemical reactions and house an intracellular enviromnent, which 
differs fi'om that of the cytosol and other organelles, specific to its function. Membrane 
impenneable substances, such as proteins and lipids are transported between these 
organelles and to and from the cell surface in membrane bound vesicles which bud from 
the donor compartment membrane and fuse with the acceptor compartment membrane, 
releasing their contents. Two distinct intracellular trafficking pathways are known to exist 
in eukaryotic cells: the endocytic and the secretory / biosynthetic pathways. 
Communication between these pathways occurs by vesicle trafficking between the Golgi 
complex and endosomes.
1.4.2. The endocytic pathway
Endocytosis is the collective tenn given to the various mechanisms by which eukaryotic 
cells take up extracellular or cell surface material (reviewed in Mellman, 1996). This
Adipose tissue controls energy expenditure through the secretion of several physiologically 
active polypeptide hormones, collectively called adipocytokines or adipokines, which may 
profoundly influence metabolism (reviewed in Ritchie et al., 2004). The best studied of 
these is leptin, which acts on receptors in the central neiwous system and other sites to 
inhibit food intake and promote energy expenditure. However, a number of other 
significant adipokines have been discovered in recent years (Ritchie et al., 2004), including 
ACRP30 (described in Section 5.1.2), adipsin, IL (interleukin)-6, TNF-a and resistin. 
Secretion of the adipokines is altered in obese individuals and many are thought to play an 
important role in insulin resistance.
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process is essential to maintain cellular homeostasis and cellular communication by the 
uptake of nutrients, extracellular fluid, ligands and receptors.
The most common type of endocytosis is known as receptor mediated endocytosis, and 
involves the selective uptake of ligands, such as proteins, glycoproteins, or carbohydrates, 
that bind with high affinity to PM receptors and are then internalised. The cell utilises this 
method to obtain nutrients, such as iron (see below) or cholesterol, and to remove 
potentially harmful molecules (such as honnones, which are needed acutely but briefly) 
from the extracellular environment. In addition, cells take up extracellular fluid in small 
vesicles, in a process known as pinocytosis, however, this will not be discussed further 
here.
Newly synthesised molecules travel along the secretory pathway (Section 1.4.3) and many 
join the endocytic pathway at the ^ra^ïi'-Golgi network (TGN) on route to their correct 
intracellular location, sometimes travelling via the PM, and as such endocytosis is a 
necessary part of the itinerary. In addition, endocytosis is required for the removal of 
molecules such as GLUT4 (Section 1.2.1), which are required at the PM for a limited time 
in response to certain stimuli, from the extracellular environment. The pathway can also be 
used to retrieve molecules that have been incorrectly targeted to the PM by secretory 
activity.
Endosomes are the major sorting stations / compartments along the endocytic pathway, and 
consist of, mainly, the early or sorting endosome (EE), recycling endosome (RE) and late 
endosome (LE) (reviewed in Clague, 1998; Mellman, 1996). The organisation of the 
endocytic pathway is depicted in Figure 1.2. Endosomes are distinguished based on, 
among other criteria, the presence of specific biochemical markers (Figure 1.2) for 
example proteins of the Rab GTPase family (Clague, 1998; Mellman, 1996). The extent to 
which these endosomes represent distinct stable compartments remains controversial, with 
the possibility that they exist transiently as intermediates in a process of endosomal 
maturation. An important element controlling sorting along the endocytic pathway is the 
pH gradient that extends tlirough the sequential endosomal compartments (Figure 1.2).
Cargo enters the endocytic pathway in vesicles budding from specialised regions of the PM 
to the EE where it is sorted and directed into various destinations (Mellman, 1996) (Figure 
1.2). Cargo to be recycled may return to the cell surface directly or via the RE, whereas 
material intended for degradation can be transferred from LEs to lysosomes, the 
comprehensive digestive centres of the cell. In cells that undergo regulated trafficking.
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cargo may be directed to specialised endosomal derived recycling vesicles or secretory 
vesicles. The TGN represents the link between the endosomal and the secretory / 
biosynthetic pathways, and as such, cargo may either be recycled back to this compartment 
through endosomes or join the endosomal system following synthesis in the ER (Section 
1.4.3). In the case of receptor-mediated endocytosis, most ligands are dissociated from 
their receptors in the acidic enviromnent of the EE or RE and the receptors are recycled to 
the PM.
The biogenesis of transport vesicles is initiated by the recruitment of large multi-subunit 
proteins called coats. The assembly of coat proteins is important in the selection of cargo 
and deforming the lipid bilayer into a budding vesicle. The coat protein centrally involved 
in endocytosis is clatlnin (reviewed in Kirchhausen, 2000), which fonns clathrin coated 
vesicles in conjunction with adaptor proteins (AP-1 to AP-4) at in addition to the PM, the 
TGN and endosomes. Clatlirin dependent endocytosis occurs at specialised patches on the 
PM, called clathrin-coated pits. The GTPase, dynamin has been implicated as being 
important in “pinching” these vesicles from the membrane (Schmid et al., 1998). The 
majority of receptor mediated endocytosis events occur via clathrin dependent endocytosis. 
So-called clathrin independent mechanisms of endocytosis exist (Mellman, 1996), 
including pinocytosis (above) and caveolae/raft dependent endocytosis (Nabi and Le,
2003). Intracellular trafficking vesicles also utilise coat proteins, known as COPs, (Salama 
and Schekman, 1995). COPl is associated with EEs and in retrograde transport from the 
Golgi to the ER (Barlow, 2000), whereas COPII is associated with vesicles targeted to the 
Golgi from the ER (Barlow, 2000; Kuehn and Schekman, 1997).
The transferrin receptor (TfR), which mediates cellular iron uptake by binding to the iron- 
carrying protein transferrin is considered a prototype resident of the early/recycling 
endosomal pathway. TfR binds to its ligand before being internalised via clathrin-coated 
pits to the EEs, where iron is released in the acidic environment of the compartment. The 
TfR, carrying iron- free transfemn, is then returned directly from the EE to the PM with a 
half time of about two to thi'ee minutes (Mayor et al., 1993), however, a proportion of TfR 
is returned to the PM via the RE, with a longer half time of about five to ten minutes (Daro 
et al., 1996).
1.4.3. The secretory pathway
The biosynthetic or secretory pathway represents the pathway by which newly synthesised 
proteins in the ER are transported to the cell surface for secretion into the extracellular
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space or to their correct intracellular destination (Ellgaard et ah, 1999). Traffic in the early 
secretory pathway between the ER and the Golgi is bidirectional, ensuring that proteins 
required to form and fuse vesicles with organelles are recycled as secretory cargo advances 
(Barlow, 2000). From the ER, newly synthesised proteins are directed, via a compartment 
commonly referred to as the intermediate compartment, to the Golgi stack (Gmenberg and 
Kreis, 1995). However, it has also been suggested that this transport process may proceed 
via a compartment maturation process (Allan and Balch, 1999). A network of tubular- 
cisternal structures, the Golgi network, is the point of entry for material destined to 
reach and transit through the cistemae of the Golgi complex. Cargo proceeds tlirougli the 
medial to ^ra^^-Golgi (Allan and Balch, 1999), where it enters the exit site of the Golgi 
complex, the TGN. The classical marker of the TGN is TGN38, a resident protein of the 
TGN, which actually recycles continuously between the TGN and the PM, presumably via 
EEs and / or LEs (Miesenboek and Rothman, 1995).
In the TGN, proteins are sorted into different vesicular carriers and delivered to their final 
destination (reviewed in Traub and Koinfeld, 1997). Depending on the cell type, the cargo 
that arrives in the TGN can be distributed, via distinct transport carriers, to several 
different intracellular locations. The intracellular itinerary taken by each protein depends 
on sorting signals encoded in the polypeptide chain. The three possibilities are summarised 
in Figure 1.3.
The first represents the constitutive or default pathway, which delivers proteins directly to 
the cell surface (Traub and Komfeld, 1997). Secretion is a constitutive activity of most 
cells, as is the biosynthesis and turnover of resident PM proteins and lipids. These 
activities result in a steady stream of both proteins and lipids from the TGN to the cell 
surface.
The second selective pathway sorts protein traffic fiom the TGN into the intracellular 
endosomal membrane system (Traub and Komfeld, 1997) (described above. Section 1.4.2). 
Once in the endosomal system, proteins can be delivered to the PM or to their intracellular 
location along the secretory pathway. A classic example of this pathway is the transport of 
hydrolytic enzymes and glycoproteins from the TGN to the lysosome where they are 
required carry out the degradative functions of the organelle. Coated vesicles transport 
hydrolytic enzymes and integral membrane glycoproteins to the lysosome via early or late 
endosomes or both. Some lysosomal membrane glycoproteins travel via the PM before 
delivery to lysosomes along the endocytic pathway. Mannose 6-phosphate receptors 
(MPRs) are responsible for binding to individual prohydrolase molecules in the TGN
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before being packaged into carrier vesicles and are delivered to lysosomes via the 
endosomal system (Ghosh et ah, 2003). After MPRs discharge their cargo, other vesicles 
carry the unoccupied MPRs back from the endosomes to the TGN.
The third fate of proteins emerging from the TGN occurs in cells that specialise in 
regulated secretion, such as endocrine, neuroendocrine and exocrine cells. These proteins 
are secreted via the so-called regulated secretory pathway (reviewed in Tooze et al., 2001). 
This pathway is required for the regulated secretion of bioactive molecules such as 
hoimones and peptides in response to hormonal or neuronal stimulation. Most of the 
body’s polypeptide honnones, enzymes used in the digestive tract, and many other 
products that are needed intennittently rather than continuously, utilise this pathway for 
secretion. Regulated secretory cells package secretory proteins into large, dense core 
granules that accumulate in the cytosol and fuse with the PM only upon stimulation.
The formation of a mature secretory granule occurs in four stages (described in Tooze et 
al., 2001). First the regulated secretory proteins are accumulated and sorted to the 
membrane in the TGN and secretory granules initially classified as immature secretory 
granules, bud from these regions of the TGN. During maturation, the immature secretory 
granules undergo homotypic fusion to build the mature secretory granule. This fusion is 
followed by remodelling and removal of excess membrane through the foimation of 
clathrin coated vesicles. This process involves the sorting away of molecules that are not 
required in mature secretory granules, such as MPR-ligand complexes (Klumperman et al., 
1998) and proteins involved in the homotypic fusion events (Wendler et al., 2001). Finally, 
the mature secretory granules accumulate, poised for the exocytotic release of their 
contents into the extracellular milieu in response to an external stimulus.
1.4.4. Membrane fusion
The final stage of intracellular protein trafficking involves the fusion of the cargo vesicles 
derived fr om the donor compartment with membrane of the correct target compartment. It 
is energetically unfavourable to fuse two membranes (phospholipid bilayers) in an aqueous 
environment, because the electrostatic repulsive and hydration forces between the two 
membranes have to be overcome. All types of membrane fusion are believed to share 
common protein machinery (Bennett and Scheller, 1993; Ferro-Novick and Jahn, 1994). 
Fusion occurs via a highly ordered mechanism that has multiple co-ordinated steps 
including vesicle docking/tethering, priming and finally fusion. As such, this process is 
thought to involve the concerted action of a number of protein families, including the
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Secl/Muncl8 homologs (SM proteins) (Jahn and Sudhof, 1999; Lin and Scheller, 2000), 
Rab GTPases, AAA ATPases and various membrane tethering proteins, the discussion of 
which is beyond the scope of this thesis. The molecules suggested to be centrally involved 
in this membrane fusion process are soluble N-ethylmaleimide-sensitive factor attachment 
protein receptor or SNARE proteins (Jahn and Sudhof, 1999; Lin and Scheller, 2000), 
which have been proposed to mediate all intracellular membrane fusion events (Section 
1.5).
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Figure 1.2 Schematic representation of the endocytic pathway
The endocytic pathway along with typical marker proteins (of the Rab GTPase 
family) for each compartment (Clague, 1998) and the characteristic pH associated 
with each compartment. Cargo enters the pathway in vesicles that bud from 
specialised regions of the PM. Recycling cargo, such as the TfR, may return to the 
PM directly or via REs. Cargo intended for degradation may be directed to the 
lysosome via LEs. The TGN represents the point of exchange between the endocytic 
and secretory / biosynthetic pathway. TGN38 and LAMPl are markers of the TGN 
and lysosomes respectively.
PM, plasma membrane; EE, early endosome; RE, recycling endosome; LE, late 
endosome; TGN, tram-Golgi network; TfR, transferrin receptor
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Figure 1.3 Schematic representation of the secretory pathway
Newly synthesised proteins exit the ER and progress through the Golgi stack to the 
TGN where the fate of the protein is decided.
(1) The constitutive secretory pathway, where cargo is directed directly to the PM for 
secretion into the extracellular milieu. (2) The regulated secretory pathway. Cargo is 
packaged into dense-core secretory granules, which accumulate in the cytosol, poised 
for exocytotic release in response to external stimuli. (3) Cargo may be directed to the 
endosomal system (Section 1.4.2 and Figure 1.2) from where it can be directed into a 
recycling pathway or to lysosomes.
ER, endoplasmic reticulum; TGN, trans-GoXgi network; PM, plasma membrane
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1.5. SNAREs
1.5.1. Introduction
The SNARE (soluble NSF attachment protein receptor where NSF stands for N-ethyl­
maleimide-sensitive fusion protein) proteins fbim a multi-gene superfamily involved in 
catalysing membrane fusion (reviewed in Chen and Scheller, 2001; Jahn and Sudhof, 1999; 
Lin and Scheller, 2000; Pelham, 2001). All SNAREs share a homologous membrane 
proximal domain of approximately 60 amino acids, known as the SNARE motif, which has 
a high propensity to form coiled coils (Fasshauer et al., 1998b; Hay, 2001; Jahn and 
Sudhof, 1999). The SNARE motif is the defining feature of all SNAREs.
The majority of SNAREs are type If integral membrane proteins, anchored to the 
membrane via a C-terminal transmembrane domain with a short extracytoplasmic domain 
and the N-terminus in the cytosol; however, some SNAREs do not contain a 
transmembrane domain but instead are tethered to the membrane via palmitoylation or 
prénylation (reviewed in Hay, 2001). The cytosolic N-terminal regions contain both 
hydrophobic and hydrophilic regions and are able to adopt cytoplasmic amphipathic 
helices.
In 1993, Rotlmian and colleagues suggested the concept of the SNARE hypothesis to 
explain the specificity of membrane fusion events (Sollner et al., 1993). It supposed that 
for all vesicle trafficking events, there exists a unique vesicle-associated SNARE (v- 
SNARE), which specifically recognises and interacts with a cognate SNARE localised to 
the target membrane (t-SNARE) (Rothman, 1994; Sollner et ah, 1993). These v-and t- 
SNAREs were thought to bind in a specific manner to fonn complexes that were capable 
of bridging the two membranes, ultimately resulting in fusion.
Functional studies have provided insights into how SNARE proteins interact with each 
other to generate the driving force needed to fuse lipid bilayers (Chen and Scheller, 2001; 
Jahn and Sudhof, 1999). Reconstitution experiments have suggested that SNAREs alone 
can indeed cause bilayer merger but at a slow rate (Weber et al., 1998), suggesting that 
additional factors are required for physiological membrane fusion.
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To date, 36 SNARE proteins have been identified in the liuman genome and 21 in the yeast 
genome (Bock et al., 2001). Figure 1.4 shows the distribution of known mammalian 
SNAREs tliroughout the secretory pathway. Most SNAREs are specifically localised to 
distinct membrane compartments thioughout the cell (Chen and Scheller, 2001; Scales et 
al., 2000), perhaps suggesting a role in controlling the specificity of membrane fusion 
events. This notion was partly responsible for the development of the SNARE hypothesis 
(Sollner et al., 1993).
In recent years, the SNARE hypothesis has been challenged by studies which suggest 
SNARE pairing may be more promiscuous than previously thought (Yang et al., 1999), 
however, it nonetheless remains the basis of our understanding of SNARE function.
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Figure 1.4 Intracellular localisation of SNARE proteins in a typical mammalian cell 
(taken from Chen and Scheller, 2001)
The mammalian SNAREs that have been studied so far localise to distinct subcellular 
compartments throughout the secretory pathway, indicating a possible role in 
controlling the specificity of membrane trafficking/fusion events.
Red, Syntaxin (STX) family; blue, VAMP family; green, SNAP-25 family; black, 
others; CCP, clathrin coated pit; CCV, clathrin coated vesicles; DCV, dense core 
vesicles; IC, intermediate compartment; RER, rough endoplasmic reticulum; SER, 
smooth endoplasmic reticulum; TGN, /raw-Golgi network; V, vesicles.
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1.5.2. The Synaptic SNAREs as a modei for other systems
In the nervous system, membrane fusion is an essential step in chemical synaptic 
transmission because neurotransmitter-filled presynaptic vesicles fuse in a calcium- 
dependent manner with the plasma membrane to release their content into the synaptic 
cleft. The first SNAREs to be discovered were those functioning in synaptic vesicle 
exocytosis in neurons (reviewed in Lin and Scheller, 2000). Much of our cuiTcnt 
knowledge regarding SNARE function is derived from numerous detailed studies of the 
synaptic SNAREs. Studies involving homologs of these and other SNARE proteins in 
yeast, suggest that parallels can be drawn from this system to all known fusion events. 
Therefore, synaptic vesicle fusion will be used here to explain the basis of SNARE 
complex fonnation and membrane fusion.
The fusion of synaptic vesicles involves the concerted action of three SNARE proteins: the 
PM associated t-SNAREs STXla (Syntaxin 1 a) (Bennett et al., 1992) and SNAP-25 (25 
kDa synaptosome-associated protein) (Oyler et al., 1989), and the vesicular protein VAMP 
(vesicle-associated membrane protein, also called synaptobrevin) (Baumert et al., 1989; 
Trimble et al., 1988). STXla and VAMP are anchored to their respective membranes via a 
transmembrane domain, and each contains one SNARE motif at the membrane proximal 
end of the molecule. SNAP-25, on the other hand, possesses two SNARE motifs, 
connected by a cysteine-rich linker region. SNAP-25 is devoid of a transmembrane domain 
and palmitoylation confers membrane attachment. The proteins interact via their SNARE 
motifs to form the SNARE complex (Section 1.6.5.1), an extremely stable four-helix 
bundle containing the four a-helical SNARE motifs at its core (two from SNAP-25 and 
one each from VAMP and STXla) (Fasshauer et al., 1998a; Poirier et al., 1998a; Poirier et 
al., 1998b; Sutton et al., 1998). Figure 1.5 shows the cycle of assembly and disassembly of 
the SNARE complex in synaptic vesicle exocytosis.
STXla contains an N-terminal region that precedes the SNARE motif and includes an 
autonomously folded three helical domain termed the Habc domain (Fernandez et al., 1998). 
The presence of this domain confers to STXla the ability to adopt two distinct 
conformations: a “closed conformation” in which the Habc domain folds back onto the 
SNARE motif, and a more “open” conformation in which the SNARE motif is exposed 
(Dulubova et al., 1999). In this way, the tliree helices of the Habc domain compete with the 
SNARE motifs of VAMP and SNAP-25 for binding to the STXla SNARE motif (Misura
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et al., 2001). The SM protein (Section 1.5.7) MunclSa binds to the “closed” conforaiation 
of STXla (Dulubova et al., 1999; Misura et al., 2000). These features perhaps impose 
some regulation on SNARE complex formation.
It has been suggested that when not present in a complex, SNAREs are relatively 
unstructured (Fasshauer et al., 1998a). The “zipper” model of SNARE function postulates 
that the pairing begins at the membrane distal end and “zips-up” towards the membrane 
proximal end, with the SNAREs becoming more a-helical in character as zipping proceeds 
(Lin and Scheller, 1997). This “zipping” of the SNAREs brings the vesicle and plasma 
membranes into close contact and the formation of the stable SNARE complex is 
hypothesised to overcome the energy barrier to drive fusion of the lipid bilayers (Lin and 
Scheller, 1997). Partially assembled / “zipped” complexes have been isolated, suggesting 
that complexes exist in various stages of completion (Zhang et al., 2005). To account for 
this, SNAREs are often r e f e iT c d  to being in either cis - (on the same membrane) (Weber et 
al., 1998) or tmns - (on opposing membranes) conformations (Chen and Scheller, 2001). A 
SNARE complex in the cis confonnation probably resembles the fully assembled complex, 
whereas SNAREs in a complex might only loosely or partially interact because of 
the resistance posed by the membranes.
After fusion, and the release of the vesicle contents, cw-SNARE complexes can be 
disassembled and SNAREs recycled for another round of fusion. Due to the extremely 
stable nature of the complex, energy in the form of ATP is required to dissociate it into 
monomeric components (Chen and Scheller, 2001). Disassembly is carried out by two 
proteins, the ATPase NSF (N-ethyl-maleimide-sensitive fusion protein) and an adaptor 
protein, a-SNAP (soluble NSF attachment protein). Several structural studies of a-SNAP, 
NSF and a SNARE-SNAP-NSF complex formed prior to dissociation (Hanson et al., 1997; 
Hohl et al., 1998; Lenzen et al., 1998; May et al., 1999; Yu et al., 1998; Yu et al., 1999) 
suggest NSF may act as a “rotational shear” to dissociate the complex.
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Figure 1.5 Cycle of assembly and disassembly of the SNARE complex in synaptic vesicle 
exocytosis (taken from Rizo and Sudhof, 2002)
STXla (Syntaxin in this figure) exists in a closed conformation, which may inhibit 
SNARE complex assembly with its SNARE partners, SNAP-25 and VAMP2. After 
conversion to the open conformation, SNARE complex assembly (nucléation) can 
proceed. “Zippering” of the trans-SNARE complex in the direction of the carboxyl 
terminus brings the vesicle and PM into close contact, which may ultimately result in 
fusion. After fusion and release of the vesicle contents, the cA-SNARE complexes are 
disassembled by NSF in conjunction with SNAP proteins. Thus the SNAREs are 
recycled to take part in another round of membrane fusion.
Orange, STXla Habc domain; yellow, STXla SNARE motif; red, VAMP2 SNARE 
motif; blue, SNAP-25 N-terminus SNARE motif; green, SNAP-25 C-terminus SNARE 
motif.
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1.5.3. Classification of SNAREs
As mentioned previously, on the basis of their localisation to target or vesicle membranes, 
SNAREs were initially classified as t-SNAREs and v-SNAREs (Sollner et ah, 1993). ' 
However, due to promiscuous binding and the ability of SNAREs to interact in a number 
of various trafficking steps, this classification was considered to be a huge 
oversimplification. With the additional benefit of preventing ambiguity in homotypic 
fusion events, SNAREs were giouped according to their homology with the synaptic 
SNAREs into the Syntaxin, SNAP-25 (described in detail in Sections 1,5.4 and 1.5.5) and 
VAMP families, on the basis of their sequence homology and domain structure. SNAREs 
were then further categorised according to the identity of a highly conserved ionic residue 
located in the SNARE motif (Fasshauer et ah, 1998b), as R-SNAREs (arginine-containing 
SNAREs) or Q-SNAREs (glutamine containing SNAREs). Using the coiled-coil SNARE 
domain of the 35 known SNAREs in the human genome and all known yeast, D. 
melanogaster and C. elegans SNAREs, Bock et. a l (Bock et ah, 2001) classified Q- and 
R-SNAREs into four groups. Qa-SNAREs are homologous to Syntaxins, R-SNAREs to 
VAMPs, and Qb- and Qc-SNAREs are homologous to the N and C-terminus of SNAP-25 
respectively. This classification has prompted a revision of the SNARE hypothesis and 
postulates that one member of each group contributes one chain to the four-helix bundle 
SNARE complex.
1.5.4.The SNARE core-compiex
Biochemical studies with the soluble coiled-coil-forming domains of recombinant STXla, 
SNAP-25 and VAMP have indicated that the neuronal SNARE complex is extremely 
stable (Fasshauer et ah, 1998a; Poirier et ah, 1998a). For example, it is resistant to SDS 
dénaturation (Hayashi et ah, 1994), protease digestion (Fasshauer et ah, 1998a; Hayashi et 
ah, 1994; Poirier et al., 1998a) and clostridial neurotoxin cleavage (Hayashi et ah, 1994) 
and is heat stable up to 90 “C (Yang et ah, 1999).
The crystal structure of the neuronal SNARE core complex has been solved revealing a 
four-helical bundle comprising one Syntaxin, one VAMP and two SNAP-25 coils (Sutton 
et ah, 1998) (Figure 1.6). The four a-helical SNARE motifs are arranged in a parallel 
fashion with all amino termini at one end of the bundle. The crystal structure revealed that 
the helix bundle is highly twisted and contains several salt bridges on the surface, as well
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as layers of interior hydrophobic residues (Sutton et al., 1998). Like other coiled-coil 
structures, the residues residing at “a” or “d” positions on a heptad helical wheel contribute 
to the hydrophobic core interactions that are important in stabilising the structure. These 
residues are the most conserved in the SNARE family (Fasshauer et ah, 1998b). The 
interactions between the SNAREs occur on 16 levels with the so-called zero-layer at the 
core (Figure 1.6). This layer is characterised by the presence of the ionic residues 
mentioned above (an R residue from VAMP and three Q residues, one from STXla and 
two from SNAP-25). The purpose of this zero layer is not totally known althougli it has 
been suggested that it may support the correct “register” during SNARE complex 
formation. This polar layer is present throughout the SNARE family (Fasshauer et ah, 
1998b; Sutton et al., 1998).
These observations have led to the proposal that all core complexes consist of four-helix 
bundles that are formed by three Q-SNAREs and one R-SNARE. Indeed, the crystal 
stmcture of a mammalian endosomal SNARE complex is remarkably similar to that of the 
neuronal complex, despite the low level of sequence conservation (Antonin et al., 2002). 
However, whereas SNAP-25 provides both the Qb- and Qc-SNAREs in SNARE 
complexes involved in exocytosis, it is thought that in intracellular membrane fusion 
events, the Qb- and Qc- chains are provided by separate SNAREs (Fasshauer et al., 1998b) 
and therefore requires the concerted action of four independent SNARE motifs/ proteins. 
This proposal has been supported by biophysical and reconstitution experiments (Antonin 
et al., 2002; McNew et a l, 2000; Nicholson et al, 1998; Parlati et al, 2002; Paumet et al,
2001).
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Figure 1.6 SNARE proteins form a four-helical bundle complex that drives membrane 
fusion (taken from Chen and Scheller, 2001)
a) VAMP (blue) on the vesicle interacts with STXla (Syntaxin in this figure, red) 
and SNAP-25 (green) on the PM to form a four-helix bundle that zips-up 
concomitant with bilayer fusion.
b) The backbone of the SNARE complex is shown on the left (Sutton et al., 1998), 
with the central ionic layer (red) and 15 hydrophobic layers (black) that mediate 
the core interactions highlighted. Top-down views of side-ehain interactions are 
shown on the right, with the four SNARE helices shown as ribbons. The ball and 
stick structures represent the indicated amino acids; the dotted lines represent 
hydrogen bonds or salt bridges that stabilise interactions between SNAREs. Q- 
SNAREs and R-SNAREs are characterised by a glutamine (Q) or arginine (R) 
residue, respectively, in the central layer of the SNARE complex
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1.5.5, Syntaxins
Syntaxins comprise the largest SNARE family identified to date (reviewed in Teng et al.,
2001) with 15 genes in mammals and 7 in yeast (Gerst, 1999). Their importance is 
emphasised by the presence of Syntaxin-like sequences in all eukaryotes examined to date 
(Teng et al., 2001). Syntaxins were originally described as two 35 kDa proteins (now 
known as STXla and STXlb) that interact with the synaptic-vesicle protein synaptotagmin 
(Bennett et ah, 1992). Typically, Syntaxins are proteins of about 300 amino acids. 
Subsequently, a number of the members of Syntaxin family were identified in a variety of 
membrane compartments of the exocytic and endocytic pathways of eukaryotic cells 
(Figure 1.4).
STXs 1,2,3 and 4 are predominantly localised to the PM where they take part in 
constitutive and regulated vesicle transport to the PM (Bennett et al., 1993; Inoue et al., 
1992). STX5 is localised to the Golgi (Dascher et al., 1994). The majority of STX6 (Bock 
et ah, 1997), STXIO (Tang et al, 1998b), STXll (Valdez et a l, 1999) and STXlb 
(Simonsen et al, 1998; Tang et al, 1998a) are localised to the TGN. Recently, STXs 6, 8 
and 10 have been classified as Qc-SNAREs, rather than Qa-SNAREs based on the genome 
scale comparison of SNARE-motif sequences described above (Bock et al, 2001). STX7 
(Wong et al, 1998), STX8 (Subramaniam et al, 2000) and STX 12 (Tang et al, 1998c) 
which is considered to be identical to STX13, are localised in post-Golgi endosomal 
membranes. STX 17 is distributed in smooth endoplasmic reticulum (Steegmaier et al, 
2000) and STX18 in the endoplasmic reticulum (Hatsuzawa et al, 2000).
Syntaxins share similar stmctural features like those described above for STXla (Section 
1.5.2) (reviewed in Teng et al, 2001). All mammalian Syntaxins except STXl 1 are type II 
integral membrane proteins anchored to the membrane by their C-terminal tail. The TM 
tail anchor is essential for Syntaxin membrane localisation, but in most cases it is not 
sufficient for targeting to specific membranes. Compartmental targeting signals, which are 
ill defined, reside in the targeting domains. The cytosolic N-terminus contains several 
hydrophobic regions with the potential to form coiled-coil a-helical structures. Four such 
domains have been recognised from the majority of Qa-SNAREs. One of these comprises 
the characteristic membrane proximal SNARE motif of approximately 60 residues. The 
remaining three domains may constitute the existence of Habc domains, similar to that 
proposed for STXla. N-terminal domains of Syntaxin are conserved between Syntaxins
M l
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that function in the same trafficking pathway. These domains were found to be different 
between Syntaxins that function at different trafficking steps (Weimbs et ah, 1997).
1.5.6. SNAP-25
SNAP-25 was first identified as a 206 amino acid synaptosomal protein expressed in 
neuronal tissues (Oyler et al., 1989). As described above, SNAP-25 contributes two 
SNARE motifs, separated by a cysteine rich linker region, to the neuronal SNARE 
complex and as such has been categorised as a Qbc-SNARE. Subsequently, two 
ubiquitously expressed homologs SNAP-23 and SNAP-29 were described (Hodel, 1998; 
Steegmaier et ah, 1998) with highly conseiwed N- and C- terminal domains also predicted 
to form coiled-coil structures. Like SNAP-25, SNAP-23 is primarily localised to the PM 
and confers membrane attachment tlirough palmitoyl residues that are thioester linked to 
four adjacent cysteine residues located in the middle of the protein (Hodel, 1998). While 
SNAP-25 is involved in synaptic vesicle exocytosis (Section 1.5.2), SNAP-23 has been 
implicated in the exocytosis of GLUT4 containing vesicles with the PM in conjunction 
with STX4 in muscle and fat cells (Section 1.7.7). SNAP-29 is predominantly found in 
intracellular membranes and lacks this cysteine rich palmitoylation site and is thought to be 
associated with membranes by interaction with other membrane proteins such as Syntaxins 
(Steegmaier et ah, 1998).
1.5.7.SM proteins
SM (Secl/Muncl8) proteins are a family of hydrophilic 60-70 kDa polypeptides that share 
homology evenly tliroughout their sequence (reviewed in Rizo and Sudhof, 2002). Seel 
was discovered in screens for genes involved in the yeast secretory pathway (Steegmaier et 
ah, 1998), whereas its mammalian homolog MunclSa was isolated due to its ability to bind 
to STXla (Hata et ah, 1993). Members of the family are now refeiTcd to as SM 
(Secl/Muncl8) proteins. Various studies indicate that SM proteins are essential for fusion. 
For example, neurotransmitter release and /or general secretion can be completely blocked 
by mutations in SM proteins (Harrison et ah, 1994; Hosono et ah, 1992; Ossig et al., 1991; 
Schekman, 1992; Verhage et ah, 2000), and further studies have indicated that all types of 
intracellular membrane traffic require an SM protein, similar to the requirement for 
SNAREs (reviewed in Rizo and Sudhof, 2002).
As mentioned previously, the SM protein involved in neuronal exocytosis, MunclSa, binds 
tightly to the closed conformation of STXla (Hata et ah, 1993) and this binding is not
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compatible with SNARE complex formation. This appears to be the general trend, with 
each SM protein associated with a cognate Qa-SNARE or Syntaxin molecule. However, 
the mode of binding to the cognate Syntaxin remains controversial. Studies involving 
STXla and MunclSa led to the general belief that all SM proteins function by binding to 
the closed confonuation of the corresponding Syntaxin. However, where the yeast plasma 
membrane Syntaxin Ssolp adopts a closed conformation (Munson et al., 2000), the 
coiTesponding SM protein Seclp binds to core complexes containing Ssolp rather than to 
isolated Ssolp (CaiT et al., 1999). In addition, the yeast vacuolar Syntaxin Vam3p does not 
adopt a closed confonuation and its SNARE motif is sufficient to capture the SM protein 
Vps33p from yeast extracts (Dulubova et al., 2001). More recently, it was shown that the 
yeast ER and Golgi Syntaxins, Ufelp and SedSp, bind to the SM proteins tluough a novel, 
evolutionarily conserved mode that involves a short peptide motif at the very N-terminus 
of Ufelp and SedSp (Yamaguchi et al., 2002). Figure 1.7 shows the two hypothesised 
modes of binding between SNAREs and SM proteins, with the general belief that 
complexes involved in exocytosis may follow the STXl a/Munc 18a mode of binding, 
whereas those involved in intracellular complexes the SM protein binding is compatible 
with SNARE complex formation (Rizo and Sudhof, 2002).
Since Muncl8a is essential for exocytosis (Verhage et ah, 2000), it was suggested that SM 
proteins may somehow assist in core complex assembly (Misura et ah, 2000; Munson et 
ah, 2000). However, the exact function of SM proteins remains ambiguous, with studies 
suggesting that they may exert both positive and negative regulatory effects on SNARE 
complex formation. It has also been suggested that they may play a role in stabilising the 
associated syntaxin (Bryant and James, 2001).
1.5.8.Regulation of SNARE complex formation
A  plethora of molecules are known to bind to SNAREs, either directly or indirectly, and in 
doing so to exert regulatory effects on them. These molecules include synaptotagmin, 
GATE-16, LMAl, Muncl3/UNC13, synaptophysin, tomosyn, and Vsml. A detailed 
discussion of all of these potential regulatory molecules is beyond the scope of this thesis. 
For more information refer to the excellent review by J.E. Gerst (Gerst, 2003). Most 
relevant to this study is the possible regulation provided by SM proteins, the presence of a 
Syntaxin autoinhibitory domain (both of which will be considered in Chapter 4) and 
phosphorylation (Chapter 3).
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Figure 1.7 Two different modes of coupling between Syntaxins and SM proteins (taken 
from Rizo and Sudhof, 2002)
a) In neuronal exocytosis (Section 1.5.2), the interaction between MunclSa (Muncl8-1 
in this figure, grey) and the closed conformation of STXla (Syntaxin 1 in this figure, 
yellow and orange) (Dulubova et al., 1999; Misura et al., 2000) is incompatible with 
formation of the core complex by the SNARE motifs of STXla, SNAP-25 and VAMP2.
b) The interaction of Syntaxin amino-terminal peptide motifs with Seel/Muncl 8 
homologs (SM proteins) that occurs in the ER, the Golgi apparatus, TGN and the EE is 
fully compatible with core-complex formation (Dulubova et al., 2002).
Orange, STXla Habc domain; yellow, STXla SNARE motif; red, VAMP2 SNARE 
motif; blue, SNAP-25 N-terminus SNARE motif; green, SNAP-25 C-terminus SNARE 
motif.
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1.6. Syntaxin 16 (STXl 6)
1.6.1.STX16
STXl 6, the key protein in this study, has been implicated as playing a role in GLUT4 
trafficking (Perera et ah, 2003; Shewan et ah, 2003). STXl 6 belongs to the superfamily of 
SNARE proteins. As a member of the Syntaxin family, STXl 6 is a t-SNARE and more 
specifically, has been categorised as a Qa-SNARE (Bock et al., 2001) (Section 1.5.3).
STXl6 was first cloned and sequenced by Simonsen et. al., who demonstrated that the 
protein exists in tliree spliced forms, STXl6A, STX16B and STX16C (Simonsen et al., 
1998). The investigators searched the expressed sequence tag (EST) database of randomly 
sequenced cDNAs for sequences similar to the C-tennini of Syntaxins, After identifying a 
Syntaxin-like EST ft'om human colon (Genbank accession no. AA100145), which 
contained a 246 bp region with Syntaxin homology, they designed PGR primers to amplify 
the ftill-length cDNA from HeLa and brain plasmid cDNA libraries. The two longest HeLa 
cDNAs obtained (STXl 6A and STX16C) were identical, except for a 161 bp insertion and 
a 12 bp deletion in STXl6A compared to STX16C. The STX16C cDNA contained an in- 
frame stop codon instead of the STX16A insert, giving rise to a C-tenninally truncated 
translation product. The longest cDNA obtained from brain (STX16B) was identical to 
STX16A, but it contained in addition a 63 bp insertion. The three forms were supposed to 
originate from alternative splicing of the same transcript. STX16A, STX16B and STX16C 
cDNAs encode proteins of 303, 324 and 115 residues respectively and respective 
molecular masses of 34621 Da, 36840 Da and 13018 Da. The relative tissue distribution of 
each individual STX 16 form could not be determined due to the similarity in size of the 
mRNAs in a Northern Blotting experiment, however, the distribution of the combined 
signal was emiched particularly in the pancreas, followed by skeletal muscle, heart, and 
brain. Epitope-tagged STX16A and STX16B were found to colocalise with the Golgi 
marker p-COP, while STX16C was found in the cytosol. STX16A associated 
posttranslationally with microsomes, and appeared to be transported to the Golgi via the 
endoplasmic reticulum. The authors concluded that the three STXl 6 fonns might have 
different roles in intracellular trafficking. Sequence comparisons with other Syntaxins 
suggested that STXl 6A and STX16B contained the hydrophobic C-tenuinus characteristic 
for Syntaxins, as well as a conserved coiled-coil region, potentially the SNARE domain,
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close to the C-temiinus. STX16C, on the other hand, a truncated version of STX 16A, 
lacked these C-tenuinal coiled-coil and hydrophobic regions characteristic of Syntaxins.
In a similar study to identify and clone potential members of the Syntaxin family, the same 
human EST (Genbank accession no. AA100145) was identified and used as a probe to 
isolate cDNAs from a human pancreas cDNA library (Tang et al,, 1998a). Sequeneing 
revealed an open reading frame encoding a polypeptide of 307 amino acids bearing 
sequence homology to other Syntaxin molecules, with potential coiled-coil domains and a 
21 amino acid carboxy-terminal hydrophobic tail, characteristic of other members of the 
Syntaxin family. The cDNA was highly homologous, but not identical to, both STXl 6A 
and STX16B (Simonsen et ah, 1998) and the N-terminal 115 amino acids were identical to 
STX16C. However, it remained unclear how the sequences were related and so the 
sequence was denoted human Syntaxin 16 or STX16H (Tang et al., 1998a).
The tissue distribution of STX16H was shown to be fairly ubiquitous, being slightly more 
enriched in the heart and the pancreas (Tang et al., 1998a). The Golgi localisation 
described by Simonsen et. a l (Simonsen et al., 1998), was verified when a myc-tagged 
STX16H was localised to the Golgi apparatus by immunofluorescence, showing 
colocalisation with lens culinaris agglutinin, an established Golgi marker (Tang et ah, 
1998a).
A more recent study attempted to characterise the STXl6 splice variants (Dulubova et al., 
2002). The study showed that STX16C is tmncated in the middle of the Habc domain, with 
a stop codon in the middle of the predieted Hy helix. NMR analysis indicated that STX16C 
is largely unfolded and that the only intact functional domain is an N-terminal peptide 
region predicted to bind to its cognate SM protein, mVps45 (Section 1.6.5). STXl 6 A, B 
and H differ in an alternatively splieed region located between the N-temiinal peptide that 
binds to mVps45 and the Habc domain, and NMR analysis of the predicted Habc domain 
STX16H indicated that it does indeed foim a three-helix bundle. The investigators also 
highlighted the presence of another STXl 6 splice variant, STX16D, which contains a stop 
codon after the Habc domain but before the SNARE domain (Dulubova et al., 2002). The 
sequences of the known STXl6 spice variants are compared in Figure 1.8. Although 
northern blot analysis indicated that the STXl 6 splice variants are unifoimly expressed in 
all tissues (Simonsen et al., 1998; Tang et al., 1998a), only one immunoreactive band, 
corresponding to the full length protein, was expressed in all tissues tested with the highest 
abundance in brain (Dulubova et ah, 2002), suggesting that the truncated variants were not 
normally present at detectable steady-state levels, especially in brain.
mi
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Despite the discrepancies in nomenclature and sequences described above, recent studies 
refer to the full-length protein in various cell types, such as HeLa cells and 3T3-L1 
adipocytes, simply as STXl6 (Dulubova et al., 2002; Mallard et al., 2002; Perera et ah, 
2003; Shewan et ah, 2003). In this study, I investigated the function of overexpressed 
STX16A (Simonsen et. ah, 1998) and endogenous murine STXl6 expressed in 3T3-L1 
adipocytes. For simplicity, these full-length molecules will be referred to henceforth as 
STXl 6.
STXl 6 has been shown to interact with STX6 (Mallard et ah, 2002; Perera et ah, 2003; 
Shewan et ah, 2003), another SNARE protein previously implicated in GLUT4 trafficking, 
and the SM protein mVps45 (Dulubova et ah, 2002). Each of these important molecules, 
including the yeast homolog of STXl 6, Tlg2p (Abeliovich et ah, 1998), will be considered 
below.
1.6.2. Syntaxin 6 (STX6)
STX6 is perhaps one of the most distant members of the Syntaxin family, due to its ability 
to exhibit both Qa- and Qc-SNARE behaviour (reviewed in Wendler and Tooze, 2001). 
STX6 was originally identified through its homology to the yeast Qa-SNARE Pepl2p, 
however, it was also shown to share significant homology with the C-terminus of SNAP- 
25 (Bock et ah, 1996). As such, despite its classification as a Syntaxin, STX6 has been 
categorised as a Qc-SNARE (Section 1.5.3) (Bock et ah, 2001). Interestingly, the crystal 
structure of the N-terminal domain of STX6 was recently solved and revealed strong 
stmctural similarity to the Syntaxin family members STXla and Ssolp, despite a very low 
level of sequence similarity (Misura et ah, 2002). However, the STX6 SNARE motif was 
able to substitute for the C-temiinal SNARE motif of SNAP-25, supporting its 
classification as a Qc-SNARE. The closest yeast homolog of STX6 is therefore considered 
to be Tig Ip (Bock et ah, 2001), which is known to fonn a SNARE complex with the 
STXl 6 homolog Tlg2p (Section 1.6.4)
STX6 is a 255- amino acid protein, expressed in a variety of cell types with higher 
expression levels in brain, lung and kidney (Boek et ah, 1996). STX6 contains a C-terminal 
transmembrane anchor, and two N-terminal regions, denoted HI and H2, which mediate 
interactions with other proteins, each with a high probability of forming coiled-coils (Bock 
et ah, 1996). The membrane proximal H2 domain, showed similarity to the STXla 
SNARE motif, and was therefore predicted to represent the SNARE motif, whereas the 
more amino terminal HI domain was suggested to be involved in a-SNAP binding (Bock
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et al., 1996). Another function was suggested for the H2 domain in conferring TGN 
localisation (Watson and Pessin, 2000). This domain was also predicted to function in 
concert with a PM retrieval signal (YGRL), located between the HI and H2 domains, to 
maintain STX6 in the TGN (Watson and Pessin, 2000).
The high SNARE-pairing specificity observed between SNAREs involved in exocytosis, 
such as the neuronal SNARE complex (Section 1.5.2), appears to be less important for 
SNAREs that take part in intracellular membrane fusion. STX6 is a classic example of this 
scenario, as studies show it is found in many intracellular compartments and can associate 
with multiple SNARE partners, in addition to STX16, suggesting it is involved in multiple 
membrane-trafficking events (Wendler and Tooze, 2001). In addition, recent studies 
suggest that STX6 may exhibit cell-type specific function and SNARE-hinding specificity 
(Wendler and Tooze, 2001).
As anticipated for a Qc-SNARE, STX6 has been found associated with a number of R-, Qa 
and Qb-SNAREs. The R-SNAREs include cellubrevin and / or VAMP2, VAMP4, VAMP7 
and VAMPS (Bock et al., 1997; Steegmaier et al., 1999; Wade et al., 2001). Along with 
VAMP7 and VAMPS, STX6 was shown to form a SNARE complex with the Qa-SNARE 
STX7 and the Qb-SNARE Vtilb (Wade et al., 2001). Curiously, STX6 was also shown to 
interact with SNAP-25-like Qbc- SNARE proteins, including SNAP-23, during exocytosis 
in human neutrophils, and SNAP-25 and SNAP-29 in PCI2 cells (Martin-Martin et al., 
2000; Wendler et al., 2001). The interaction of STX6 with SNAP-25-like SNAREs, is a 
further indication that the molecule possesses properties of both Qa- and Qc-SNAREs.
STX6 is mainly localised to the TGN in fibroblast cell lines (Bock et al., 1996; Bock et al., 
1997; Klumpennan et al., 1998), suggesting a role for STX6 in trans-Go\^ or post Golgi 
membrane fusion events. However, a role for STX6 in maturation of immature secretory 
granules (Section 1.4.3) in neuroendocrine cells has also been suggested. STX6 has been 
localised to post-Golgi immature secretory granules in the neuroendocrine PC 12 eell line 
and this study suggested that STX6 is sorted away from these gi'anules during maturation, 
along with MPR-ligand complexes, by AP-1/clathiin coated vesicles, which may then fuse 
with endosomes (Klumperman et al., 1998). These findings were supported by a more 
recent study, in which STX6 was shown to be absent from mature secretoiy granules in 
PC 12 cells (Wendler et al., 2001). In the same study STX6 was shown to be required for 
the homotypic fusion of immature secretory granules and that its presence was required on 
both the donor and aceeptor membranes (Wendler et al., 2001).
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1.6.3.STX16 and STX6 binding
STX16 and STX6 have been shown to interact in a number of systems, for example in 
3T3-L1 adipocytes and synaptosomes (Kreykenbohm et al., 2002; Perera et al., 2003). 
Mallard et. al. demonstrated that STX6 and STX16 form part of a SNARE complex with 
the t-SNARE Vtila, and the v-SNAREs VAMP3 and VAMP4 in HeLa cells (Mallard et 
al., 2002). This SNARE complex was shown to control trafficking of cargo between 
endosomes and the TGN.
The interaction between the Qa-SNARE, STX16 and the Qc-SNARE STX6 has been 
proposed to be similar to that between SNAP-25 and STXla in the foimation of the 
neuronal SNARE complex described in Section 1.5.2.
1.6.4. Yeast homolog -  Tig2p
Tlg2p, the yeast homolog of STX16, is localised to the TGN and early endosomes in yeast, 
and plays a critical role in membrane traffie in these compartments. Recent work in our 
laboratory demonstrated that STX16 was able to compliment Tlg2p in yeast lacking Tlg2p 
(Marion Symington Struthers, unpublished data).
Tlg2p is a 396 amino acid protein with a putative SNARE motif (based on the sequence 
homology among the SNARE motifs Ifom the Syntaxin family) followed by a 
transmembrane region and a 63 residue C-terminal sequence that is unusual in the Syntaxin 
family and is not essential for Tlg2p function (Abeliovich et al., 1998; Dulubova et al.,
2002).
Cells lacking Tlg2p exhibit defects in endocytosis, in soiling of vacuolar proteins such as 
carboxypeptidase Y, and in retrieval of TGN-resident proteins such as Kex2p (Abeliovich 
et al., 1998; Holthuis et al., 1998b). In addition, Tlg2p carries out a number of other 
functions, which are beyond the scope of this thesis but are described elsewhere 
(Abeliovich et al, 1999; Brickner et al, 2001; Lewis et al, 2000; Panek et al, 2000; Seron 
et al, 1998). The SNARE Vtilp and the STX6 homolog, Tlglp are required for some of 
these trafficing events, and both co-immunoprecipitate with Tlg2p, suggesting that they 
participate in a common SNARE complex (Coe et al, 1999; Holthuis et al, 1998a). As 
mentioned previously STX16, STX6 and Vtila, the putative mammalian homologs of 
Tlg2p, Tlglp and Vtilp, have been implicated in EE to TGN transport (Mallard et al,
2002). The yeast Tig SNAREs also co-immunoprecipitate with the v-SNARE Snclp or the
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closely related Snc2p (Abeliovich et ah, 1998; Holthuis et ah, 1998a). Wliile these v- 
SNAREs mediate exocytosis, they also function in endocytosis (Gurunathan et ah, 2000). 
The notion that Snclp or Snc2p can form a functional core complex with 
Tlg2p/TlglpWtilp acting as the t-SNAREs was recently supported by experiments with 
recombinant proteins reconstituted into liposomes (Paumet et ah, 2001).
Tlg2p interacts physically and functionally with Vps45p, the SM protein involved in 
TGN/early endosomal transport (Abeliovich et ah, 1999; Brickner et ah, 2001; Bryant and 
James, 2001).
1.6.5.mVps45
The mammalian homolog of Vps45p, mVps45 (Tellam et ah, 1997), was recently shown to 
bind directly to STX16 (Dulubova et ah, 2002; Yamaguchi et ah, 2002). mVps45 is a 
ubiquitously expressed SM protein with a predicted molecular mass of 65 kDa, which 
localises to perinuclear Golgi-like and TGN compartments in CHO cells. The tissue 
distribution was found to match that of STX6 and conespondingly, it was shown to 
interact weakly with STX6 (Bock et ah, 1996; Bock et ah, 1997; Tellam et ah, 1997) 
although the interaction was quantitatively less than that observed between other SM 
protein / Syntaxin isofoims. This weak interaction could be explained by indirect binding 
to STX6, as more recently, mVps45 was shown to bind directly to STX16, which also 
binds to STX6 (Dulubova et ah, 2002; Perera et ah, 2003; Yamaguchi et ah, 2002). Like 
other SM proteins, mVps45 is a cytosolic protein, but confers membrane association 
presumably tlrrough its interaction with STX6 (Bock et ah, 1997) or STX16 .
Dulubova et. al. demonstrated that mVps45 binds directly to STX16 through an 
evolutionarily conserved peptide motif in the N-terminal 55 residues of the protein in a 
mode of interaction identical to Tlg2p binding to Vps45p (Dulubova et ah, 2002). 
Sequence alignments suggested that STX16 has a similar domain structure to Tig2p, with 
the well-conserved N-terminal peptide motif responsible for binding to mVps45, and an 
Habc domain characteristie of Syntaxins (Dulubova et ah, 2002). A matter of current debate 
is whether all Syntaxins ean adopt a closed conformation similar to STXla, required for 
binding to the associated SM protein (Section 1.5.7). Although Dulubova et. al 
demonstrated that Tlg2p does not adopt a closed conformation (Dulubova et ah, 2002), 
STX16 was not tested in this regard. This possibility will be considered elsewhere in this 
thesis.
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Figure 1.8 Naturally occurring STX16 splice variants (adapted from Simonsen et al., 1998 
and Dulubova et al., 2002)
A) Domain structures of STX16A, B and C. STX16A consists of an N-terminal motif 
predicted to facilitate binding of mVps45 (green), followed by the Habc domain (blue), 
the SNARE motif (pink) and a C-terminal transmembrane domain (purple). STX16B is 
identical, except for a 21 amino acid insertion (red), predicted to occur between the 
mVps45 binding motif and the Habc domain. STX16C is truncated in the middle of the 
predicted Hy helix. B) Sequence comparisons of STX16 (Syntl6 in this figure) A, B, C, 
D and H. Asterisks, positions of stop codons; dashes, gaps; double underlined sequence, 
N-terminal peptide sequence that binds to mVps45; sequences in bold, predicted _- 
helices of the Habc domain (based on sequence comparison with Tlg2p); italicised 
sequence underlined with a dotted line, SNARE motif; boxed sequence, transmembrane 
domain. Numbers on the right correspond to STX16H splice variant.
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1.7. Intracellular trafficking of GLUT4
As described in Section 1.2.1, insulin stimulates glucose uptake in muscle and fat cells by 
triggering the translocation of the glucose transporter, GLUT4, from an intracellular 
compartment to the cell surface (Bryant et al., 2002; Pessin et al., 1999; Watson et al.,
2004). Section 1.7 will detail the current knowledge involving the intracellular trafficking 
of GLUT4, concluding with the cuii’ent accepted model for insulin-stimulated GLUT4 
translocation.
1.7.1.Intracellular locations of GLUT4
In contrast to the other members of the facilitative glucose transporter family (Section 1.2), 
GLUT4 is almost completely intracellularly localised under basal conditions and exhibits a 
complex intracellular itinerary. In the absence of insulin, > 90 % of cellular GLUT4 is 
intracellularly sequestered and has been localised to the endosomal system, the TGN and a 
tubulo-vesicular compartment present throughout the cell (Martin et al., 1994; Martin et 
al., 2000a; Ploug et al., 1998; Ramm et al., 2000; Slot et al., 1991b; Slot et al., 1997). In 
response to insulin, GLUT4 levels in each of these regions are decreased in parallel with 
the movement of GLUT4 to the cell surface (Martin et al., 1994; Ploug et al., 1998; Ramm 
et al., 2000; Slot et al., 1991b; Slot et al., 1991a).
1.7.2. Endosomes
Previous studies have indicated a role for endosomes in GLUT4 trafficking (Livingstone et 
al., 1996; Slot et al., 1991b) but suggest that they may not represent a major storage 
compartment in adipocytes. GLUT4 shows co-localisation with known endosomal 
recycling proteins, for example the TfR (one of the most well studied constitutive recycling 
proteins in mammalian cells (Section 1.4.2)) (Livingstone et al., 1996). However, detailed 
analysis of GLUT4 traffic to and from the cell surface revealed that in non-insulin- 
stimulated adipocytes, the exocytosis of GLUT4 is approximately 10-fold slower than that 
of TfR (Holman et al., 1994; Tamier and Lienhard, 1987). This finding points to the 
intracellular retention of GLUT4 in a more static compartment or futile cycle distinct fi'om 
endosomes. This assumption was verified when chemical ablation of endosomes 
containing the TfR using a transferrin (Tf)-horseradish peroxidase (HRP) conjugate
Kirsty M. Proctor, 2006 Chapter 1, 52
demonstrated that only ~ 30-40 % of intracellular GLUT4 (Livingstone et ah, 1996; Martin 
et ah, 1996) was subject to ablation. Furthermore, it has been shown that following 
endocytosis of GLUT4 from the cell surface, GLUT4 is segregated from the TfR in the 
endosomal system into a separate population of transport vesicles (Lampson et ah, 2001; 
Lim et ah, 2001; Martin et ah, 1996; Sandoval et ah, 2000). The possible nature of these 
vesicles will be considered in Section 1.7.4.
1.7.3. The role of the TGN
Several observations suggest an important role for the TGN in GLUT4 trafficking, 
however, the precise role of this organelle is at present unclear. There is a significant 
amount of GLUT4 in the TGN area in insulin responsive cells (Martin et ah, 2000a; Ploug 
et ah, 1998; Ralston and Ploug, 1996; Slot et ah, 1991b; Slot et ah, 1991a; Slot et ah, 1997; 
Wang et ah, 1996) a proportion of which does not represent newly synthesised protein 
(Slot et ah, 1991b; Slot et ah, 1991a). In addition, there is significant overlap between 
GLUT4 and proteins known to traffic between the TGN and endosomes, including the 
cation-dependent mannose 6-phosphate receptor (CD-MPR) (Martin et ah, 2000a), the 
cation independent mamiose 6-phosphate receptor (CI-MPR) (Kandror and Pilch, 1996b) 
and AP-1 (Gillingham et ah, 1999; Martin et ah, 2000a). By following the internalisation 
of GLUT4 from the cell surface of adipocytes, it has been shown that the transporter is 
transported through endosomes into a perinuclear compartment that is distinct from 
recycling endosomes (Palacios et ah, 2001). More recently, it was shown that this 
perinuclear compartment represents a subdomain of the TGN enriched in STX6 and 
STX16 (Shewan et ah, 2003). Furthermore, in atrial cardiomyocytes, approximately 60 % 
of the entire GLUT4 pool is localised to atrial natriuretic factor (ANF)-containing 
secretory granules and this appears to be due to recycling of GLUT4 through the TGN area 
(Slot et ah, 1997).
1.7.4.GSVS
Various studies suggest that much of the remainder of non-endosomal GLUT4 is localised 
to a population of ill-defined vesicles, commonly called GLUT4 storage vesicles (GSVs) 
(reviewed in Bryant et ah, 2002; Pessin et ah, 1999; Rea and James, 1997) and that the 
majority of GLUT4 that is delivered to the plasma membrane in response to insulin comes 
from these unique vesicles. GLUT4 does not colocalise with other adipocyte secretory 
proteins, such as ACRP30, leptin or adipsin (Barr et ah, 1997; Bogan and Lodish, 1999; 
Millar et ah, 2000), suggesting that GSVs may be specialised vesicles for the translocation
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of GLUT4. However, the nature of these vesicles is largely unknown, with regard to 
whether they represent a static or dynamic recycling pool of GLUT4 in the absence of 
insulin.
Some studies suggest the existence of a more static secretory pool of insulin-responsive 
GLUT4, that is analogous to small secretory vesicles present in neuroendocrine tissues and 
that these can move directly to the cell surface in response to insulin. For example, a 
discrete population of small (50 nm diameter) vesicles, devoid of other recycling proteins, 
such as the TfR and the CD-MPR were identified in insulin-responsive cells (Hashiramoto 
and James, 2000; Kandror and Pilch, 1996a; Ramm et al., 2000). These vesicles were 
highly responsive to insulin and were emiched in the v-SNARE VAMP2 (the same v- 
SNARE that is involved in the exocytosis of synaptic vesicles with the PM (Section 1.5.2)) 
suggesting that they may move directly to the cell surface in response to insulin.
On the other hand, some evidence points to the dynamic recycling of GLUT4 between 
intracellular compartments, perhaps in some futile cycle. For example, the presence of 
GLUT4 in AP-l/clatlirin coated intracellular transport vesicles suggests that GLUT4 is not 
restricted to a stable storage compartment within the cell (Gillingham et ah, 1999; Martin 
et al., 2 0 0 0 b).
1.7.5.Biogenesis of GSVs
Little is known about the biogenesis of the GSV compai-tment. Because GLUT4 is present 
in both the endosomes and the TGN, it has been speculated that GSVs may arise from 
either or both of these compartments (Rea and James, 1997). However, it seems plausible 
that transit tlrrough the TGN precedes the packaging of GLUT4 into its insulin-responsive 
compartment because prolonged incubation of adipocytes at 19 “C, a temperature that 
blocks exit fi'om the TGN, inhibits insulin action (Robinson and James, 1992).
1.7.6.Targeting signals on GLUT4
The existence of such a complex intracellular itinerary suggests that GLUT4 trafficking 
must be controlled at various cellular locations by the presence of a number of targeting 
signals. Indeed, two such signals have been identified which mediate GLUT4 endocytosis. 
GLUT4 is localised to AP-2 / clatlrrin coated pits at the cell surface and is endocytosed via 
a clathrin-mediated process (Kao et al., 1998; Robinson et al., 1992). This is regulated by 
two endocytosis motifs in GLUT4; a dileucine motif in the C-terminus and an aromatic
''■t
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amino acid-based motif in the N-terminus (Garippa et al, 1994; Garippa et al., 1996; Kao 
et ai., 1998; Verhey et al., 1995). Furthermore, recent studies identified the presence of a 
targeting domain in the C-terminus of GLUT4 distal to the di-leucine motif (Shewan et al.,
2000), which is responsible for the targeting of GLUT4 to the TGN subdomain enriched in 
STX6  and STX16 mentioned above.
1.7.7.SNAREs involved In GLUT4 vesicle fusion with the PM
In order to increase the concentration of GLUT4 at the PM in response to insulin, it is 
necessary for GSVs to fuse with the PM, following translocation from their intracellular 
location. This event is mediated, at least in part, by a specific set of SNARE proteins (Chen 
and Scheller, 2001; Jahn and Sudhof, 1999) that are essential in the fusion step (Foster and 
Klip, 2000). As mentioned previously, GSVs were shown to be emiched in the v- SNARE 
VAMP2 (Martin et ah, 1996). VAMP2 has been shown to fonn a complex with the t- 
SNAREs STX4 and SNAP-23, which are highly enriched in the PM of muscle and fat cells 
(Foster and Klip, 2000). The importance of these proteins was evidenced by the use of 
clostridial toxins that selectively cleaved both VAMP2 and VAMP3, blocking the insulin - 
dependent translocation (Cheatham et al., 1996; Chen et al., 1997; Foran et al., 1999; 
Randhawa et al., 2000; Tamori et al., 1996), and recombinant forms of these SNAREs, 
which also interfered with the insulin-dependent GLUT4 translocation (Cheatham et al.,
1996; Martin et al., 1998; Olson et al., 1997). Muncl8 c has been identified as the SM 
protein that controls the foimation of this ternary complex (Foster and Klip, 2000). Figure 
1.9 (insert) depicts this SNARE complex.
1.7.8.GLUT4 Trafficking Model
To account for the findings described above, several models of GLUT4 traffic have been 
proposed which can be summarised as follows: GLUT4 could be selectively retained in a 
sub-domain of the endosomal system or another of its intracellular locations; packaged into 
specialised secretory vesicles that are mobilised only in response to insulin; or 'trapped' in 
a futile trafficking cycle within the cell which diverts the molecule away from recycling 
endosomes and thus away from the cell surface. There is evidence in the literature in 
support of each of these models (reviewed in Bryant et al., 2002), however, in reality, the 
situation is likely to posses features of each of these three extreme models.
Bryant et. al. (Bryant et al., 2002) suggested a model to accommodate the conflicting 
evidence on GLUT4 trafficking (Figure 1.9). In this model, GLUT4 is engaged in two
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intracellular cycles: a fast trafficking event between the PM and endosomes and a more 
slowly recycling pool between endosomes and the TGN. In this model, insulin-responsive 
GSVs arise from the TGN and may represent a more static pool of vesicles that are only 
mobilised in response to insulin, however, it is suggested that they may slowly fuse with 
endosomes to prevent depletion of GLUT4 in the other locations.
This model therefore supposes that GLUT4 is intracellularly sequestered in the absence of 
insulin by a mechanism that excludes it from the endosomal system and involves the 
packaging of GLUT4 into an insulin-responsive vesicular compartment. The molecular 
mechanisms that control these intracellular steps remain largely unknown.
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Figure 1.9 A model depicting the transport of GLUT4 in insulin responsive cells (from 
Bryant et al., 2002)
In this model, GLUT4 occupies two intracellular recycling pathways: cycle 1, between 
the cell surface and endosomes and cycle 2, between endosomes and the TGN. GLUT4 
is sorted into a secretory pathway in the TGN, which may involve the biogenesis of the 
GSVs. This insulin-responsive compartment may contain the majority of the non- 
endosomal GLUT4. In the absence of insulin, GSVs might slowly fuse with endosomes 
to prevent depletion of GLUT4 in other locations. In response to insulin, the GSVs 
would translocate to and fuse with the PM.
The insert shows the SNARE proteins that are thought to regulate docking and fusion of 
GSVs with the cell surface (Foster and Klip, 2000). The t-SNAREs STX4 and SNAP- 
23 in the PM of fat and muscle cells form a ternary complex with the v-SNARE 
VAMP2, which is present on GSVs. MuncISc has been identified as the SM protein 
that controls the formation of this ternary complex.
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1.8. STX16 in GLUT4 trafficking
1.8.1.Evidence implicating STX6 and STX16 in trafficking of 
GLUT4
There is much evidence to suggest a role for STX6  and STX16 in GLUT4 trafficking in 
adipocytes. As mentioned previously, a STX6/STX16 interaction was demonstrated in 
3T3-L1 adipocytes (Perera et al., 2003; Shewan et al., 2003) and so it is anticipated that 
they will act in the same SNARE complex to influence GLUT4 trafficking.
The characteristic ability of 3T3-L1 adipocytes to fomi an insulin-responsive GLUT4 
compartment is markedly upregulated soon after adipocyte differentiation (El Jack et al., 
1999), suggesting that the machinery required for the biogenesis of this compartment 
might be specifically upregulated in these cells. Interestingly, the expression of STX6  and 
STX16 is upregulated during adipocyte differentiation (Shewan et ah, 2003). In addition, 
both STX6  and STX16 display insulin-stimulated translocation to the PM in 3T3-L1 
adipocytes (Perera et al., 2003; Shewan et ah, 2003). It has previously been shown that not 
all TGN proteins undergo insulin-responsive movement to the cell surface (Martin et ah, 
1994). Insulin caused a slight increase in surface levels of STX13, an endosomal t-SNARE 
involved in the recycling of the TfR, but quantitatively less than for STX6  or STX16 
(Perera et ah, 2003). Also the kinetics of STX6  translocation to the cell surface were 
identical to those of GLUT4, suggesting that GLUT4 and STX6  are transported in the 
same vesicle to the plasma membrane upon insulin stimulation. In support of this finding, 
STX6  and STX16 were shown to co-localise extensively with GLUT4 (Perera et ah, 2003). 
Wliile STX7, STX8 and STX12 are present in GSVs to some extent, only STX6  and 
STX16 exhibited extensive overlap with GLUT4. Immuno-isolation of GLUT4 containing 
vesicles showed that ~ 85 % of the cellular STX6  and STX16 was present in GLUT4- 
containing vesicles (Perera et ah, 2003). As mentioned previously, GLUT4 was shown to 
traffic from the cell surface to a TGN subdomain emiched in STX16 and STX6  via early 
endosomes and an acidic targeting motif in the C-teiminal tail of GLUT4 was shown to 
play an important role in this process (Shewan et ah, 2003).
Previous work in our laboratory tested STX6  for its involvement in GLUT4 trafficking. 
The dominant negative cytosolic domain of this protein was expressed in 3T3-L1
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adipocytes and was shown to peiturb GLUT4 trafficking (Perera et ah, 2003). Cells 
overexpressing STX6  cytosolic domain exhibited increased levels of basal transport, but 
the ability of insulin to stimulate glucose transport and GLUT4 translocation was not 
impaired. In addition, the ability of GLUT4 to be reintemalised from the cell surface was 
significantly slowed. This data was rationalised within a model that suggested STX6  was 
involved in the intracellular sequestration of GLUT4 in 3T3-L1 adipocytes. The role of 
STX16 was not addressed in this regard. As such, Chapters 4 and 5 of this thesis directly 
investigate the role of STX16 in GLUT4 trafficking.
1.8.2.Phosphorylation ofSTXIS
Perhaps one of the most compelling pieces of evidence that suggests a role for STX16 in 
the regulation of GLUT4 trafficking comes from previous work in our laboratoiy (Perera et 
al., 2003). STX16 was shown to be a phosphoprotein in 3T3-L1 adipocytes and 
interestingly, acute insulin stimulation causes approximately a 50 % decrease in 
phosphorylation. Studies of other SNAREs have suggested that dephosphorylation of t- 
SNAREs could regulate the foimation of a functional SNARE complex (Gerst, 2003). It 
was therefore speculated that STX16 may be involved in regulating the formation of a 
SNARE complex, perhaps involving STX6 , which may be involved in GLUT4 trafficking. 
This will be considered further in Chapter 3 of this thesis.
I-
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1.9. Hypothesis
STX16 is upregulated upon differentiation of 3T3-L1 fibroblasts into adipocytes (Shewan 
et ah, 2003), suggesting that it may be part of the machinery required for GLUT4 
trafficking in these highly differentiated cells. The presence of STX16 in multiple GLUT4 
containing compartments, such as the TGN and GSVs (Perera et ah, 2003; Shewan et al., 
2003), combined with its intriguing translocation to the cell surface in response to insulin, 
suggests a role for STX16 in the intracellular sorting or the translocation of GLUT4 to the 
cell surface. Combined with this is the curious dephosphorylation of STX16 following 
insulin stimulation (Perera et ah, 2003), suggesting a role for STX16 in the regulation of 
this process. With these thoughts in mind I offer the following hypotheses for this thesis:
• STXl 6  plays a key role in the sorting / translocation of GLUT4
• The phosphorylation status of STXl6  regulates SNARE complex assembly 
(perhaps with STX6 ), which ultimately controls GLUT4 sorting / translocation
These hypotheses are depicted in Figures 1.10 and 1.11 and were tested experimentally in 
this thesis.
1.10. Aims
The ultimate aim of this thesis was to determine the role, if any, that STXl 6  plays in 
GLUT4 trafficking in 3T3-L1 adipocytes, and additionally, to determine if the 
phosphorylation status of STXl 6  was responsible for the regulation of this process. The 
main aims of each Chapter are summarised as follows:
Chapter 3: identification of the site of insulin-regulated phosphorylation and SNARE 
binding partners of STXl 6  in basal and insulin-stimulated 3T3-L1 adipocytes
Chapter 4: optimisation of adenovirus-mediated expression of STXl6  mutants and full- 
length STXl6  in 3T3-L1 adipocytes
Chapter 5: the effects of expression of these proteins, as well as knockdown of endogenous 
STXl 6 , on GLUT4 trafficking in 3T3-L1 adipocytes
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Figure 1.10 A model depicting the potential involvement of STX l6 in GLUT4 trafficking 
in adipocytes (adapted from Bryant et al., 2002)
In this model, GLUT4 occupies two main intracellular recycling pathways. Cycle 1: 
GLUT4 recycles between the cell surface and endosomes, showing co-localisation 
with molecules such as the TfR. Cycle 2: GLUT4 is sequestered away from the 
endosomal system and recycles more slowly between the TGN and endosomes. 
Insulin-responsive GSVs, enriched with VAMP2 may bud from the TGN.
1 hypothesise that STXl6  is involved in the intracellular sorting (steps 1 or 2, mauve 
arrows) and / or the translocation (step 3, blue arrow) of GLUT4.
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Figure 1.11 Model depicting a possible role of STXl6 phosphorylation in regulation of a 
SNARE complex involved in GLUT4 trafficking
In this model, phosphorylated (purple circle) STXl6  (pink oval) can enter into a 
SNARE complex, perhaps involving STX6  (blue circle), whereas dephosphorylation in 
response to insulin inhibits formation of this SNARE complex. 1 hypothesise that each 
scenario would exert a different regulatory effect on GLUT4 trafficking.
Previous work has suggested that (de)phosphorylation of t-SNAREs could regulate the 
formation of functional SNARE complexes (Gerst, 2003). This model is based on the 
assumption that phosphorylation of STXl 6  will promote SNARE assembly. However, 
the opposite may also be true, a possibility which will be considered in Chapter 3 of 
this thesis. The precise role of STXl 6  in GLUT4 trafficking will also be explored.
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2. Materials and Methods
2.1. Materials
Materials used in this study were obtained from the following suppliers:
2.1.1, General reagents
Ainersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, UK
ECL Western Blotting Detection Reagents 
Horseradish peroxidase (HRP)-conjugated IgG antibodies 
Horseradish peroxidase (HRP)-conjugated protein A 
Protein G Sepharose
Phosphorus-32 (H3^^P0 4 -Orthophosphate in dilute HCl solution)
Anachem Ltd., Luton, Bedfordshire, UK
30 % acrylamide/bisacrylamide
BIOMOL International, LP, Exeter, Devon, UK
MG-132 (Z-Leu-Leu-Leu-CHO), proteasome inhibitor
Bio-Rad Laboratories Ltd, Hemel Hampstead, Hertfordshire, UK
Bradford protein assay reagent
N,N,N ’ ,N ’ -tetramethyl ethyl enediamine (TEMED)
Boehringer Mannheim, Germany
Pro tease inhibitor cocktail tablets: complete™ and complete mini™
Thesit (C12E8: Octaethylene glycol dodecyl ether)
Fischer Scientific Ltd, Loughborough, Leicestershire, UK
Ammonium persulphate 
Calcium chloride (CaCh)
Diaminoethanetetra-acetic acid, disodium salt (EDTA)
Disodium hydrogen orthophosphate (Na2HP0 4 )
D-Glucose
Glycerol
Glycine
N-2-hydroxyethylpiperizine-N’-2-ethanesulphonic acid (HEPES) 
Hydrochloric acid (HCl)
Isopropanol
Magnesium sulphate (MgS0 4 )
Methanol
Potassium chloride (KCl)
Potassium dihydrogen orthophosphate (K H 2 PO4 )
Sodium chloride (NaCl)
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Sodium dihydrogen orthophosphate dihydrate (NaH2P0 4 )
Sodium dodecyl sulphate (SDS)
Sodium hydrogen carbonate (NaHCOs)
Sucrose
Tetra-sodium citrate (Na4C6Hs0 7 )
Trichloroacetic acid (TCA)
Invitrogen, Groningen, The Netherlands
Electroporation cuvettes 
TA Cloning® Kit (pCR2.1)
Kodak Ltd, Hemel Hempstead, Hertfordshire, UK
X-Omat S film
Life Technologies, Paisley, Scotland, UK
Agarose
1 kb DNA ladder
Merck Ltd (BDH), Lutterworth, Leicestershire, UK
Magnesium chloride (MgCh)
Tween 20
Zinc chloride (ZnCh)
MWG-Biotech, Germany
Some oligonucleotide primers
New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK
Pre-stained protein marker, broad range (6-175 kDa)
Novo Nor disk, Denmark
Insulin (Porcine, monocomponent)
Oxoid Ltd, Hampshire, UK
Bacteriological agar
Tryptone
Yeast Extract
Perkinelmer LAS, Boston, USA
Deoxy-D-Glucose (C6H12O5) (deGlc) 2-[l,2-^H (G)]-
Pierce, Rockford, Illinois, USA
Slide-a-lyser™ dialysis cassettes
Premier Brands UK, Knighton, Adbaston, Staffordshire, UK
Marvel powdered milk
Promega, Southampton, UK
All restriction enzymes 
Deoxynucleotide triphosphates (dNTPs)
1 kb DNA Ladder 
Nuclease-ffee water 
Pfu polymerase 
Taq polymerase
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Blue/Orange 6  x D N A  loading dye
Qiagen, Crawley, West Sussex, UK
PhosphoProtein Purification Kit 
QIAprep™ spin maxiprep kit 
QIAprep™ spin miniprep kit 
Qiagen gel purification kit
Sigma-Aldrich Company Ltd., Dorset, UK
Cytochalasin B (CB)
Brij
IBMX (3 -Isobutyl-1 -methylxanthine)
Dexamethasone (9a-fluoro-l 6a-methyl-prednisolone)
Protein A Sepharose
Schleicher &Schell, Dassel, Germany
Nitrocellulose membrane (pore size; 0.45 pM)
Stratagene, La Jolla, CA, USA
Dpnl restriction enzyme (for QuickChange mutagenesis)
TAGN, Gateshead, UK
Some oligonucleotide primers
Whatman International Ltd, Maidstone, UK
Whatman 3 mm filter paper
All other chemicals used were supplied from Sigma Chemical Company Ltd, Poole, 
Dorset, UK.
2.1,2. Cell culture materials
American Type Culture Collection, Rockville, USA
3T3-L1 fibroblasts 
HEK 293 cells
HeLa cells were a kind gift from Pam Scott, University of Glasgow
AS Nunc, DK Roskilde, Denmark CHECK
50 ml centrifuge tubes
13.5 ml centrifuge tubes
Bibby-Sterlin, Staffordshire, UK
Iwaki tissue culture plasticware;
-6-well plates 
-75 cm2 flasks 
-150 cm2 flasks 
Graduated disposable pipettes
Gibco BRL, Paisley, Lanarkshire, UK
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Dulbecco’s modified Eagle’s medium (DMEM) (with 4500 mg/L glucose, without sodium 
pyruvate)
Dulbecco’s phosphate buffered saline (D-PBS)
FBS (USA)
FBS (EU)
L-Glutamine
Lipofectamine 2000 reagent 
Modified Eagles medium (MEM)
NCS
Non-essential amino acids 
Opti-MEM
Penicillin (10000 U/ml)/ Streptomycin (10000 U/ml) (P/S)
Trypsin / EDTA solution
Falcon tissue culture plastic ware, Fred Baker, UK
10 cm  ^dishes 
6-well plates 
12-well plates
Roche Diagnostics Ltd., East Sussex, UK 
Coliagenase D
Sigma-Aldrich Inc., Dorset, UK
Phosphate- free Dulbecco’s modified Eagle’s medium (DMEM) (with 4500 mg/L glucose 
and L-glutamine, without sodium phosphate and sodium bicarbonate)
2.1.3, Plasmids
The pGEM plasmid housing myc-tagged STX16A was a kind gift from H. Stenmark, The 
Norwegian Radium Hospital, Montebello, Oslo, Norway. 
pCR3.1 and pCR2.1 were from Invitrogen Ltd., Paisley, UK 
pShuttle-CMV was from Stratagene, La Jolla, CA, USA
2.1.4. Primary antibodies
Anti-ACRP30 (polyclonal) was made for this laboratory by Zymed Laboratories, South 
San Francisco, CA (Ewart et al., 2005)
Anti-Glut4 (polyclonal) was prepared previously in this laboratory (Ewart et a l, 2005) 
Anti-IRAP (monoclonal) was a kind gift from Prof. Morris J Bimbaum, University of 
Pennsylvania (Garza and Birnbaum, 2000)
Anti-IRS-1 (polyclonal) was from Ken Siddle, Cambridge, UK
Anti-mVps45 (polyclonal) was from R. Piper, University of Iowa
Anti-myc (monoclonal) was from Sigma-Aldrich Inc., Dorset, UK
Anti-myc (polyclonal) was from Santa-Cruz Biotechnology Inc., California, USA
Anti-PKB was from New England Biolabs (UK) Ltd., Herts, UK
Anti-STX16 (polyclonal) was from B.L. Tang and Wanjin Hong, Membrane Biology 
Laboratory, Institute of Molecular and Cell Biology, Singapore
Anti-STX4 (polyclonal) was from Prof David James, University of Queensland, Australia 
Anti-STX6 (polyclonal) was generated previously in this laboratory (Perera et a l, 2003)
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Anti-STX6, Vtila and Vtilb (ail monoclonal) were from BD Transduction Laboratories, 
Lexington, KY
Anti-VAMP2 (monoclonal) was from Synaptic Systems, Goettingen, Gennany 
Anti-VAMP3 / cellubrevin (polyclonal) and Arf6 (monoclonal) were from Abeam Pic., 
Cambridge, UK
Anti-j35 (80 kDa), anti-av (125 kDa), anti-av (25 kDa) and anti-|33 (90-110 kDa) (all 
polyclonal) were from W. Cushley, University of Glasgow
Random IgGs (polyclonal and monoclonal) were from Sigma-Aldrich Inc, Dorset, UK
All primary antibodies were diluted to 1:1000 in PBS-T + 1 % Maiwel (except anti- 
VAMP2, 1:10,000) prior to use.
2A.5.Escherichia coii (E. coii) strains
Supercompetent XL 1-blue were from Stratagene, La Jolla, CA, USA
(Genotype: recAl endAl gyrA96 thi-1 hsdR17supE44 relAl lac [FproAB lacI^ZdMlS
TnlO (Tef)])
Competent TOP 10 were from Invitrogen Ltd, Paisley, UK
(Genotype: F‘ mar A  AQnrr-hsdRMS-mcrBC) ^80/ncZAM15 Alac'XlA recAl araAl39 A 
{ara-leu)1691 galU galK. rpsh (Str^) endAl nupG)
2.1.6. Ceil Culture Media
HeLa growth medium
MEM (minimum essential medium), 10 % (v/v) PCS (EU origin), 1 % non-essential amino 
acids, 2 mM L-glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin
HEK 293 growth medium
DMEM, 10 % (v/v) FBS (EU origin), 2 mM L-glutamine, 100 U/ml penicillin, 100 pg/ml 
streptomycin
3T3-L1 fibroblast growth medium
DMEM, 10 % (v/v) NCS, 100 U/ml penicillin, 100 pg/ml streptomycin 
3T3-L1 adipocyte growth medium
DMEM, 10 % (v/v) FBS (USA origin), 100 U/ml penicillin, 100 pg/ml streptomycin
2.1.7. General Solutions
CsCh gradient:
60 % (w/v) CsCL in 10 mM Tris-HCl pH 7.9 
30 % (w/v) CsCl] in 10 mM Tris-HCl pH 7.9
These solutions were filtered in a fume hood with a 2 pM filter before use.
Lysis buffer
20 mM Tris-HCl, 150 mM NaCl, 1 % (w/v) C^Eg (Thesit), pH 7.4, protease inhibitors
Kirsty M. Proctor, 2006 Chapter 2, 68
Krebs Ringer Phosphate (KRP)
128 mM NaCl, 4.7 mM KCl, 5 mM NaH2P0 4 , 1.25 mM MgS0 4 , 1.25 mM CaCfr, pH7.4 
Krebs Ringer MES buffer (KRM)
128 mM NaCl, 4.7 mM KCl, 5 mM MES, 1.25 mM MgS0 4 , 1.25 mM CaClz, pH6 
HES buffer
255 mM sucrose, 20 mM HEPES, 1 mM EDTA, pH7.4 
HPFEV buffer
50 mM HEPES, 10 mM sodium pyi’ophosphate, 100 mM sodium fluoride, 2 mM EDTA, 2 
mM sodium ortho vanadate (activated) pH 7.4
HU buffer
8 M urea, 5 % (w/v) SDS, 200 mM Tris pH 6.8, 0.1 mM EDTA, bromophenol blue 
Phosphate Buffered Saline (PBS)
136 mM NaCl, 10 mM NaH2P0 4 , 2.5 mM KCl, 1.8 mM KH2PO4, pH 7.4 
Resolving gel buffer (2x)
0.2 % SDS, 4 mM EDTA, 750 mM Tris base, pH 8.9 
Resolving gel
10, 12 or 15 % acrylamide, 1 x resolving gel buffer, 0.2 % (w/v) APS, 0.08 % (v/v) 
TEMED
SDS-PAGE electrode buffer
25 mM Tris, 190 mM, 0.1 % (w/v) SDS
4 X SDS-PAGE sample buffer
250 mM Tris-HCl pH 6.8, 40 % (v/v) glycerol, 12 % (w/v) SDS, 0.05 % (w/v) 
bromophenol blue, 80 mM dithiothreitol (DTT)
Stacking gel buffer (2x)
0.2 % SDS, 4 mM EDTA, 250 mM Tris base, pH 6.8 
Stacking gel
4.5 % acrylamide, 1 x stacking gel buffer, 0.125 % (w/v) APS, 0.125 % (v/v) TEMED 
TAE
40 mM Tris acetate, 1 mM EDTA, pH 7.8 
TE buffer pH 8.0
10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0)
T ransfer buffer
25 mM Tris base, 192 mM glycine, 20 % (v/v) methanol 
Wash buffer
20 mM Tris-HCl, 150 mM NaCl 
2 x  YT
1.6 % (w/v) tryptone, 1 % (w/v) yeast extract, 0.5 % (w/v) NaCl
Kirsty M. Proctor, 2006 Chapter 2, 69
2.1.8. Primers
PCR primers
STX16 pCR3.1
Fwd: 5’-CCGGTACCATGGCCCATATGGAAC-3’
Rev: 5’-CCTCTAGATTATCGAGACTTCAC-3 ’
STX16cyt
Fwd: 5’-AAAGATCTATGGCCCATATGGAACAAAAA-3 ’
Rev: 5’-GGAAGCTTTTACCGATTCTTCTTTTGA-3 ’
STX16T
Fwd:
5’- AGATCTATGTACCCTTACGATGTGCCTGATTACGCAACAGAGGACCAGTTA - 3’ 
Rev: 5’-GGAAGCTTTTATCGAGACTTCACGCCAAC -3’
STX16F
Fwd: 5’-AAAGATCTATGGCCCATATGGAACAAAAA-3’
Rev: 5’-GGAAGCTTTTATCGAGACTTCACGCCAAC -3’
Mutagenesis primers
STX16 T90 -»A
Fwd: 5’- AAACAGACCCGCCCTGGATGACGC -3’
Rev: 5’- GCGTCATCCAGGGCGGGTCTGTTT-  3’
STX16 S94 & S95 -»A
Fwd: 5’- CCCTGGATGACGCCGCCGAAGAGGAAC- 3^  
Rev: 5’- GTTCCTCTTCGGCGGCGTCATCCAGGG - 3’
2.2. Molecular Biology Methods I  Procedures
2.2.1. Amplification of target DNA by PCR
The polymerase chain reaction (PCR) was used to amplify specific target DNA sequences 
from plasmid DNA for subsequent molecular biology procedures. Primers were designed 
to the flanking sequences of the target DNA sequence, adding tags and restriction sites if 
required. Primers were synthesised at TAGN or MWG-Biotech and supplied in a 
lyophilised form. These were resuspended in dHzO to an initial concentration of 1 mg/ml. 
A 1: 10 stock (0.1 mg/ml) was then prepared in dHzO, which was used directly for the 
PCR. Pfu DNA polymerase was used to avoid the point-mutations potentially introduced
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by Taq polymerase. The following 50 pi reaction mixture was prepared in thin walled 
tubes:
Reaction cocktail:
5 pi 10 X pfa buffer
2.5 pi forward primer (from 0.1 pg/pl stock)
2.5 pi reverse primer (from 0.1 pg/pl stock)
1 pi dNTPs
2 pi template DNA (~ 0.5 pg/pl)
37 pi dHzO
The above was pulsed in a microfuge before adding:
1 pi Pfu DNA polymerase
The tubes were then added directly to the PCR machine programmed as follows:
Cycling parameters:
94 °C for 2 min
94 °C for 15 sec 
55 ®C for 30 sec 
72 ”C for 4 min
72 "C for 5 min
Soak at 4 °C
X 30 cycles
If the yield of amplified target DNA was low, 5 pi of PCR product was substituted for the 
template DNA and subjected to a second round of PCR as above (the volume of dH20 
added was adjusted to 35 pi to maintain the 50 pi solution).
2.2.2. Purification of PCR products
Following PCR, and prior to TA cloning, the PCR product was either purified by gel 
electrophoresis followed by gel extraction (Section 2.2.3 and 2.2.4) or directly using the 
QIAquick PCR Purification Kit, using the buffers provided and according to the 
manufacturers protocol. In summary, 5 volumes of Buffer PB were added to one volume of 
PCR sample and mixed, then applied to the QIAquick column in a 2 ml collection tube and 
centrifuged for 1 min at 14, 000 rpm in a microfuge. The flow-through was discarded and 
the column was washed by adding 0.75 ml Buffer PE and centrifuging as above. Once
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again, the flow through was discarded and the column was centrifuged for a further 1 min 
to allow removal of residual buffer. The column was then placed into a clean 1.5 ml 
eppendorf and the purified PCR product was eluted in 30-50 pi (depending on the 
concentration required) Buffer EB or dH20. After adding the Buffer EB or dH20 to the 
centre of the column, it was allowed to stand for 1 min prior to centrifugation for 1 min.
2.2.3.Agarose gel electrophoresis
DNA fragments were resolved by gel electrophoresis on 1 % agarose gel, owing to 
differences in their electrophoretic mobility. A 1 % (w/v) agarose solution was prepared by 
adding the agarose to 1 x TAE buffer and heating in a microwave oven to aid dissolving. 
0.5 g agarose was added to 50 ml TAE buffer for a small gel and 1.5 g agarose to 150 ml 
TAE for a large gel. The agarose solution was allowed to cool until no more steam 
appeared, before the addition of 0.1 % (v/v) (0.5 pi) ethidium bromide (fluoresces an 
intense orange when bound to double helical DNA) with gentle mixing. DNA fragments 
were prepared for loading by diluting 10 pi DNA solution with an appropriate volume of 6 
X loading dye (Section 2,1.1). A 1 kb ladder (Section 2.1.1) was run on all gels to facilitate 
size analysis. Gels were run in TAE buffer at 80 V and DNA bands were observed under 
ultraviolet light. Bands were identified by comparison with the migration of molecules of 
known length in the DNA ladder.
2.2.4. Gel extraction of DNA
Following agarose gel electrophoresis (Section 2.2.3 above), the required DNA fi'agment 
was excised from the gel with a clean, sharp, scalpel blade and weighed in an eppendorf 
tube. The QIAquick PCR Purification Kit was used to extract the DNA from the agarose 
gel slice, following the protocol and using the buffers provided. In summary, three 
volumes of Buffer QG were added to one volume of gel (lOOmg -100 pi) and incubated at 
37 "’C, with vortexing every 2-3 min, for 10 min or until the gel slice had completely 
dissolved. After the addition of one gel volume of isopropanol, the sample was mixed and 
applied to a QIAquick column in a 2 ml collection tube. This was centriftiged for 1 min 
and the flow-through was discarded. Adding 0.5 ml Buffer QG and centriftiging for 1 min 
removed all traces of agarose. The column was then washed with 0.75 pi Buffer PE, the 
flow through was discarded and the column was centrifuged for a further 1 min to allow 
removal of residual buffer. The column was then placed into a clean 1.5 ml eppendorf tube 
and 30-50 pi Buffer EB or dH20 were added to the centre of the column. This was allowed 
to stand for 1 min, before the purified DNA was eluted by centrifugation for 1 min.
y.S
j !
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2.2.5.A-taU reaction (Taq treatment)
As Pfu polymerase was used for the PCR, it was necessary to treat the PCR product with 
Taq polymerase before TA cloning to add the overhanging A bases onto the blunt-ended 
PCR product.
The procedure was carried out by incubating the following mixture at 72 °C for 20 min in a 
PCR machine:
50 pi Gel purified PCR product
1 pi dNTPs
5 pi Multi-core buffer
1 pi Taq polyiuerase
2.2.6. TA cloning
The purified Taq-treated PCR product was cloned into the vector pCR2.1 using the TA 
Cloning® Kit according to the manufacturers instructions. Briefly, 2 pi purified PCR 
product was mixed with 0.5 pi pCR2.1 and incubated for 5 min at room temperature. After 
this incubation, 0.5 pi salt solution (provided) was added and the mixture was transfoimed 
into 50 pi TOP 10 cells as described in 2.9.9. The transformed cells were selected on 2 x 
YT agar plates containing 0.025 pg/pl Kanamycin, pre-treated with 40 pi X-Gal, to allow 
for the selection of white colonies positive for insertion of the gene of interest. The 
following day, positive white colonies were selected and propagated overnight as in 2.9.9.
2.2.7.Restriction digest
DNA was digested at specific positions using specific restriction endonucleases. The DNA 
was incubated with the appropriate restriction enzyme(s) in a suitable enzyme buffer at 37 
°C for 3 hours. The general reaction mixtures were as follows:
Single digest Double digest
3 pi DNA (~ 0.5 mg/ml) 3 pi DNA (~ 0.5 mg/ml)
2 pi 10 X enzyme buffer 2 pi 10 x enzyme buffer
14 pi dHzO 13 pi dHzO
1 pi restriction enzyme 1 pi restriction enzyme
1 pi restriction enzyme
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The volumes of DNA and dHzO could be adjusted, according to the concentration of DNA 
solution used.
2.2.8. Ligation
PCR products were digested directly or from the TA cloning vector by enzymatic digestion 
(Section 2.2.7), resolved and purified by gel electrophoresis (Section 2.2.3 and 2.2.4) and 
ligated into the required vectors, also digested at the same restriction sites in the multiple 
cloning region. The concentration of DNA was determined as in Section 2.2.14,
Each ligation reaction was optimised individually. As a general rule, an excess of insert to 
vector of 3: 1 to 10: 1 was required. The vector and insert were incubated with 1.5 pi T4 
ligase in  1 X Hgase buffer (diluted from 10 x stock) under various conditions (ice / slush 
overnight, 16 °C for 4 hours or room temperature for 1-4 hours) until optimal conditions 
were found.
3 pi ligation mixture was then transformed into TOP-10 cells as described in Section 2.2.9.
2.2.9.Transformation of E. coli
Transfonuation of plasmid DNA into competent E. coli cells was earned out as follows:
Competent E. coli strains (Section 2.1.5) were stored in 50 pi aliquots at -  80 ”C in 1.8 ml 
polypropylene cryo-vials. Prior to transformation, a vial was thawed gently on ice. Plasmid 
DNA to be transformed was added to the thawed E. coli and gently mixed with a pipette 
tip, before incubation on ice for 30 min. Heat-shock was then induced by incubation of the 
mixture in a water bath, pre-heated to 42 °C, for 90 sec, before returning to ice for 2 min. 
The cells were recovered by adding 250 u l 2 x yT  media and incubating at 37 for 45 
min with shaking. During this incubation, 2 x YT agar plates containing 0.025 pg/pl 
Kanamycin were warmed from 4 “C by incubation at 37 "C. After recovery, the entire 
culture was pipetted onto the agar plate and spread thoroughly using a sterile glass 
bacterial spreader. The plates were then allowed to dry, sealed with nescofilm, inverted and 
incubated at 37 overnight for 16 hours. The following day, single colonies could be 
picked using a sterile pipette-tip for propagation in  2 x YT media (Section 2.2.10 below).
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2.2.10. Mini-cultures
A  single colony was picked following transformation (Section 2.2.9) or from a fi'eshly 
streaked selective plate and used to inoculate a starter culture of 5 ml 2 x YT containing 
0.025 pg/pl Kanamycin in a universal tube. This was incubated at 37 °C with shaking for 
16 h. Small scale DNA preparations (Section 2.2.11) were carried out to extract the 
plasmid DNA or this 5 ml culture could be used to inoculate a larger culture volume.
2.2.11. Smail-scale DNA preparations (Mini-preps)
Small-scale DNA preparations were carried out using the QIAprep Spin Mini-prep Kit 
according to the protocol provided. Mini-preps are designed for purification of up to 20 pg 
of high-copy plasmid DNA from 1- 5 ml overnight cultures of E. coli in LB medium. All 
buffers used were supplied in the kit.
A 5 ml overnight E. coli culture (Section 2.2.10) was harvested by centrifugation at 14, 
000 rpm for 10 min in a bench-top centrifuge with subsequent removal of the supernatant. 
The pelleted bacterial cells were then resuspended in 250 pi Buffer PI (containing RNase 
A) and transfeiTcd to an eppendorf tube. Cells were lysed in 250 pi Buffer P2 with gentle 
inversion of the tube and incubation for 5 min at room temperature. To neutralise the 
sample, 350 pi Buffer N3 was added with gentle mixing before centrifugation for 10 min at 
14,000 rpm. The supernatant was carefully decanted into the QIAprep spin column, 
centrifuged for 1 min (to bind the plasmid DNA to the column) and the flow-through was 
discarded. The column was then washed with 0.5 ml Buffer PB, followed by 0.75 ml 
Buffer PE by centrifugation for 1 min following the addition of each buffer. The flow­
through was discarded and the sample was centrifuged for a further 1 min to remove 
residual wash buffer. The column was then placed in a clean 1.5 ml eppendorf tube. 
Finally, 30 -  50 pi (depending on the final concentration required) Buffer EB, TE buffer 
(Section 2.1.7) or dH20 were added to the centre of the column, allowed to stand for 1 min 
and then centrifuged for 1 min to collect the plasmid DNA.
2.2. f  2. Large-scale DNA preparations (Maxi-preps)
Large-scale plasmid DNA preparations were carried out using the QIAfilter Plasmid Maxi 
Kit in accordance with the manufacturers instructions and using the buffers supplied in the 
kit.
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Briefly, a 5 ml mini-culture (Section 2.2.10) grown for 8-16 h was used to inoculate 250 
ml 2 X YT media containing the appropriate antibiotic. This culture was incubated with 
vigorous shaking at 37 for 16 hours overnight. After this time, the bacterial cells were 
harvested by centrifugation at 6000 x g for 15 min at 4 °C in a bench-top centrifuge. The 
supernatant was carefully decanted and the cell pellet was resuspended in 10 ml Buffer PI 
by pipetting up and down until no cell clumps were visible. 10 ml Buffer P2 was then 
added to the cell suspension and mixed thoroughly by inverting the tube 4-6 times, 
followed by incubation at room temperature for 5 min. Next, to neutralise the lysates, 10 
ml chilled Buffer P3 was added and mixed immediately but gently by inverting 4-6 times. 
The lysates were then immediately poured into the barrel of the QIAfilter Maxi Cartridge 
(with screw-cap on outlet nozzle and suspended from a clamp stand) and incubated at room 
temperature for 10 min. A precipitate containing proteins, genomic DNA, and detergent 
formed at the surface. Meanwhile, the QIAGEN-tip 500 was equilibrated by applying 10 
ml Buffer QBT to the column and allowing it to empty by gravity flow. After the 10 min 
incubation the cap was removed from the QIAfilter Maxi Cartridge and the plunger was 
inserted into the barrel. The cleared cell lysates were filtered into the previously 
equilibrated QIAGEN-tip and allowed to enter the resin by gravity flow. The column was 
washed with 2 x 30 ml Buffer QC before the DNA was eluted, in 15 ml Buffer QF, into a 
clean 50 ml falcon tube. The DNA was then precipitated by the addition of 10.5 ml (0.7 
volumes) room-temperature isopropanol with mixing. The sample was immediately 
centrifuged at 4,300 rpm in a bench-top centrifuge for 1 h at 4 C^. The supernatant was 
carefully decanted the precipitated DNA pellet was washed with 5 ml of room-temperature 
70 % ethanol and centrifuged for a further 1 h in a bench-top centrifuge at 4,300 i-pm and 4 
‘^ C. The supernatant was carefully decanted to avoid disturbing the DNA pellet, which was 
subsequently allowed to air dry for 5-10 min. The DNA was then re-dissolved in a suitable 
volume (generally 200 pi) of TE buffer, pH 8.0 (Section 2.1.7).
2.2.13. Site-directed mutagenesis
Mutagenesis was carried out using the QuickChange™ Site-Directed Mutagenesis Kit 
according to the manufacturers instmctions, with some variations, as detailed here. 
Mutagenesis primers were designed and used in PCR at a concentration of 0.1 pg/pl.
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The following reaction was set up in thin walled tubes:
Reaction cocktail:
5 ul 10 X Pfu buffer
1.25 ul forward primer
1.25^1 reverse primer
1 ul dNTPs
3 ul template DNA (~ 0.5 pg/pl)
38.5 (J.1 dHzO
The above was pulsed in a microfuge before adding:
1 pi Pfu DNA polymerase
The tubes were then added directly to the PCR machine progi'ammed as follows:
Cycling parameters:
95 °C for 30sec
95 °C for 30 sec 
55 °C for 1 min 
68 °C for 12 min X 16 cycles
Soak at 4 ^C
If further amplification was required, 5 pi of the PCR product was put tlirough a second 
round of PCR as described in 2.2.1.
When the PCR was complete, parental DNA was digested by the restriction enzyme, Dpnl. 
1 pi of Dpnl was added directly to the PCR tube, which was then incubated on a hot-block 
at 37 "C for 1 hour. 1 pi of the Dpnl treated product was subsequently transfoimed into 50 
pi XL 1-Blue supercompetent cells as described in 2.2.9.
Finally, the DNA was sequenced (Section 2.2.16) to verify that the conect mutations had 
been introduced and to verify that the integrity of the remaining DNA was intact.
2.2.14. DNA concentration determination
The concentrations of DNA samples were determined by measuring the optical densities at 
260 mu and 280 nm (OD260 and OD280) using a UV-1201 UV-VIS Spectrophotometer. The
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DNA concentration was calculated from OD260. One optical density unit at 260 nm in a 1 
cm path length is approximately equal to 50 mg/ml of double stranded DNA. Therefore;
[DNA](mg/ml) = OD260 ^ 100(1/ Dilution Factor) x 50
The ratio of OD26o:OD2so was calculated as an indication of sample purity. OD26o:OD28o <
1.8 indicated possible protein contamination and OD26o:OD28o >1. 8  indicated possible 
contamination by RNA.
2.2.15. Ethanol Precipitation
Plasmid DNA could be ethanol precipitated for storage / posting or resuspended in a more 
suitable volume of appropriate buffer. For sequencing at MWG, the plasmid DNA was 
ethanol precipitated and sent dried down in an eppendorf tube. When 1 pg DNA was to be 
precipitated, 1.5 pg (to allow for loss) DNA in dH20 or Buffer EB was added to a clean 
eppendorf tube, followed by 2.5 x volume (of DNA) 100 % ethanol and 0.1 x volume 
(DNA + ethanol) 3.2 M NaOAc, pH 5.2. This mixture was stored at -  80 °C for 30 min to 
ovemiglit to aid precipitation. The samples were then centrifuged at 14, 000 rpm for 15 
min at 4 ° C i n a  microfuge. After careful removal of the supernatant, 500 pi 70 % ethanol 
was added with care to the precipitated DNA and the samples were spun again at 14, 000 
rpm for 15 min at 4 °C. The supernatant was gently decanted and the tubes were stored 
open and inverted at room temperature and allowed to air-dry overnight.
2.2.16. Sequencing
DNA sequencing reactions were carried out at MWG Biotech, Germany or The 
Sequencing Service, University of Dundee, Dundee, UK.
2.2.17. Preparation of giycerol stocks of transformed
bacteria
Glycerol stocks were made from each transformed E. coli sample (Section 2.2.9). 850 pi of 
an overnight 5 ml culture (Section 2.2.10) was added to 150 pi sterile 100 % glycerol in a
1.8 ml polypropylene cryo-vial. The vial was inverted several times to mix the contents, 
snap-frozen in liquid nitrogen and transfeiTed for storage at -  80 °C.
_J:I
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A small amount of cells could then be streaked out onto agar plates using a sterile tip and 
selected using the appropriate antibiotic prior to inoculating a culture (Section 2.2.10).
2.3. Mammalian Cell Culture Methods I Procedures
2.3.1. General conditions
All cells were grown in Iwaki plasticware, with the exception of 3T3-L1 cells for 
differentiation, which were grown in Falcon plasticware for improved adhesion. All cells 
were grown in Galaxy S incubators (Wolf Laboratories) at 37 "C and 5 % or 10 % CO2 as 
indicated. All cell culture procedures were earned out in a UniMat^ Class II 
microbiological safety cabinet (flow-hood).
2.3.2. Trypsinisation and passage of cells
Cells were passaged when they were 70-80 % confluent. The medium was aspirated from 
the sub-confluent fibroblasts and 2-5 ml of trypsin/EDTA, pre-warmed to 37 °C, was added 
to cover the base of the flask. After incubation at 37 °C and 10 % CO2 (for 3T3-L1) or 5 % 
CO2 (for HeLa and HEK 293) for 2 to 5 min, the cells were detached by gentle tapping of 
the flask (verified by viewing under a 20 x objective lens). The trypsinised cells were then 
resuspended in the required volume of appropriate growth medium and distributed into 75 
cm  ^flasks, 12-well plates or 6-well plates, depending on requirements.
2.3.3. Freezing down and resurrection of cells
Cells were trypsinised as described in section 2.3.2 and resuspended in approximately 8 ml 
of appropriate growth medium. The cells were then pelleted by centrifugation at 2000 xg 
for 5 min before being resuspended in 1 ml giowth medium containing 10 % (v/v) DMSO 
in a 1.8 ml polypropylene cryo-vial. This was stored at -80 °C overnight before being 
transferred to a liquid nitrogen vat for long-term storage.
Prior to use, cells were thawed rapidly at 37 °C and transferred to a 75 cm  ^flask containing 
15 ml appropriate giowth medium, pre-wanued to 37 °C and incubated overnight at 37 °C 
at 10 % CO2. The following day, media containing DMSO were removed and replaced 
with fresh growth media.
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2.3.4.3T3-L1 
2.3.4.1. Culture of 3T3-L1 murine fibroblasts
3T3-L1 fibroblasts were cultured in 3T3-L1 fibroblast growth medium (Section 2.1.5.), 
and maintained at 37 ”C and 10 % CO2. Cells for passaging were grown in 75 cm  ^ flasks 
and fed every two to three days, until approximately 80 % confluent, when they were 
trypsinised and passaged as described in section 2.3.2. Cells were used between passage 2 
and 12 and typically frozen down (Section 2.3.3) between passage 2 and 4. Cells for 
differentiation and subsequent experiments were split into 12-well or 6-well falcon plates 
(for better adhesion), and fed every two to thi'ee days, until 2-4 days post confluence, and 
then differentiated into adipocytes.
2.3.4.2. Differentiation of 3T3-L1 fibroblasts
3T3-L1 adipocytes were grown to confluency on falcon plastic-ware as described above 
(Section 2.3.4.1). At confluency, the cells were fed with 3T3-L1 fibroblast growth medium 
(Section 2.1.6) and then allowed to grow for a further 2 to 4 days. Differentiation was 
carried out by treating the cells with 0.25 qM dexamethasone, 0.5 mM isobutyl methyl 
xanthine (IBMX), and 1 pg/ml insulin in 3T3-L1 adipocyte growth medium.
This was considered to be day 1 post-differentiation. This feed was carefully aspirated on 
day 3 or 4 (depending on requirements of the cells) and gently replaced with 3T3-L1 
adipocyte giowth medium containing 1 pg/ml insulin only. The cells were fed again 
thereafter with 3T3-L1 adipocyte growth medium as required. In this study, the cells were 
assayed on day 8 post-differentiation.
2.3 4.3. Preparation of 3T3-L1 adipocyte lysates
Lysates were generally prepared fr'om 3T3-L1 adipocytes on day 8 post-differentiation 
following experimental treatment. Cells were washed three times in ice-cold Wash Buffer 
(Section 2.1.7), and then an appropriate volume of Lysis buffer (Section 2.1.7) ± 1 % (v/v) 
thesit (supplemented with Complete Protease inhibitor tablets) was added (~ 100 pi / well 
of a 12-well plate). The cells were detached by scraping with a plastic cell scraper and 
transferred to a clean eppendorf using a pipette. The cells were lysed by passage thi'ough a 
26G needle six times, then incubated on ice for 30 min, before being spun at 14,000 rpm 
for 20 min at 4 °C in a bench-top centrifuge. This centrifugation step resulted in the
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separation of the lysates into a heavy insoluble pellet, soluble lysate and a buoyant layer of 
fat. The soluble lysate and fat layer were carefully removed and added separately to clean 
eppendorf tubes. All fractions of the lysates were stored at -  20 °C prior to analysis.
2.3.5. HeLa
2.3.5.1. Culture of HeLa cells
Human cervical caicinoma (HeLa) cells were cultured in 75 cm  ^ flasks in HeLa growth 
medium (Section 2.1.6) and maintained at 5 % CO2 and at 37 °C. Cells were fed every two 
to three days, until approximately 80 % confluent, when they were trypsinised and 
passaged as described in section 2.3.2.
2.3.5.2. Transfection with Lipofectamine™ 2000
Transfection of HeLa cells was earned out using Lipofectamine 2000 according to the 
manufacturers instructions. Briefly, cells were gi'own in 6 or 12 well plates to 90-95 % 
confluence in HeLa growth medium. DNA-Lipofectamine 2000 complexes were prepared 
(per well of a 12-well plate) as follows: 4 pi Lipofectamine 2000 was diluted in 100 pi 
Opti-MEM, mixed gently and incubated for 5 min at room temperature. Meanwhile, 1.6 pg 
DNA was also diluted in 100 pi Opti-MEM. The diluted Lipofectamine 2000 was added 
drop-wise to the diluted DNA, mixed gently and incubated for 20 min at room temperature 
to allow the DNA- Lipofectamine 2000 complexes to form. During this incubation, the 
HeLa growth medium was aspirated and the HeLa cells were washed twice in warm Opti- 
MEM, pre-heated to 37 °C. The volume of the DNA- Lipofectamine 2000 complexes was 
made up to 1 ml (per well of a 12-well plate) with Opti-MEM before adding to the cells. 
The cells were then incubated at 37 “C and 5 % CO2 for 24 to 48 hours. After 5 hours, 1 ml 
HeLa growth medium (containing 20 % PCS) was added to each well (without removal of 
the DNA-Lipofectamine 2000 complexes). If the cells were to be incubated for 48 hours, 
the transfection medium was removed and replaced with normal HeLa growth medium for 
the remaining 24 hours.
2.3.5 3. Preparation of HeLa lysates
Following experimental treatment, cells were washed three times in ice-cold HES buffer 
(Section 2.1.7). An appropriate volume of HES buffer containing protease inliibitors ± 1 % 
thesit (typically 100 pi / well of a 12-well plate) was added to the cells and a plastic cell
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scraper was used to detach the cells from the plastic-ware. They were then transferred to a 
clean eppendorf using a pipette and lysed by passage tluough a 26G needle six times. This 
was followed by incubation on ice for 30 min, before centrifugation at 14,000 rpm for 20 
min at 4 °C in a microfuge to pellet insoluble material. The supernatant was transfened to a 
clean eppendorf tube for analysis and stored at -  80 ‘’C, along with the insoluble pellets, for 
analysis at a later date.
2.3.6.HEK 293
2.3.6.1. Culture of HEK 293 cells
Human embryonic kidney (HEK) 293 cells were cultured in 75 cm  ^ flasks in HEK 293 
growth medium (Section 2.1.6) and maintained at 5 % CO2 and 37 ‘^ C. Cells were fed every 
two to three days, until approximately 80 % confluent, when they were trypsinised and 
passaged as described in Section 2.3.2.
2 3.6.2. Transfection with Lipofectamine 2000
Transfection of HEK 293 cells with Lipofectamine 2000 was earned out as for transfection 
of HeLa cells above (Section 2.3.5.2)
2.3.G.3. Caicium phosphate transfection
HEK 293 cells were plated out appropriately into plates or dishes at least one day before 
the experiment and incubated at 37 and 5 % CO2 until approximately 50 % confluent. 
Fresh media was added 4 h prior to the experiment. The following mixture was prepared 
per 10 cm  ^dish:
30 pg DNA 
125 pi 1 M CaCl2 
500 pi dH20
500 pi 2 X HBS (HEPES buffered saline. Section 2.1.7)
These quantities were divided by a factor of 8 if transfection was to be earned out in a 12 
well plate.
This mixture was then incubated in the flow-hood at room temperature for 20 min before 
being added drop-wise to the cells and swirled gently to mix. This was then incubated
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overnight at 37 °C. The next morning, the cells were washed three times in HEK 293 
growth medium and then incubated for a further 24 h in HEK 293 growth medium prior to 
the assay.
2.3.6.4. Preparation of HEK 293 lysates
HEK 293 lysates were prepared as for HeLa lysates in Section 2.3.5.3.
2.4. Biochemical Methods I  Procedures
2.4.1. Immunoprécipitation
2.4.1.1. Immunoprécipitation from 3T3-L1 adipocytes
Lysates were prepared as in Section 2.3.4.3 using 500 pi Lysis Buffer (Section 2.1.7) 
containing 1 % thesit. The required amount of the appropriate antibody (generally 2 pg) or 
a random IgG were added to each, mixed by inversion of the tube several times, then 
incubated on ice for at least one 1 hour. During this incubation, the adsorbent was prepared 
using either Protein A or Protein G Sepharose as follows: The beads were washed three 
times by adding 1 ml Lysis Buffer (containing 1 % thesit) (Section 2.1.7), mixing gently, 
and then spinning at 14,000 rpm for 1 min at 4 in a bench-top centrifuge. The 
supernatant was aspirated carefully each time, taking care not to disturb the beads. The 
beads were then resuspended in roughly an equal volume of Lysis Buffer. 40 pi of this 
suspension was added to each of the cell lysates in screw cap tubes. These were then mixed 
by end over end rotation for at least 2-4 hours at 4 "C.
The samples were then centrifuged at 14, 000 rpm for 1 min at 4 °C. The supernatants were 
removed and snap-frozen at -80 for later analysis by SDS-PAGE (Section 2.4.3.). The 
pellet was then washed twice by adding 1 ml Lysis Buffer (1 % thesit) (Section 2.1.7), 
centrifuging and removing the supernatant by careful aspiration. All traces of buffer were 
removed using a 26G needle to ensure no beads were lost. A final wash into Lysis Buffer 
(Section 2.1.7) with a lower concentration (0.1 %) of thesit was perfonued to minimise the 
detergent in the final sample. The samples were centrifuged and again, all the supernatant 
was carefully removed using a 26G needle. 40 pi 2 x SDS-PAGE sample buffer (Section
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2.1.7) was then added and the samples were boiled for 5 min in a water bath to remove the 
immunoprecipitated protein and antibody from the beads. Finally, the samples were 
centrifuged at 14,000 rpm and 4 °C for 1 min to pellet the beads and the 
immunoprecipitated material was carefully removed and transferred to a clean eppendorf 
for storage at -20 °C and subsequent analysis by SDS-PAGE (Section 2.4.3).
2.4.1.2. labelling of HEK 293 cells
HEK 293 cells were transfected in 6-well plates as described in Section 2.3.6.3. The 
remainder of this procedure was earned out in a controlled radioisotope laboratory. On the 
morning of the assay, the cells were washed twice in serum-free, phosphate-fr'ee DMEM 
(Section 2.1.2), pre-wanued to 37 ®C, before incubation in 0.5 ml of the same for 2 hours at 
37 °C and 5 % 00%. After 1 hour of the incubation, 250 pCi ^^ Pi was added to each well to 
be assayed behind a lead-glass shield and then transferred to the CO2 incubator for a 
further 1 h. The radioactive medium was then removed fi*om the cells behind the lead-glass 
shield and placed in a beaker containing Decon for subsequent appropriate disposal. 0.5 ml 
HPFEV buffer (Section 2.1.7) containing 1 % thesit, supplemented with protease inhibitors 
was added per well. The cells were lysed by pipetting up and down, taking care avoid 
creating an aerosol, and transferred to screw-capped eppendorfs. The lysates were then 
incubated on ice for 15 min before centrifuging at 13, 000 rpm for 10 min at 4 ‘’C in a 
microfuge. The solid and liquid contaminated waste was disposed of appropriately, 
according to current regulations.
2.4.1.3. Immunoprécipitation from HeLa and HEK 293 
cells
Immunoprécipitation was carried out from ^^Pi labelled HEK 293 lysates or unlabelled 
HeLa lysates as in Section 2.4.1.1 except HPFEV buffer (Section 2.1.7) containing 1 % (or
0.1 % where appropriate) thesit and supplemented with protease inliibitors, was used 
throughout in place of Lysis Buffer (Section 2.1.7) and appropriate care was exercised 
when ^^ Pi labelled lysates were used.
2.4.1.4. Activation of Sodium Orthovanadate
Sodium orthovanadate was activated for maximal inhibition of protein phosphotyiosyl- 
phosphatases by depolymerisation of the vanadate, converting it into a more potent 
inhibitor of the protein tyrosine phosphatases. This was earned out according to the
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protocol given on the Upstate website (www.upstate.com) and summarised briefly here. A 
200 mM solution was prepared of sodium orthovanadate. The pH was adjusted to 10.0 
(yellow) using either 1 N NaOH or 1 N HCl, depending on the starting pH, which can vary 
with large amounts of the chemical. The solution was boiled in the flow-hood for ~ 10 min 
until it turned colourless. It was then cooled to room temperature and the pH was adjusted 
to 10.0. This process of boiling, cooling and returning the pH to 10.0 was repeated until the 
solution remained colourless and the pH stabilised at 10.0. The activated sodium 
oithovanadate was stored in aliquots at -20 "C until required.
2.4.2. Trichloroacetic acid (TCA) precipitation
Proteins could be precipitated from cell lysates or from Secretion Assay fractions (Section 
5.4.1.1). The protein sample was first subjected to a slow spin of 2000 rpm in a bench-top 
centrifuge at 4 °C for 20 min to pellet any whole cells, and the volume was adjusted to 500 
pi with distilled water. 50 pi of 0.15 % (w/v) sodium deoxycholate was then added and the 
sample was subjected to vortexing followed by incubation for 5 min at room temperature. 
100 pi of 72 % TCA was added and again, the sample was vortexed and incubated on ice 
for 1 hour, before spinning in a chilled bench top centrifuge at 4 °C for 5 min at 14, 000 
rpm. The supernatant was aspirated and the pellet was washed in 1 ml acetone (pre-cooled 
on dry ice) with vortexing. The sample was then centrifuged at 14, 000 rpm and 4 ”C for 5 
min and the acetate was carefully aspirated. This process was repeated and the pellet was 
allowed to air-dry. Finally, the pellet was resuspended in 50 pi HU buffer (Section 2.1.7) 
for Secretion Assay samples or 50 pi 2 x SDS-PAGE Sample Buffer (Section 2.1.7) for 
SDS-PAGE analysis (Section 2.4.3).
2.4.3.SDS gel electrophoresis /  SDS-PAGE
Proteins were resolved by gel electrophoresis through polyacrylamide gels, owing to 
differences in their electrophoretic mobility. Protein samples were denatured in a solution 
of sodium dodecyl sulphate (SDS, an anionic detergent that disrupts non-covalent 
interactions) and dithiothreitol (DTT, reduces disulfide bonds) by adding an appropriate 
volume o f  4 X SDS sample buffer (Section 2.1.7) for a final concentration o f  1 x SDS 
sample buffer. The samples were then boiled in a water bath for 5 min (or at 65 °C for 
GLUT4-containing samples) prior to loading on the SDS gel.
Bio-Rad Upright Gel Kits, consisting of two glass plates with a 1 mm space between, were 
generally used. Acrylamide, which polymerises with the addition of TEMED, was poured
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between the two glass plates. The gel pore size was controlled by changing the 
concentration of acrylamide used, allowing the resolution of various sizes of proteins. In 
this study, resolving gels containing 10, 12 or 15 % acrylamide were used (Section 2.1.7) 
and stacking gels contained 4.5 % acrylamide (Section 2.1.7). The protein samples were 
loaded and 80 V was applied across the gel until the samples had passed tlirough the 
stacking gel, into the resolving gel at which time the voltage was increased to up to 130 V 
until the dye front reached the base of the gel or until the proteins were sufficiently 
resolved. Resolved proteins were compared to protein markers of known sizes.
2.4.4. Transfer to nitrocellulose
Proteins were transfened to nitrocellulose membrane using wet blotting apparatus. Two 
sections of filter paper and one section of nitrocellulose were cut to fit the blotting 
apparatus and soaked in transfer buffer prior to use. Starting fr'om the black surface of the 
blotting case, a sponge soaked in transfer buffer was placed down, followed by filter paper. 
The SDS-PAGE gel (Section 2.4.3) was then carefully removed from between the glass 
plates using a plastic spatula and placed on top of the filter paper. The nitrocellulose 
membrane was placed on top of the gel and smoothed down before another sheet of filter 
paper and a sponge were placed on top. Air bubbles were removed at each stage by rolling 
over the surface with a cylindrical tube. The case was then closed and placed in a tank 
filled with Transfer Buffer (Section 2.1.7) in order that the current ran from the gel to the 
nitrocellulose in the positive direction. The current (70 mA overnight or at 250 mA for 1 h 
45 min) was then applied and the negatively charged SDS-protein complexes migrated 
fi’om the gel and bound to the nitrocellulose membrane.
2.4.5.lmmunoblotting (Western blotting)
The nitrocellulose containing the bound proteins (Section 2.4.4) was washed twice in PBS- 
T for 5 min before incubation in blocking buffer (PBS-T, 5 % marvel) for 45 min. This 
was then incubated with primary antibody (at appropriate concentration in PBS-T, 1 % 
mai*vel) for 1 hour. The nitrocellulose was then washed five times in PBS-T for 5 min 
before incubation with appropriate HRP-conjugated secondary antibody (1:1000 in PBS-T, 
1 % marvel) for 45 min. The blots were then washed twice in PBS-T for 5 min, once in 
high salt (0.5 M NaCl) PBS-T for 30 min and twice again in PBS-T for 5 min. The blots 
were then developed using ECL Western Blotting Detection Reagents.
Protein concentrations were measured using the Bradford Assay (Bradford, 1976) using 
Bio-Rad Brilliant Coomassie Blue Reagent. Protein samples were prepared in duplicate in 
plastic 1 ml cuvettes, according to the manufacturers instructions, and absorbance at 595 
nm was measured using a UV-1201 UV-VIS Spectrophotometer. A standard curve was 
generated using 1-5 pg BSA and sample volumes were used within the linear range of the 
standard curve. Unknown protein concentrations were calculated from the standard values.
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Quantification of immunoblot signals was performed using a Bio-Rad (Hercules, CA) 
scanner and Scion Imaging software. In all cases, multiple exposures of x-ray film were 
analysed to be certain of studying immunoreactive signals within the linear range of both 
the detection antibodies and film.
2.4.6.Stripping nitrocellulose
Protein bound to nitrocellulose used for Western Blotting could be stripped of antibody 
and re-probed with a different primary antibody. 50 mM glycine pH 2.5 (pH with HCl) 
was applied to the nitrocellulose with shaking for exactly one minute. The nitrocellulose 
was then washed with PBS-T prior to further immunoblotting (Section 2.4.5).
2.4.7.Protein concentration determination (Bradford Assay)
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Chapter 3
Phosphorylation of STX16
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3. Phosphorylation of STX16
3.1. Introduction
There is much evidence to implicate STX16 as a potential regulator of GLUT4 trafficking 
in 3T3-L1 adipocytes (Section 1.8, Chapter 1), perhaps involving a SNARE complex with 
STX6. This Chapter aimed to investigate if the intriguing dephosphorylation of STX16 in 
response to insulin could be responsible for regulating the assembly of this SNARE 
complex. Indeed, phosphorylation has been shown to control the formation of many other 
SNARE complexes (Gerst, 2003). Section 3.1 provides an introduction to phosphorylation 
and its role in regulating the assembly of SNAREs into functional SNARE complexes.
3.1.1. P hosphoryla tion
3.1.1.1. Regulation by phosphorylation
Phosphorylation is the most common and ubiquitous type of reversible covalent 
modification, involved in regulating the activity of enzymes, membrane chamiels and other 
target proteins (reviewed in Cohen, 2002). A protein kinase catalyses the covalent 
attachment of phosphate groups, donated by ATP, to the hydroxyl gi'oups on the side 
chains of specific amino acid residues. The process can then be reversed by a protein 
phosphatase, which restores the umnodified hydroxyl group by catalysing the hydrolysis of 
the phosphate gi'oup with the generation of orthophosphate. This reversible process is 
utilised by cells to modify the function of a protein by altering its structural, 
theimodynamic and kinetic properties to increase or decrease its biological activity and 
initiate or disrupt protein-protein interactions (Cohen, 2002).
There are over 500 protein kinases in the human genome, with 130 homologs identified in 
yeast (Maiming et. al., 2002; Pawson et. al, 2003; Pawson et. a l, 2005). The greatest 
majority of the mammalian protein kinases phosphorylate proteins on specific serine, 
threonine or tyrosine residues. Indeed, the majority of phosphatases are known to be 
associated with these residues, with over 100 genes in the human genome representing 
tyrosine phosphatases alone (Alonso et. al, 2004).
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Almost every aspect of cellular fonction can be controlled by reversible phosphorylation 
and as such, kinases and phosphatases have a plethora of targets throughout the cell and 
varying degrees of specificity (Cohen, 2002). Some protein kinases phosphorylate just one 
or several closely related proteins and are referred to as dedicated protein kinases, whereas 
others referred to as multifonctional protein kinases, modify many different targets, with 
the ability to coordinate diverse processes. Multifonctional kinases recognise related 
sequences, known as consensus motifs, surrounding the phosphorylated residue.
Many protein kinases are themselves regulated by phosphorylation, leading to so-called 
phosphorylation cascades (Cohen, 2002) in which one protein kinase activates another, 
such as the MAP kinase pathway (Ray and Sturgill, 1987), which is activated by insulin 
signalling among other stimuli. In addition, many proteins are now known to exhibit 
multisite phosphorylation, being phosphorylated on two or more residues by two or more 
kinases (Cohen, 2002).
3.1.1.2. Phosphorylation of SNAREs
SNARE complex fonuation is fundamental to cell survival and so is subject to regulation 
(Section 1.5). From studies of phosphoiylated SNARE proteins, it is clear that 
phosphorylation plays a key role in the regulation of the assembly of many SNARE 
complexes and the resulting cellular effects. It appears that phosphorylation can increase 
the affinity of SNAREs for other SNAREs or for SNARE regulators, such as SM proteins 
(Gerst, 2003) as described below.
At the mammalian synapse (Section 1.5.2), SNAP-25 binding to STXla is reduced by m 
vitro phosphorylation of SNAP-25 by PKC (Shimazaki et al., 1996) and phosphorylation 
of Muncl8 by cyclin-dependent kinase 5 also displays reduced affinity for STXla 
(Shuang et al., 1998). STXla itself can be phosphorylated by Casein Kinase II, increasing
its affinity for the SNARE regulator synaptotagiuin 1 (Risinger and Bennett, 1999).
Gerst and co-workers earned out a number of studies that demonstrate that regulation of 
SNARE assembly by phosphorylation is also apparent in yeast. They demonstrated that 
yeast utilize the PKA (Section 3.1.2) / CAPP (a sphingoid base- and ceramide- activated 
protein phosphatase) kinase / phosphatase pathway to regulate exo- and endocytosis by 
means of the déphosphorylation of the Sso and Tig t-SNAREs respectively and their 
subsequent assembly into SNARE complexes (Gurunathan et ah, 2002; Marash and Gerst,
2001). Not only did PKA phosphorylation of the autoinhibitory (Habc) domain of the Sso t-
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SNAREs inhibit SNARE complex assembly and exocytosis (Marash and Gerst, 2001), it 
also promoted the binding of Vsml, a potential SNARE regulator (Marash and Gerst, 
2003). Interestingly, when bound to Vsml, Sso was unable to bind to its cognate t- 
SNARE, Sec9 (a yeast SNAP-25 homolog), and vice versa. Dephosphorylation of Sso, on 
the other hand, promoted SNARE complex assembly with Sec9 in vitro and in vivo 
(Marash and Gerst, 2001).
3.1.1.3. Tlg2p is phosphorylated in yeast
Perhaps most significant with regard to my study is the phosphorylation data regarding the 
STX16 and STX6 yeast homologs, Tlg2p and Tlglp respectively (Section 1.6.4), which, 
among other functions, mediate endocytosis yeast in conjunction with the Snc v-SNAREs 
(Paumet et al., 2001). It was shown that, in yeast, PKA phosphorylation of Tlg2p and 
Tlglp inhibited SNARE complex assembly and, as a result, blocked endocytosis 
(Gurunathan et al., 2002). The addition of ceramide precursors was able to rescue yeast 
mutants defective in endocytosis by activation of CAPP and subsequent dephosphorylation 
of the t-SNAREs, followed by their assembly into SNARE complexes (Gurunathan et ah,
2002). Because the restoration of endocytosis by CAPP activation correlated with 
dephosphorylation of Tlglp and Tlg2p, mutants bearing alanine substitutions at potential 
phosphorylation sites in the Habc domains were generated and tested for their ability to 
confer the uptake of the vacuolar staining dye, FM4-64, in yeast cells defective in 
endocytosis in the absence of CAPP activation. It was found that alanine substitutions at 
position 31 of Tlglp and position 90 of Tlg2p restored uptake of FM4-64 to the vacuole 
(Gumnathan et al., 2002), suggesting that these residues conespond to the sites of 
phosphorylation in Tlglp and Tlg2p.
3.1.1.4. STX16 is a phosphoprotein in 3T3-L1 adipocytes
Previous work in our laboratory demonstrated that STX16 is a phosphoprotein in 3T3-L1 
adipocytes and, intriguingly, that dephosphorylation appears to occur in response to acute 
insulin stimulation (Perera et al., 2003). The phosphorylation status of both endogenous 
STX16 and STX6 were examined by immunoprécipitation from 3T3-L1 adipocytes 
labelled with ^^Pi. STX16 was highlighted as a phosphoprotein, displaying a 50 % 
reduction in phosphorylation in response to acute insulin treatment (1 pM insulin for 30 
min) compared to basal cells. STX6, on the other hand, was not observed to be 
phosphorylated in either basal or insulin stimulated cells (Perera et al., 2003).
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The SM protein mVps45 (Section 1.6.5) was shown to interact weakly with STX6 (Bock et 
al., 1997; Tellam et al., 1997), and more recently to bind directly to STX16 (Dulubova et 
ah, 2002; Yamaguchi et ah, 2002). Interestingly, recent data from our laboratory suggests 
that the yeast homolog of mVps45, Vps45p (Section 1.6.4) is a phosphoprotein (Scott 
Shanks, unpublished data).
3.1.2. Is STX16 p h o sp h o ry la ted  b y  PKA?  
3.1.2.1. PKA
The cyclic AMP activated kinase / protein kinase A (PKA) is a multifunctional kinase that 
phosphorylates specific serine or threonine residues (Cohen, 2002). PKA is responsible for 
propagating the effects of the intracellular messenger cyclic AMP, the fonuation of which 
is triggered by many hormones. PKA is widely distributed in animal tissues and other 
organisms and has been shown to phosphorylate a vast number of substrates with an 
extensive range of functions (Cohen, 2002).
3.1.2.2. Insulin-stimulated GLUT4 trafficking and 
regulation of PKA
As mentioned previously (Section 1.3.2, Chapter 1), insulin exerts its effects by binding to 
a cell surface receptor expressed in insulin-responsive cells, such as muscle and fat cells. 
The insulin receptor is a heterotetramer that is comprised of two a- and two |3-subunits. 
When insulin binds to the extracellular portion of the a-subunits, a confonuational change 
is induced in the receptor, leading to activation of its tyrosine-kinase domain, which is 
located within the intracellular portion of its p-subunits. On activation, the receptor 
phosphorylates several proximal substrates, translating the signal into an intracellular 
cascade responsible for the many cellular effects of insulin (reviewed in Saltiel and Kahn, 
2001).
Most relevant to this study is the insulin-stimulated translocation of GLUT4 and insulin- 
regulation of PKA. The lipid kinase phosphatidylinositol 3-kinase (PI3K) has been 
implicated in both these signalling pathways (Saltiel and Kahn, 2001; Bryant et. ah 2002; 
Conti, 2000; Cannen et. ah 2005) (Figure 3.0). The insulin-regulated PI3K pathway is 
initiated by tyrosine phosphorylation of members of the insulin-receptor-substrate (1RS) 
family, which recruit PI3K to the PM. IRS-1 and IRS-2 are the most important insulin- 
receptor substrates in muscle and fat cells (Saltiel and Kahn, 2001).
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There is considerable evidence to suggest that the Class la  PI3K may be required for 
insulin-stimulated GLUT4 translocation, although other isofoims may potentially be 
involved (Bryant et ah, 2002; Saltiel and Kahn, 2001; Tengholm and Meyer, 2002). PI3K 
exerts its effects on GLUT4 translocation through activation of the serine/tlireonine kinase 
Akt/PKB and the atypical protein kinase C (PKC) isoform PKC^, both of which have been 
directly implicated in the process (Bryant et ah, 2002; Saltiel and Kahn, 2001). The 
mechanism by which PKCÇ is activated is cuiTcntly unknown, however, its presence on 
intracellular GLUT4-containing vesicles suggests this may involve its recruitment to 
intracellular membranes. PKB is activated by binding to phosphoinositides, generated by 
PI3K, in the imier leaflet of the PM, bringing it into close apposition with its upstream 
regulatory kinase phosphatidylinositol-dependent kinase-1 (PDK-1).
Insulin regulation of PKA activity also utilises a PI3K signalling cascade to activate 
phosphodiesterases (PDEs) which impinge upon the cyclic nucleotide-regulated pathway 
(reviwed in Conti, 2000; Carmen et. ah 2005). PDEs are enzymes which inactivate cAMP 
by hydrolysis to 5’-ATP, therefore, insulin exerts a negative regulatory effect on PKA 
activity. Activation of PI3K by insulin is associated with an increase in PDE3 activity in 
adipocytes (Rahn et. ah, 1994) and it has been shown that PDE3 is directly phosphorylated 
by PKB (Wijkander et. ah, 1998). However, recently it was suggested that an additional 
mechanism of PDE3 activation by insulin might directly involve phosphorylation of 
PDE3B by the PI3K associated with the insulin receptor (Rondinone et. ah, 2000).
This pathway is utilized in adipocytes to mediate the insulin-stimulated inhibition of 
lipolysis (Conti et. ah, 2000). The hydrolysis of triglycerides stored in adipocytes is 
catalysed by PKA phosphorylation of hormone-sensitive lipase (HSL). Insulin-stimulation 
results in phosphorylation and activation of PDE3B, decreasing cAMP levels. The 
subsequent inactivation of PKA and dephosphorylation of HSL leads to inliibition of 
lipolysis.
It could be envisaged that regulation of PKA activity by insulin in this maimer may also 
contribute to the dephosphorylation of STX16 following insulin stimulation observed in 
3T3-L1 adipocytes (Section 3.1.1.4) (Perera et. ah, 2003), particularly in light of the fact 
that the yeast homolog of STX16, Tlg2p, was shown to be phosphorylated by PKA 
(Section 3.1.1.3) (Gurunathan et ah, 2002). This scenario is depicted in Figure 3.0.
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Figure 3.0 Insulin regulation of GLUT4 translocation and PKA activity in adipocytes 
(adapted from Bryant et. al., 2002 and Conti, 2000)
Binding of insulin to the a-subunits of the insulin receptor results in a conformational 
change in the receptor and subsequent activation of its tyrosine-kinase domain, located 
within the intracellular portion of its p-subunits. Phosphorylation of 1RS-1 activates the 
PI3K pathway, which has been implicated both in GLUT4 translocation and PKA 
regulation. P13K generates phosphoinositides in the PM, which act as a docking site for 
PKB via its plekstrin homology domain, bringing it into close apposition to its 
upstream activator PDK-1.
A) PKB has been implicated in insulin-stimulated GLUT4 translocation, along with 
PKC^, which may be recruited to intracellular GLUT4 containing membranes.
B) PKB phosphorylation of PDE3B activates the enzyme to hydrolyse cAMP, thus 
acting as a negative regulator of PKA activity. In adipocytes, this results in inhibition of 
HSL phosphorylation and subsequent lipolysis.
C) The dephosphorylation of STX16 observed in response to insulin could be due to 
deactivation of PKA. It is hypothesised that the phosphorylation status of STX 16 could 
ultimately be involved in controlling the translocation and / or intracellular trafficking 
ofGLUT4.
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3.2. Hypothesis
After considering examples of SNARE complex assembly regulated by phosphorylation 
and / or associated SM proteins, I offer the following hypothesis for this Chapter: The 
phosphorylation status of STX16 (perhaps controlled by PKA, Section 3.1.2) regulates 
binding of mVps45, which in turn regulates SNARE complex assembly with its cognate 
SNAREs, perhaps including STX6. Figure 3.1 demonstrates this hypothesis. Ultimately, I 
hypothesise that this SNARE complex may be responsible for the regulated trafficking of 
GLUT4, however, this will be investigated further in Chapters 4 and 5.
3.3. Aims
This Chapter aimed to directly investigate the STXl 6-containing SNARE complex that 
may be involved in GLUT4 trafficking. The specific aims of this Chapter were:
1. To identify the site of insulin-regulated phosphorylation in STXl 6
2. To identify the members of the STXl 6 containing SNARE complex
3. To address whether the phosphorylation status of STXl 6 (regulated by insulin) 
regulates SNARE complex assembly and mVps45 binding
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Figure 3.1 Model for the regulation of a SNARE complex involving S TX l6 and STX6 by 
phosphorylation (adapted from Gerst, 2003).
This model is based on current knowledge of SNARE complexes and also on my 
assumption that the phosphorylation status of STX 16 determines its existence in an 
active or inactive conformation, depicted here as the so-called “open” and “closed” 
conformations. In the closed conformation, the N-terminal three-helix bundle or Habc 
domain (blue) folds over and interacts with the SNARE or H3 domain (pink), whereas 
in the open conformation, the SNARE motif is exposed. When in the inactive 
conformation, STX 16 is unable to bind to the SNARE domain of its partner t-SNARE, 
SNAP-25 homolog, STX6 (purple). At present, it is not known if this inactive 
conformation is rendered by the action of the kinase or the corresponding phosphatase. 
Based on the corresponding system at the mammalian synapse (Section 1.5.2), 1 
speculate that mVps45 binding to this inactive conformation would be permitted. Then 
in response to a change in the phosphorylation status of STX 16, mVps45 may facilitate 
the transition of STX 16 to the active conformation and permit binding to STX6 and 
other members of the SNARE complex.
Pink: STX 16 SNARE domain 
Blue: STXl6 Habc domain 
Purple: STX6 SNARE domain
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3.4. Methods
3.4.1.PhosphoProtein Purification Kit
Phosphorylated proteins were purified from HEK 293 cell lysates as described in the 
PhosphoProtein Purification Handbook (Qiagen) and summarised briefly here.
Approximately 10^  cells were required for each condition. This was estimated to be 
approximately equal to three confluent 10 cm  ^ dishes of cells. HEK 293 cells were 
trypsinised as in Section 2.3.2, and an equal amount was plated into each of nine 10 cm  ^
dishes 24 hours prior to transfection. The cells were plated so as to be approximately 50 % 
confluent and therefore to reach a confluence of 90 -  100 % 72 h later on the day of the 
experiment. The cells were transfected using the calcium phosphate method (Section 
2.3.6.3). 48 h later, the cells were haiwested. HEK 293 cells are notoriously fragile and 
easily become detached from the dish. Therefore, to ensure that no cells were lost 
(resulting in uneven cell numbers), they were not subjected to washes directly in the 
dishes, as suggested in the protocol. Instead, the cells were scraped from the dish in the 
original culture medium, pelleted by centrifugation and washed twice in HES buffer 
(Section 2.1.7) with subsequent spins.
The harvested HEK 293 cells were gently lysed in the lysis buffer provided 
(PhosphoProtein Lysis Buffer, 0.25 % (w/v) CHAPS, protease inhibitors, Benzonase). The 
lysate was cleared by centrifugation before the protein concentration was determined by 
Bradford Assay (Section 2.4.7) and adjusted to 0.1 mg/ml (to ensure that all phosphate 
groups were accessible during purification). The lysate was then loaded onto the 
Phosphoprotein Purification Column, pre-equilibrated with lysis buffer (Phosphoprotein 
Lysis Buffer, 0.25 % (w/v) CHAPS, protease inliibitors, Benzonase) and the flow-through 
fraction containing the non-phosphorylated proteins was collected. After a wash step to 
remove any unphosphorylated proteins, the proteins containing phosphate gi'oups were 
eluted in the buffer provided (PhosphoProtein Elution Buffer, 0.25 % CHAPS) in four 500 
pi fractions. The protein concentrations of the fractions were detenuined and those with the 
highest concentration (fractions 3 and 4 in each case) were pooled and concentrated to a 
volume of 50 pi using the Nanosep Ultrafiltration columns provided.
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3.4.2Jmmunoprecipitation of STX6 from 3T3-L1 adipocytes 
+/- insulin +/- NEM
3.4.2.1. Cell treatment and preparation of lysates
3T3-L1 fibroblasts were cultured as in Section 2.3.4.1. The cells (between P3 and PIG) 
were trypsinised as in Section 2.3.2, plated out into 12-well plates and grown to confluence 
at which time they were differentiated into adipocytes as in Section 2.3.4.2. On day 8 post 
differentiation, 3T3-L1 adipocytes were incubated in 1 ml serum-free DMEM per well for 
2 hours prior to the experiment. Four plates were assayed in the following way: 1) Basal, 
2) Basal + NEM, 3) Insulin, 4) Insulin + NEM. 100 pi 50 mM NEM was added to the 
appropriate wells (final concentration 5 mM) for 15 min and incubated at 37 °C and 5 % 
CÜ2, after which time 1 pM insulin was added to the appropriate wells for a further 15 min 
with incubation at 37 ^C. The cells were then washed rapidly into ice-cold Wash Buffer 
(Section 2.1.7) by tlrree additions with subsequent aspiration of 1 ml Wash Buffer. 
Solubilisation was achieved by adding 1 ml Lysis Buffer (Section 2.1.7) ± 5 mM NEM as 
appropriate between three wells (~ 330 pi / well). The cells fi'om each set of three wells 
were then scraped with a cell scraper and transferred into a clean eppendorf. The lysates 
were incubated on ice for 30 min before centrifugation in a bench top centrifuge for 20 min 
at 14,000 ipm and 4 °C. The supernatants (the soluble lysates) were then transferred to 
clean cryo-vials and stored at -  80 °C until required for immunoprécipitation.
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3.5. Results
3.5.1Jdentification of phosphorylation site in STX16 
3.5.1.1. Overview
It was reasoned that identification of the site of insulin-regulated phosphorylation in 
STX16 would be the first step towards elucidation of its function in 3T3-L1 adipocytes. 
Although this study will ultimately be carried out in 3T3-L1 adipocytes, the initial studies 
described in this Chapter were carried out in HeLa or HEK 293 cells, since 3T3-L1 
adipocytes are notoriously difficult to transfect using standard teclmiques (Gnudi et al., 
1997).
As mentioned previously, STX16 has been shown to exist in various spliced fonns: 
STX16A, B, C, D and H (Figure 1.8, Chapter 1) (Dulubova et ah, 2002; Simonsen et al., 
1998; Tang et al., 1998a). This phosphorylation study involved the cloning and 
mutagenesis of STX16A, a full-length splice variant (Section 1.6, Figure 1.8), however, for 
simplicity, it will be refeiTed to here as STX16.
The study began by analysing the STX16 sequence in silico to pinpoint candidate sites of 
phosphorylation. Mutants were then generated bearing alanine substitutions at these 
potential sites and tested for phosphorylation using the PhosphoProtein Purification Kit 
(Section 3.5.1.8) and ^^ P analysis (Section 3.5.1.9).
3.5.1.2. in siiico analysis of possible phosphorylation 
sites
It was decided to base the in silico investigation on Tlg2p, the yeast homolog of STX16. 
The first step was, therefore, to generate a sequence alignment of STX16 with Tlg2p 
(Figure 3.2) using ClustalW (http://www.ebi.ac.uk/clustalw/). Tlg2p sequence was 
obtained fi'om NCBI (Accession number NP_014624). The nucleotide sequence of 
STX16A published by Simonsen et. al. (Simonsen et al,, 1998) and submitted to the 
GenBank (Accession number AF008935), did not match the sequence of the cDNA used in 
this study (kindly provided by H. Stenmark, The Norwegian Radium Hospital, Montebello, 
Oslo/Norway). The sequences were identical except for five point-mutations (base number, 
cDNA base - published base; 233, C-T; 474, A-G; 615, G-C; 663, G-T; 758, T-C) and a
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frame shift error caused by an “extra” G at base 360 in the cDNA. Therefore the STX16 
sequence presented in this thesis (Figure 3.2) was obtained by the direct sequencing of the 
STX16A cDNA used in my study (verified by multiple sequencing runs on both strands at 
MWG-Biotech). As mentioned previously, Tlg2p has a putative PKA site at serine residue 
90 (Gurunathan et al., 2002); however, sequence alignment of Tlg2p with STX16 did not 
reveal high homology in this region (Figure 3.2).
Therefore NetPhos 2.0 (http://www.cbs.dtu.dk/services/NetPhos/) was utilised to analyse 
the STX16 protein sequence for potential phosphorylation sites (Figure 3.3). At first it was 
hypothesised that STX16 would be phosphorylated on a serine residue, evolutionarily 
conseiwed from Tlg2p. The search implicated S94 and S95 as the most likely candidates of 
the serine residues with output scores of 0.996 and 0.998 respectively (on a scale of 0.000 
to 1.000). These sites were favoured over other high scoring serine residues (S80, S131 
and S224) because they were closest in sequence to the S90 phosphoiylation site in Tlg2p. 
However, careful analysis of the threonine residues generated revealed another strong 
candidate - T90. Although the probability (0.601) was not as high as for the serine residues 
chosen (S94 and S95) or some of the other threonine residues implicated (T3, T105, T178, 
T197), it corresponded well with the site in Tlg2p and occuiTed within the predicted Habc 
domain. T90 was therefore included in the list of residues to be investigated further. 
Residues of interest were then examined using the Scansite (Obenauer et al., 2003) 
(http://scansite.mit.edu.l program Motif Scan (httn://scansite.mit.edu/motifscan seq .phtml) 
which searches for motifs within proteins that are likely to be phosphorylated by specific 
protein kinases (Figure 3.4). The analysis focused mainly on identifying potential PKA 
sites within the STX16 sequence, as, in addition to Tlg2p being phosphorylated by PKA 
(Gurunathan et ah, 2002), it was envisaged that insulin regulation of PKA could be 
responsible for the dephosphorylation of STX16 (Section 3.1.2) observed upon insulin- 
stimulation (Perera et. ah, 2003). Only two potential PKA phosphorylation sites were 
identified, S17 and intriguingly, T90, adding further weight to the argument in support of 
this residue. SI7 was not considered further at this stage as its output score in the previous 
search (0.026) was below the threshold of 0.500 (Figure 3.3). This program linked S94 and 
S95 with Casein Kinase II.
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AVFPMILW RED Small (small+ hydrophobic (Incl.aromatic -Y))
DE BLUE Acidic
RHK MAGENTA Basic
STYHCNGQ GREEN Hydroxyl + Amine + Basic - Q
Others Gray
Figure 3.2 Sequence alignment of STX16 with Tlg2p
Sequence alignment of STX16A and yeast Tlg2p, generated using ClustalW. Identical 
residues are indicated by an asterisk, conserved residues by double dots and semi­
conserved residues by a single dot. The STX16 sites tested for phosphorylation in this 
study (T90, S94 and S95) are denoted by red dots while a red star highlights the Tlg2p 
PKA site (S90) (Gurunathan et al., 2002). The transmembrane domains of both proteins, 
consisting of mostly small hydrophobic residues, are highlighted with a red arrow. The 
Tlg2p extracellular domain can be observed at the C- terminus.
Figure 3.3 Analysis of STX16 sequence for potential phosphorylation sites
NetPhos 2.0 was utilized to analyse the STX16 sequence for potential 
phosphorylation sites. A) Graph illustrating the predictions in B. The potential sites 
chosen (T90, S94 and S95) and their output scores are denoted by red dots. B) Output 
format: Column 1: sequence name, Column 2: position of residue being analysed. 
Column 3: sequence context (shown as a 9- residue sequence centred on the residue 
being analysed), Column 4; output score (value in the range [0.000-1.000]), Column 
5: assignment (scores above the threshold of 0.500 are assigned as or
“*Y*”). A red star indicates sites of interest chosen for this study. S94 and S95 were 
chosen, as they were the most likely serine residues with the highest output scores. 
T90 was chosen because it correlated well with the Tlg2p phosphorylation site. 
Although its output score is lower than the serine residues chosen, it is, nonetheless, 
above the threshold of 0.500.
A
NetPhos 2.0: predicted phosphorylation sites in STX16
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B
NetPhos 2.0 Server - prediction results
Technical University of Denmark
Serine predictions
Name Pos Context
V
Score Pred
STX16 17 LRNNSIQNR 0 . 0 2 6
STX16 37 MALVSGISL 0.685 *S*
STX16 40 VSGISLDPE 0 . 0 4 1
STX16 78 KMKESASLH 0 . 2 6 0
STX16 80 KESASLHDK 0.992
STX16 94 TLDDSSEEE 0.996 * s *  i
STX16 95 LDDSSEEEH 0 . 998 * s * 1
STX16 131 GPAPSRRGG 0.945 * s *
STX16 151 LQELSTSFR 0.031 .
STX16 153 ELSTSFRHA 0 . 2 6 0 .
STX16 159 RHAQSGYLK 0.328
STX16 172 REERSQHFF 0.581 *s*
STX16 179 FFDTSVPLM 0.006
STX16 224 QMVQSISDL 0,928 * s *
STX16 226 VQSISDLNE 0.130 .
STX16 256 NVEQSCIKT 0.562 *s*
STX16 302 VGVKSR-- 0 . 0 3 2
Threonine predictions
Name Pos Context
V
Score Pred
STX16 3 — MATRRLT 0.737
STX16 7 TRRLTDAFL 0.236
STX16 50 AIGVTKRPP 0.621
*T* ikSTX16 90 LNRPTLDDS 0.  601
STX16 104 AIEITTQEI 0.052
STX16 105 lEITTQEIT 0.734 * T *
STX16 109 TQEITQLFH 0.005 .
STX16 139 GCLGTWCLV 0.108 .
STX16 152 QELSTSFRH 0. 070 .
STX16 178 HFFDTSVPL 0. 915 * T *
STX16 190 GDDNTLYHR 0.137 .
STX16 197 HRGFTEDQL 0. 813
STX16 208 VEQNTLMVE 0.  646 *T*
STX16 244 VEQGTVLDR 0.271 .
STX16 260 SCIKTEDGL 0.408
Tyrosine predictions
Name Pos Context
V
Score Pred
STX16 66 DEIQYDVGR 0.701
STX16 161 AQSGYLKRM 0 . 0 7 3 .
STX16 192 DNTLYHRGF 0.490
STX16 251 DRIDYNVEQ 0.093
STX16 273 KAEQYQKKN 0 .863
Figure 3.4 STX16 sequence analysed for consensus motifs pertaining to a particular kinase
Generated using the Scansite Motif Scan option. Scansite was used to identify short protein 
sequence motifs that eould be phosphorylated by protein Serine / Threonine or Tyrosine 
kinases. STX16 sequence was analysed for potential phosphorylation sites with low 
stringency. The analysis focused on identifying potential PKA sites, as well as assigning 
possible kinases to the previously identified residues of interest. A) A search for potential 
PKA sites revealed two candidates, T90 and SI7. A further search suggested S94 and S95 
could be phosphorylated by Casein Kinase II. Residues T90, 894 and S95 are indicated by 
red stars. B) Graphical representation of sites in (A) indicating that the sites of interest fall 
in the syntaxin homology region (the Habc domain).
Scores in Scansite start at 0.000 if the sequence optimally matches the given motif, and the 
scores increase for sequences as they diverge from the optimal match 
(http://scansite.mit.edu.). The score histograms and the percentile are the main ways to tell 
how good a score is for a given motif. It is considered to be quite good if the site ranks in 
the best 0.2% of all sites (http://scansite.mit.edu.). For the Motif Scan program, the 
percentile is calculated from a reference database search, which is the vertebrate section of 
the Swiss-Prot database.
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Basophi lic scr inc/ thrconi iie kinase «roup (Baso_S I _kin)
Protein Kinase A Gene Card
Site Score Percentile Sequence SA
S17 0.5791 2.913 % FLLLRNNSIONRQLL 1.736
Protein Kinase A Gene Card TRKACG
Site Score Percentile Sequence SA
★  T90 0.5524 2.079 % DKHLNRPTLDDSSEE 2.304
Aeidophi l ie ser ine/ threonine kinase «roup (Aeid S I kin)
C asein Kinase 2 Gene Card C
Site Score Percentile Sequence SA
★  S95 0.4079 0.187% RPTLDDSSEEEHAIE 3.570
Casein Kinase 2
Site Score Percentile Sequence SA
★  S94 0.4546 0.401 % NRPTLDDSSEEEHAI 3.442
B Baso_SI_kin  S17
Baso_ST_kin  
T90
Acid_ST_kin  
p^id_ST_kin
Syntaxin(W-159)
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SHARE(214-276)Sunaptobrevin(S6-300)
OUF1707(226-237
SurfaceA ccessib ility
1 .0
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303 AA
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3.5.1.3. Construction of STX16 pCR3.1
STX16A cDNA was cloned into the mammalian expression vector pCR3.1 (see Appendix) 
for subsequent transfection into mammalian cells. The phosphorylation mutants were then 
generated in this construct.
STX16A cDNA was PCR amplified using the conditions and cycling parameters described 
in Section 2.2.1. The template DNA was used at a concentration of 0.5 mg/ml. Primers 
were designed to amplify the entire STX16A open reading frame (915 bp) including the N- 
terminal myc-tag (63 bp), and restriction sites compatible with pCRS.l {Kpnl at the N- 
terminus and Xbal at the C-terminus). The primers were as follows (restriction sites 
underlined; start and stop codons in bold):
Fwd: 5’-CCGGTACCATGGCCCATATGGAAC-3 ’
Rev: 5 ' -CCTCTAGATTATCGAGACTTCAC-3 ’
The resulting PCR product was gel purified as described in Sections 2.2.3 and 2.2.4 
(Figure 3.5A). Digestion of the PCR fragment (Figure 3.5B) and pCR3.1 (not shown) with 
Kpnl and Xbal (Section 2.2.7) preceded the ligation of myc-tagged STX16 into pCR3.1 as 
described in Section 2.2.8. Ligated product was transformed into TOP-10 cells and 
colonies were selected in the presence of Kanamycin (Section 2.2.9). Plasmid DNA was 
isolated as described in Section 2.2.11 and successful transformants were identified by 
restriction digest (Section 2.2.7) with Kpnl and Xbal (Figure 3.5C). Plasmids found to 
contain the insert were ethanol precipitated (Section 2.2.15) and fully sequenced on both 
strands (Section 2.2.16) to confirm the veracity of the PCR experiment.
3.5.1.4. Transfection of HeLa cells with STX16 pCR3.1
The STX16 pCR3,l plasmid was first tested for expression in HeLa cells. Cells were 
transfected with STX16 pCR3.1 or empty pCR3.1 (negative control) when 50 % confluent 
using Lipofectamine 2000 (Section 2.3.5.2). Cells treated with Lipofectamine 2000 alone 
provided a further negative control. Lysates were prepared after 24 hours (Section 2.3.5.3) 
and expression of myc-tagged STXl 6 was examined by SDS-PAGE electrophoresis on a 
12 % SDS gel (Section 2.4.3) followed by Western Blotting (Section 2.4.4) using
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monoclonal anti-myc (Figure 3.6) antibody. The construct was found to successfully 
express myc-tagged STXl6. As a STXl6 specific antibody was not obtained until later in 
the study, the level of expressed protein was not compared to that of the endogenous 
protein.
3.5.1.5. Immunoprécipitation of myc-tagged STXl6 
expressed in HeLa cells
It was necessary to ensure that myc-tagged STXl 6 could be immunoprecipitated fi'om 
HeLa cells. HeLa cells were transfected using Lipofectamine 2000 as above. 1 ml lysates 
were prepared (Section 2.3.5.3) and immunoprécipitations were earned out according to 
the protocol in Section 2,4.1.3 using 2 pg monoclonal anti-myc antibody or random IgG as 
a control. Immunoprecipitates and post-immunoprecipitation supernatants were analysed 
by immunoblotting (Section 2.4.4) with polyclonal anti-myc (Figure 3.7) antibody. This 
experiment demonstrated that myc-tagged STXl 6, expressed in HeLa cells, could be 
immunoprecipitated by means of its functional myc-tag. The interaction with the myc 
antibody was specific as STXl 6 was not immunoprecipitated with a random IgG.
Kirsty M. Proctor, 2006 Chapter 3,107
L T 1 2
1 kb STXl 6
B L
1 kb STXl 6
5 kb
1 kb —
pCR3.1
STXl 6
Figure 3.5 Construction of S TX l6 pCRS.I plasmid
A) Uncut template DNA (T) used for PCR alongside the products of two 
independent PCRs (Lanes 1 and 2) resolved on a 1 % agarose gel. The template 
DNA present in each sample is of equal concentration. The strongly stained bands at 
~ 1 kb correspond to STX16A cDNA. B) Restriction digests of the 1 kb bands in (A) 
with Kpnl and Xbal (Lanes 1 and 2). pCR3.1 vector was also digested (not shown).
C) Restriction digests with Kpnl and Xbal of six potential ligation products (Lanes 
1-6) following ligation of STXl 6 into pCR3.1. The bands at 5 kb can be attributed to 
pCR3.1; the insert, freed by the restriction digest, is observed in samples 1,2,3,5 and 
6 .
L: 1 kb DNA ladder. The 1 kb mark is indicated.
In (A) and (B) Lanes 1 and 2 contain the products of two independent PCRs.
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Figure 3.6 Western Blot of myc-tagged STX16 expressed in HeLa cells
Cells were transfected using Lipofectamine 2000 either in the absence of DNA (0), or 
in the presence of pCR3.1 (pCR3.1) or STXl6 pCR3.1 (STXl6) and lysates were 
prepared 24 h after transfection (Section 2.3.5.3). The lysates were separated by SDS- 
PAGE on a 12 % gel and immunoblotted with monoclonal anti-myc.
The first three lanes of the 12 % SDS-PAGE gel were loaded with 10 pi of the 
appropriate sample, followed by 20 pi of each in the remaining three wells. The lysate 
loaded in each well corresponds to 2 % of the total lysate obtained from one well of a 
12-well plate.
Control: 36 kDa protein bearing a myc-tag and known to be successfully visualised by 
Western Blotting with anti-myc.
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Figure 3.7 Immunoprécipitation of myc-tagged STX16 expressed in HeLa cells
Immunoprécipitation was carried out from HeLa cells, which had been transfected 
with STXl6 pCR3.1 (STXl6), empty pCR3.1 (pCR3.1) or treated with 
Lipofectamine 2000 alone (0), with 2 pg monoclonal anti-myc or random IgG. The 
immunoprecipitates and post-immunoprecipitate supernatants were resolved on a 
12 % SDS-PAGE gel, followed by immunoblotting with polyclonal anti-myc. Myc- 
tagged STXl6 can be observed at 34 kDa as indicated and was partially 
immunoprecipitated using 2 pg monoclonal anti-myc. The interaction with the myc 
antibody is specific as STXl 6 is not immunoprecipitated with a random IgG.
IP: immunoprecipitate
S: supernatant collected after immunoprécipitation
Fractions loaded: IP, 2/5 of total immunoprecipitate from 1 well of a 6-well plate; 
S, 1/20 of the total S obtained from one well of a 6-well plate
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3.5.1.6. Mutagenesis of potential phosphorylation sites in 
STXl 6: T90, 894 & 8 9 4 -^A
The QuikChange™ Site-Directed Mutagenesis Kit was employed to mutate the potential 
sites of phosphorylation in STXl 6 (T90, S94 and S95) to alanine residues. Given that it 
coiTesponded well with the putative PKA site in Tlg2p, it was hypothesised that T90 was 
the most promising residue, and therefore should be tested first. Then a double mutant was 
generated in which both S94 and S95 were substituted for alanine residues. The 
mutagenesis forward primers were designed as follows:
T90 ^ A
T
5’- A AAC AG A CGC ACC CTG GAT GAC A G -3 ' -► Original sequence
5’- A AAC AGA CCC.GCC CTG GAT GAC AG -3 ’ Mutant primer
A
S94 & S95 -^A
S S
5’- CC CTG GAT GAC AGC AGC GAA GAG GAA C -3’ Original sequence
III lii
5’- CC CTG GAT G A C ^G ^^G ^G A A  GAG GAA C -3 ’ Mutant primer
A A
The reverse primers were simply the complementary strands. Therefore, the primers were: 
T90 ^ A  Fwd: 5’- AAACAGACCCGCCCTGGATGACGC -3’
Rev; 5’- GCGTCATCCAGGGCGGGTCTGTTT -  3'
S94 & S95 ->A Fwd: 5’- CCCTGGATGACGCCGCCGAAGAGGAAC- 3’
Rev: 5’- GTTCCTCTTCGGCGGCGTCATCCAGGG - 3’
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The mutagenesis PCR was carried out as in Section 2.2.13. 5 pi were then electrophoresed 
on a 1 % agarose gel (Section 2.2,3) to verify that the resulting plasmid was of the correct 
size (not shown), while 1 pi of the product was transformed into TOP-10 cells and colonies 
were selected in the presence of Kanamycin (Section 2.2.9). The plasmid DNA was 
extracted from 20 individual colonies (Section 2.2.11), which were then screened for 
mutations by sequencing fully on both strands (Section 2.2.16). Stocks of plasmids found 
to contain the correct mutations were generated from the conesponding glycerol stocks 
(Section 2.2.17) by carrying out large-scale DNA preparations (Section 2.2.12). The 
resulting mutants will be referred to as T90 and S94&95.
3.5.1.7. Expression of STXl 6 and T90 in HEK 293 ceiis
Transfection of HEK 293 cells with Lipofectamine 2000 often caused them to become 
unhealthy; therefore the calcium phosphate method of transfection (Section 2.3.6.3) was 
utilized. The transfection efficiency was optimised by expressing GFP-tagged SNAP-25 
and viewing the cells directly with an upright fluorescent microscope (results not shown). 
The optimum quantity of DNA was found to be 3.75 pg per well of a 12 well plate to 
achieve 70 -  80 % transfection efficiency at these conditions. Cells were transfected with 
STXl6 pCR3.1, T90 and empty pCR3.1 and lysates were analysed for expression by 
immunoblotting with either anti- STXl6 or anti-myc antibodies. Figure 3.8 shows that the 
T90 mutant and STXl 6 were expressed at comparable levels. Both were expressed to a 
level exceeding that of endogenous STXl 6 in these cells.
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Figure 3.8 Expression of STXl 6 and STXl 6 T90 in HEK cells
The calcium phosphate method (Section 2.3.6.3) was utilised to 
express STXl6 and T90 in HEK 293 cells. The expressed proteins 
could be observed by means of the N-terminal myc-tag by Western 
Blotting with anti-myc (lower panel) and by a STXl 6 specific 
antibody (upper panel). Endogenous STXl6, myc-tagged STXl6 and 
myc-tagged T90 are all recognised by the STXl6 specific antibody, 
highlighting that the myc-tagged proteins are expressed to a level 
exceeding that of the endogenous protein.
The lysate on the gel corresponds to 2 % of the total lysate from cells 
in one well of a 12 well plate.
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3.5.1.8. PhosphoProtein purification kit
The PhosphoProtein Purification Kit (Qiagen) is designed to specifically purify 
phosphorylated proteins from complex cell lysates. Proteins that carry a phosphate group 
on any amino acid are bound with high specificity to a PhosphoProtein Purification 
Column, while proteins without phosphate groups do not bind to the column and can 
therefore be found in the column flow-through fraction. Phosphorylated proteins were 
purified from HEK 293 cell lysates as described in Section 3.4.1.
Samples were collected from the original cell lysates, from the lysates after concentration 
normalisation to 0.1 mg / ml prior to loading on the column, and the flow-through from the 
column (the non-phosphorylated proteins). The proteins were resolved by SDS-PAGE 
electrophoresis on a 12 % SDS gel (Section 2.4.3), followed by Western Blotting using 
anti-myc antibody (1:1000 dilution) (Figure 3.9A). Figure 3.9A highlights that a large 
fraction of the myc-tagged STXl 6 and T90 did not bind to the column, perhaps suggesting 
that this fi'action of the total protein present was not phosphorylated or that the capacity of 
the column had been exceeded.
The concentrated eluants were analysed in the same way by Western Blotting with anti- 
STX16 and anti-myc antibodies (Figure 3.9B). Endogenous STXl6, myc-tagged STXl6 
and STXl 6 T90 were all obseiwed in the eluant, perhaps suggesting that a fraction of each 
was indeed phosphorylated and therefore that T90 is not the sole site of phosphorylation. 
The phosphorylated protein fraetions were probed for IRSl, PKB and STX6, all of which 
were observed to one extent or another. IRSl and PKB are both phosphorylated in 
response to insulin (Gual et al., 2005; Hill et al., 2001); therefore their presence in the 
eluant was expected. As mentioned previously, STX6 was not observed to be a 
phosphoprotein (Perera et al., 2003), however, its presence in the eluant may be due to 
binding to endogenous STXl 6, which is known to be a phosphoprotein. On the other hand, 
this may be evidence of non-specific binding to the column. The eluants were then probed 
for STX4, GLUT4, and Arf6 (Figure 3.9C). Previous work indicates that GLUT4 and 
STX4 are phosphorylated (Piper et al., 1993; Risinger and Bennett, 1999). All are observed 
except Arf6, which was not visible even after long exposure times. To date, no literature 
exists to implicate Arf6 as a phosphoprotein, however, it is not possible to be certain that 
this provides a reliable negative control and evidence that the binding is specific.
Figure 3.9 Fractions collected before and after the purification on the Phosphoprotein- 
binding column
Phosphorylated proteins were purified from the HEK 293 lysates using the PhosphoProtein 
Purification Kit and analysed by gel electrophoresis and Western Blotting. A) Original cell 
lysates (L), lysates after concentration normalisation to 0.1 mg / ml prior to loading on the 
column (B), and the flow-through from the column (the non-phosphorylated proteins) (F) 
were analysed with anti-myc antibody. This highlights that a large fraction of STXl 6 and 
T90 did not bind to the column. B) The eluants were analysed in the same way with anti- 
myc and anti-STX16. Endogenous STXl6 can be observed in the pCR3.1 lane probed with 
anti-STX16. The lysates were also probed with anti-bodies to IRSl and PKB, both of 
which are phosphorylated in response to insulin (Gual et al., 2005; Hill et al., 2001), and 
STX6, which was previously shown not to be phosphorylated (Perera et al., 2003). C) 
Further controls involved looking for the presence of STX4, GLUT4 and Afr6 by probing 
with the appropriate antibodies.
Kirsty M. Proctor, 2006 Chapter 3,115
34 kDa
STXl 6 SIX  16X90  A____________A____pCR3.1
C Y Y \L B F L B F L B F
-------------------  I I ---------Z Z — ------------------ a-Myc
B
m
UCl. g OG\H
34 kDa l «  ' # i m i  “ -Myc
a-STX16
a-PKB
34 kDa 
65 kDa y   " ■■ .
165 kDa 
32 kDa
a-IRSl
a-STX6
35 kDa
20 kDa
S
u04
\or-H
cyo
0G\H
1 •(ÜÜft
"1 # »
f ■ • •ij?
a-STX4
a-Arf6
Kirsty M. Proctor, 2006 Chapter 3,116
3.5.1.9. Analysis of STX16, T90 and S94&95 with “ P
Given that the results obtained from the PhosphoProtein Purification Kit were 
inconclusive, it was decided to go on and examine the phosphorylation status of both 
mutants by ^^ P analysis. This method was chosen allow the quantitative analysis of STXl 6 
phosphorylation compared to that of the mutants, allowing for the possibility that STXl 6 is 
phosphorylated on more than one residue.
3.5.1.10. Expression of mutants
HEK 293 cells were transfected with STXl6 pCR3.1, T90, S94&95 and empty pCR3.1 
using the calcium phosphate method (Section 2.3.6.3). Figure 3.10A shows the expression 
levels prior to the experiment as visualised by Western Blotting with anti-myc antibody.
3.5.1.11. Analysis of mutants with
First it was ensured that the proteins could be immunoprecipitated by means of their N- 
teiininal myc-tags (Figure 3,1 OB). Immunoprécipitation was carried out as in Section 
2.4.1.3 using polyclonal anti-myc or random IgG, and the immunoprecipitates were 
compared by immunoblotting with monoclonal anti-myc antibody. 2 pg of polyclonal 
anti-myc immunoprecipitated more than 90 % of myc-tagged STXl6 (not shown). The 
immunoprécipitation was selective as no inununoprecipitated material was observed in a 
cell-free control or cells transfected with empty vector.
3.5.1.12. Labelling with and immunoprécipitation
48 hours after transfection, the cells were washed and labelled using 250 pCi ^^ Pi per well 
of a 6-well plate as described in Section 2.4.1.2. The cells were treated with or without 1 
pM insulin for 30 min prior to the experiment. The immunoprécipitation was then carried 
out from labelled cells as in Section 2.4.1.3. The immunoprecipitated material from the 
^^Pi labelled cells was subjected to electrophoresis on two separate 12 % SDS-PAGE gels. 
One gel was dried, and the phosphorylation status of the proteins examined by 
autoradiogiaphy while the other was transfeixed to nitrocellulose and analysed by Western 
Blotting with monoclonal anti-myc antibody. Figure 3.11A shows the autoradiograph. It is 
clear that no significant or specific phospho-bands are observed in these experiments.
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Figure 3.1 IB shows the Western Blot analysis of the immunoprecipitates and indicates that 
although the proteins are not observed by autoradiography, the immunoprécipitations were 
carried out successfully. Therefore, it is likely that the proteins have not been labelled by 
the ^^Pi. The conditions used for ^^ Pi labelling have previously been shown to be sufficient 
to equilibrate the ATP pool of 3T3-L1 adipocytes (G.Gould, unpublished observation) 
(Gibbs et ah, 1986). This strongly suggests that STXl 6, T90 and S94&95 are not 
posttranslationally modified in HEK 293 cells.
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Figure 3.10 Expression and immunoprécipitation of myc-tagged S TX l6, T90 and S94&95 
in HEK 293 cells
A) STXl6, T90 and S94&95 were expressed in HEK 293 cells and visualised by 
Western Blotting with monoclonal anti- myc and compared to cells transfected with 
empty vector (pCR3.1). B) Immunoprécipitation of the proteins with polyclonal anti- 
myc (black arrow) or random IgG (no arrow). The myc-tagged proteins were 
immunoprecipitated successfully as shown by Western Blotting with monoclonal anti- 
myc. The immunoprécipitation was specific since the proteins were not 
immunoprecipitated with the random IgG and no immunoprecipitated bands were 
observed in cells transfeeted with pCR3.1 only (pCR3.1) or in a no cell control (no 
cells).
Fractions loaded: A) 1/20 of the total lysate from one well of a 6-well plate; B) 2/5 of 
the total immunoprecipitated material from one well of a 6-well plate
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Figure 3.11 analysis of S T X l6 in HEK 293 cells
STXl6, T90 and S94&95 were immunoprecipitated, using anti-myc (black arrow) or 
random IgG (no arrow), from ^^Pi-labelled HEK 293 cells treated aeutely with (+) or 
without (-) 1 pM insulin for 30 min. A) The autoradiograph comparing the polyclonal 
anti-myc and IgG immunoprecipitates. STXl6, T90 and S94&95 were not observed in 
anti-myc immunoprecipitates at ~ 34 kDa as anticipated. Molecular weight standards 
are shown. B) The corresponding immunoprecipitates from basal cells were analysed 
by Western Blotting with monoclonal anti-myc antibody. This demonstrates that 
although the proteins cannot be seen in the autoradiograph, it is not due to an 
unsuccessful immunopreeipitation but instead suggests that the proteins are not 
labelled with ^^ Pi.
Fractions loaded: A) and B) 2/5 of the total immunoprecipitated material from one 
well of a 6-well plate.
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3.5.2,ldentificatîon ofSTX16 SNARE binding partners in 3T3- 
L1 adipocytes
3.5.2.1. Overview
Immunoprécipitation studies were earned out in an effort to identify members of the 
insulin-regulated STXl 6-containing SNARE complex in 3T3-L1 adipocytes. 
Immunoprécipitations were carried out from 3T3-L1 adipocytes in the presence (STXl 6 is 
dephosphorylated) or absence (STXl 6 is phosphorylated) of insulin-stiraulation. These 
studies attempted to address if binding to STXl 6 was altered by phosphorylation, and 
ultimately if the formation of a functional SNARE complex could by regulated by insulin.
The experiment was carried out both in the presence and absence of NEM (N-Ethyl- 
Maleimide), a reagent that prevents SNARE complex disassembly and therefore, favours 
the chances of pulling down intact complexes. Because a STXl 6 specific antibody was not 
obtained until later in the study, the immunopreeipitations were carried out using anti- 
STX6 and immunoprecipitates were probed for STXl 6 and other possible SNARE binding 
partners.
3.5 2.2. Immunoprécipitation of STX6 from 3T3-L1 
adipocytes
3T3-L1 adipocytes were treated as described in Section 3.4.2, ± 5 mM NEM and ± 1 pM 
insulin for 15 min. Lysates were prepared as in Section 2.3.4.3 and immunopreeipitation 
was carried out as in Section 2.4.1.1 using monoclonal anti-STX6 or random IgG per 500 
pi lysate. Immunoprecipitates and post- immunopreeipitation supernatants were resolved 
on a 12 % SDS-PAGE gel, and analysed by immunoblotting with polyclonal anti-STX6 
(Figure 3.12). STX6 was immunoprecipitated both in the presence and absence of NEM 
and in both basal and insulin-stimulated cells. 2 pg monoclonal anti -STX6 was found to 
be optimum for the immunopreeipitation, even although STX6 was not absorbed 
completely from the lysates. Using greater than 2 pg antibody did not result in more STX6 
in the immunoprecipitate and in fact was detrimental, resulting in strong signals from the 
heavy and light chains of the antibody in the Western Blot, which obscured the STX6
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signal and the signals from its binding partners, when resolved by gel electrophoresis (not 
shown).
3.5.2.3. STX6 co-immunoprecipitates STX16
The first aim was to ensure that the STX6 immunoprecipitated from the lysates was in a 
complex with STXl6. Figure 3.12 shows that STXl6 does indeed co-immunoprecipitate 
with STX6. The interaction could be observed both in the presence and absence of insulin, 
suggesting perhaps that SNARE complex formation can occur in both basal and insulin- 
stimulated cells. Intact cells were treated with (Figure 3.12B) or without (Figure 3.12A) 5 
mM NEM prior to lysis, to accumulate SNARE complexes. Comparison of Figure 3.12A 
and Figure 3.12B reveals that more STXl6 was co-immunoprecipitated in the cells pre­
treated with NEM (judged by the corresponding decrease in the amount of protein left in 
the post-immunoprecipitation supernatant). This is indicative that the complexes did not 
form after lysis (Galli et ah, 1998).
3.5.2.4. STX6 co-immunoprecipitates Vti1 a
The TGN-localised t-SNARE Vtila fonns a SNARE complex with both STX6 and STXl6 
in HeLa cells (Mallard et ah, 2002), To check if this interaction is also viable in 3T3-L1 
adipocytes, the immunoprecipitates were probed with antibodies to Vti la. Figure 3.13 A 
shows that Vti la  was co -immunoprecipitated with STX6, suggesting that it could indeed 
be the third member of a SNARE complex formed in adipocytes. As with STXl 6, the 
interaction was observed both in the presence and absence of insulin. In addition, 
preliminary data appeared to suggest that antibody to Vti la  also co-immunoprecipitates 
STX6 (not shown).
3.5.2.5. STX6 does not co-immunoprecipitate mVps45
As previous work has suggested that mVps45 interacts weakly with STX6 (Bock et ah, 
1997; Tellam et ah, 1997), and directly with STXl6 (Dulubova et ah, 2002; Yamaguchi et 
ah, 2002), the STX6 immunoprecipitates were probed for the presence of mVps45. Under 
my experimental conditions, mVps45 did not co-immunoprecipitate with STX6, either in 
the presence or absence of insulin, with all of the mVps45 remaining in the post- 
immunoprecipitation supernatant (Figure 3.13B). As well as suggesting that mVps45 does 
not bind to STX6 in 3T3-L1 adipocytes this result also suggests that no interaction occurs 
with STXl6 (which is also present in the immunoprecipitate) when STXl6 is part of the
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ISTX6/STX16/Vtila SNARE complex. However, it is highly plausible that the fraction of
STX16 that remains in the post-immunoprecipitation supernatant (Figure 3.12) constitutes 
uncomplexed STX16 that may be bound to mVps45.
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Figure 3.12 STX6 and STX16 co-Immunoprecipitate in 3T3-L1 adipocytes
STX6 was immunoprecipitated from 3T3-L1 adipocytes, which, after serum starving for 2 
h, had been treated with (I) or without (B) 1 pM insulin for 15 min and with (+ NEM) or 
without (- NEM) 5 mM NEM as indicated on the left. Lysates were prepared and STX6 
was immunoprecipitated using 2 pg monoclonal anti-STX6. The immunoprecipitates and 
corresponding post-immunoprecipitate supernatants were resolved by electrophoresis, 
transferred to nitrocellulose and analysed by Western Blotting with polyclonal anti-STX6 
and anti-STX16 as indicated on the right. A) The monoclonal STX6 antibody was capable 
of immunoprecipitating STX6 itself from the cell lysates. STX16 was co- 
immunoprecipitated to a similar extent in the presence or absence of insulin stimulation. 
The interaction with the STX6 antibody was specific as neither STX6 nor STX16 interact 
with a random IgG. B) STX6 was immunoprecipitated from cells treated with NEM prior 
to lysis. A larger proportion of STX16 was coimmunoprecipitated in this case (judged by 
the corresponding decrease in protein in the post-immunoprecipitation supernatant), 
indicating that the complexes did not form after lysis (Galli et al., 1998).
IP: immunoprecipitate
S: supernatant collected after immunoprécipitation
Fractions loaded: IP, 2/5 of total immunoprecipitate from 1 well of a 12-well plate; S, 
1/20 of the total supernatant obtained from one well of a 12-well plate
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Figure 3.13 STX6 co-immunoprecipltates V tila  but not mVps45 in 3T3-L1 adipocytes
3T3-L1 adipocytes treated with 5 mM NEM and with (I) or without (B) 1 pM insulin for 
15 min were lysed and STX6 was immunoprecipitated using 2 pg monoclonal anti-STX6. 
The immunoprecipitates were compared to the post immunoprécipitation supernatants by 
resolving on a 12 % gel, and probing for possible binding partners by immunoblotting 
with specific antibodies. A) The blots were probed with anti-Vtila, revealing that Vtila 
co-immunoprecipitated with STX6 both in basal and insulin-stimulated cells. B) Analysis 
with anti-mVps45 indicated that STX6 did not co-immunoprecipitate mVps45 either in 
the presence or absence of insulin.
IP: immunoprecipitate
S: supernatant collected after immunoprécipitation 
Lysate: lysate prior to immunoprécipitation
Fractions loaded: IP, 2/5 of total immunoprecipitate from 1 well of a 12-well plate; S, 
1/20 of the total supernatant obtained from one well of a 12-well plate; Lysate, 1/20 of 
the total lysate obtained from one well of a 6-well plate
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3.6. Discussion
Phosphorylation of t-SNAREs has been known for some time to regulate the formation of 
functional SNARE complexes and the binding of their respective SM proteins (Gerst, 
2003). The intriguing dephosphorylation of STX16 in response to insulin (Perera et al., 
2003) combined with this knowledge, led to the speculation that STX16 phosphorylation 
could be responsible for the regulation of a SNARE complex involved in GLUT4 
trafficking. This Chapter describes the initial steps taken to identify the site of insulin- 
regulated phosphorylation, from which future studies can build, as well as the 
identification of STX16 binding partners in basal and insulin-stimulated 3T3-L1 
adipocytes.
It was reasoned that the identification of the exact site insulin-regulated phosphorylation in 
STX16 would be the first step towards elucidating its function. The method employed by 
Gerst and co-workers was adopted, which involved the generation of specific STX16 
mutants bearing alanine substitutions at potential sites of phosphorylation (Gurunathan et 
ah, 2002) which were tested for phosphorylation in HER 293 cells.
The yeast t-SNARE, Tlg2p has recently been shown to be a functional homolog of STX16 
(Marion Struthers, unpublished data), and it was hypothesised that the site of PKA 
phosphorylation at S90 (Gurunathan et ah, 2002) may have been evolutionally conserved 
in STX16. This hypothesis gained further credence by in silico investigation, which 
identified T90 as a potential PKA site in STX16 (Figures 3.3 and 3.4). The notion that 
STX16 could be phosphorylated by PKA is supported by the fact that insulin-stimulation 
leads to deactivation of PKA (Section 3.1.2) (Conti, 2000; Carmen et. ah 2005), a finding 
that could support the dephosphorylation of STX16 upon acute insulin-stimulation. 
Therefore, T90 was mutated to an alanine residue, the resulting mutant was expressed in 
HER 293 cells and the phosphorylation status was examined by its ability to bind to a 
phosphoprotein-binding column. Figure 3.9B suggests that endogenous STX16, myc- 
tagged STX16 and T90 are all phosphorylated in HER 293 cells and perhaps, that T90 is 
not the correct or only site of phosphorylation. However, careful analysis of the controls 
highlighted some important points. In the first instance, it proved difficult to find a reliable 
negative control, considering approximately 1/3 of all eukaryotic gene products can be 
posttranslationally phosphorylated. STX6 and Arf6 were chosen for this purpose as
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previous work showed that STX6 was not phosphorylated (Perera et ah, 2003), and Arf6 
has not been reported to be phosphorylated to date. While Arf6 was not obseiwed in the 
eluant from the phosphoprotein-binding column, STX6 was observed, (Figures 3.9B and 
3.9C) however, it was reasoned that STX6 could be evident through its interaction with 
phosphorylated endogenous STX16. Positive controls were supplied by looking for the 
presence of STX4, PKB and IRSl. Both STX4 and GLUT4 are known to be 
phosphorylated (Piper et al., 1993; Risinger and Bennett, 1999) and bound to the column 
as expected (Figure 3.9C). Both PKB and IRSl are phosphorylated upon insulin 
stimulation (Gual et al., 2005; Hill et al, 2001). The fact that they are observed in the 
eluant under basal conditions suggests that perhaps the serum present during transfection 
was responsible for stimulating the insulin receptors and the subsequent phosphorylation of 
their substrates. If this was the case, however, STX16 would be dephosphorylated and 
binding to the column would not be observed. This led to the notion that there was perhaps 
a second site of phosphorylation in STX16, which is constitutively active and responsible 
for the binding observed in Figure 3.9B. Recall that only a 50 % reduction in 
phosphorylation is observed upon insulin stimulation (Perera et a l, 2003). For this reason, 
it was not possible to conclude with certainty that T90 was not the correct site of 
phosphorylation. In addition, the possibility that there was simply non-specific binding to 
the column could not be ruled out. In effect, this experiment left more questions than 
answers.
^^ P analysis was therefore utilised in an attempt to clarify the above by allowing the 
quantitative analysis of any changes in phosphorylation observed in the T90 mutant. In 
addition, two more sites were chosen for analysis. Tlg2p is phosphorylated on a serine 
residue, and as such, two serine residues (S94 and S95) with the highest probability of 
being phosphorylated were chosen (Figures 3.3 and 3.4), mutated to alanine residues and 
screened for phosphorylation in the same way. Unexpectedly, Figure 3.11 A clearly 
demonstrates that neither wild type STX16 nor the mutants are labelled, strongly 
suggesting that STX16 is not phosphorylated in HEK 293 cells. It is therefore speculated 
that the phosphorylation of STX16 previously observed in adipocytes by the same method 
of ^^ Pi labelling is in fact cell-type specific. This presents the intriguing possibility of a 
SNARE complex specifically regulated in highly insulin-responsive cells, a concept which 
will be discussed further below. Clearly, the next step in this investigation will be to test 
the phosphorylation status of the STX16 mutants in 3T3-L1 adipocytes.
I sought to find STX16 binding partners in 3T3-L1 adipocytes with the aim of identifying 
the insulin-regulated STX16 complex. It was found that STX16 was co-
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immunoprecipitated with STX6 and that the t-SNARE, Vtila, was also present in the 
immunoprecipitate (Figures 3.12 and 3.13). An interaction between STX6 and STX16 in 
3T3-L1 adipocytes was identified previously (Perera et al., 2003; Shewan et al., 2003) and 
in the time since these immunoprécipitation studies were conducted, an interaction 
between Vtila and STX16 has been reported in these cells (Bose et al., 2005).
Mallard et a l (Mallard et al., 2002) demonstrated that a SNARE complex is formed 
between STX6, STX16 and Vtila in HeLa cells and that this complex, along with the v- 
SNAREs VAMP3/cellubrevin and VAMP4, controls trafficking between endosomes and 
the TGN. In this study, I have shown that the STX16/STX6/Vtila complex also exists in 
3T3-L1 adipocytes and that the interaction is viable in basal and insulin-stimulated cells 
(Figures 3.12 and 3.13). As such, the change in binding affinity anticipated between 
STX16 and its binding partners with a change in phosphorylation status (Figure 3.1) does 
not appear to apply to this complex. At present, it is not known if this complex has the 
same function in 3T3-L1 adipocytes as reported in HeLa cells. As GLUT4 may traffic 
from endosomes to the TGN in adipocytes (Bryant et al., 2002) (Figure 1.9, Chapter 1), it 
seems plausible that the STX6/STX16/Vti 1 a complex may be required to accomplish this 
trafficking step. On the other hand, as my data suggests that formation of this complex is 
not regulated by insulin, it may not represent the complex involved in regulated GLUT4 
trafficking.
Perhaps the STX6/STX16A^tila complex is indeed involved in the general traffic from 
endosomes to the TGN in adipocytes and a distinct specialised complex controls GLUT4 
trafficking, thus avoiding all cargo bound for the TGN being regulated by insulin. The 
upregulation of STX16 and STX6 observed upon differentiation of 3T3-L1 fibroblasts 
(Shewan et al., 2003) could be required for a specialised transport system in adipocytes 
coiTcsponding with the biogenesis of the GS V compartment. In support of this theoiy is the 
observation that STX16 phosphorylation may be cell specific (Figure 3.11) suggesting that 
this regulation is only necessary in insulin-responsive cells.
What then would be the components of this specialised SNARE complex? I speculate that 
it includes STX6 and STX16 (due to the evidence presented in Section 1.8.1) with an 
alternative t- or v-SNARE. After all, many SNAREs are known to take part in more than 
one SNARE complex in more than one trafficking step. In HeLa cells, the 
STX6/STX16Wti 1 a complex was shown to interact with two different v- SNAREs, 
VAMP3/cellubrevin and VAMP4, most likely in two distinct complexes (Mallard et ah, 
2002). STX6 has also been shown to interact with VAMP7 and VAMPS, along with Vtilb
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and STX7, in a complex from melanoma cells (Wade et al., 2001). Perhaps in 3T3-L1 
adipocytes, STX16, STX6 and Vtila interact with one v-SNARE to accept incoming 
general traffic from endosomes to the TGN and with another v-SNARE, present on 
GLUT4 containing vesicles, in a complex that is regulated by insulin and STX16 
phosphorylation. Unfortunately, no data were recorded in this study regarding the possible 
v-SNAREs involved in 3T3-L1 adipocytes due to lack of good specific antibodies. 
However, previous work in our laboratory identified, intriguingly, a weak but perhaps 
insignificant interaction between VAMP2 and STX6 (H.K.I. Perera, unpublished 
observation). GSVs are enriched in VAMP2 (Ramm et al., 2000), and although this v- 
SNARE is associated with the fusion of GSVs with the PM in adipocytes (Foster and Klip, 
2000) could it also function as the v-SNARE for incoming GLUT4 containing vesicles to 
the TGN?
I then considered an alternative t-SNARE that could participate in a STX6 and STX16 
containing complex. Of the 14 known mammalian syntaxins, only four are localised to the 
Golgi apparatus, with STX6, STX16 and STXIO localised to the TGN (Bock et al., 1997; 
Mallard et al., 2002; Simonsen et al., 1998; Tang et al., 1998a; Tang et al., 1998b). 
Although STXIO was shown to co-immunoprecipitate with STX6 and STX16, it was 
shown to act independently of STX6 and STX16 in a separate trafficking step (Wang et al., 
2005). However, as mentioned above, STX6 was shown to interact with the t-SNARE 
Vtilb, in melanoma cells (Wade et al., 2001) and more recently, in activated 
macrophages. Vtilb is localised mostly on tubules and vesicles in the TGN area and on 
endosomes in synaptosomes (Kreykenbohm et al., 2002). Therefore, althougli STX16 did 
not co-immunoprecipitate Vtilb in HeLa cells (Mallard et al,, 2002) it was decided to test 
Vtilb as a potential member of the SNARE complex in 3T3-L1 adipocytes. However, it 
was not possible to observe Vtilb in the STX6 immunoprecipitates due to the similarity in 
size of Vtilb and the light chain of the STX6 antibody used for the immunoprécipitation. 
Both resolved at approximately 25 kDa on the SDS-PAGE gel and the Vtilb signal was 
therefore obscured. Attempts to resolve the proteins using various percentages of 
acrylamide in the SDS gels (Section 2,4.3) were without success (not shown). Future 
studies will be required to address this issue, perhaps by caiTying out the 
immunoprécipitation with antibody to Vtilb and probing for STX6 and STX16.
Figure 3.1 demonstrates the scenario anticipated between STX16 and its SM binding 
partner mVps45 with a change in phosphorylation status. Recent data from our laboratory 
suggests that the yeast homologue of mVps45, Vps45p (Section 1.6.4) is a phosphoprotein 
(Scott Shanks, unpublished data) in yeast. Perhaps the apparent phosphorylation of
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Vps45p, if shared by mVps45, could add a further layer of regulation to the STX16- 
containing SNARE complex like its synaptic counterpart MunclS (Shuang et al., 1998). 
Further work will be required to test this possibility. Previously, mVps45 was shown to 
bind weakly to STX6 (Bock et al., 1997; Tellam et al., 1997), however, under my 
experimental conditions, mVps45 does not co-immunoprecipitate with STX6 (Figure 
3.13B). Conespondingly, it would seem that neither does it bind to the fraction of STX16 
present in the STX6 immunoprecipitate, despite the fact that previous work has 
demonstrated a direct interaction between STX16 and mVps45 (Dulubova et al., 2002; 
Yamaguchi et al., 2002). The reason for this discrepancy could be that mVps45 is unable to 
bind STX16 when STX16 is participating in a SNARE complex. As mentioned previously, 
it is highly plausible that the fraction of STX16 left in the post-immunoprecipitation 
supernatant (Figure 3.12) could constitute uncomplexed STX16 and could be found 
associated with mVps45.
The suggestion that mVps45 binding to STX16 is incompatible with SNARE complex 
formation is in agreement with current knowledge of SNARE complexes involved in 
exocytosis but contrary to reports regarding intracellular complexes, in which t-SNAREs 
can simultaneously bind to SM proteins while participating in a ternary complex (Rizo and 
Sudhof, 2002) (Section 1.5.6). Perhaps my data is suggestive that STX16 can indeed adopt 
a so-called “open” and “closed” conformation (as depicted in Figure 3.1), like its synaptic 
counterpart STXla (Dulubova et al., 1999) (Section 1.5.2), and mVps45 binding is 
dependent on the fonnation of the inactive closed conformation. This possibility will be 
investigated further in Chapters 4 and 5.
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Chapter 4
Generation of Recombinant Adenoviruses and 
Optimisation of Adenovirus-Mediated Expression 
of STX16 mutants in 3T3-L1 Adipocytes
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4. Generation of Recombinant Adenoviruses and 
Optimisation of Adenovirus-Mediated 
Expression of STX16 mutants in 3T3-L1 
Adipocytes
4.1. Introduction
The main aim of this study was to elucidate the role, if any, of STX16 in GLUT4 
trafficking in 3T3-L1 adipocytes. Experiments were therefore conducted to examine the 
effects on GLUT4 trafficking of expressing various domains of STX16 in 3T3-L1 
adipocytes, the results of which are presented in Chapter 5. In order to make these 
experiments possible, it was first necessary to constmct the tools required to conduct such 
an investigation. This Chapter, therefore, details the generation of recombinant 
adenoviruses to express the cytosolic domain, an N-terminal truncation mutant and full- 
length STX16, and to optimise the expression of these proteins in 3T3-L1 adipocytes. 
Section 4.1.1 provides an introduction to the adenovirus and its use as a vehicle for the 
expression of recombinant proteins in cell culture.
4.1,1. Introduction to adenovirus
4.1.1.1. General properties of the adenovirus
The adenovirus was first isolated fi-om human adenoids in the early 1950s during a study 
into the cause of the common cold (ROWE et al., 1953). Members of the adenovirus 
family, or Adenoviridae, are known to infect a wide variety of post-mitotic cells, even 
those associated with highly differentiated tissues including skeletal muscle, lung, brain 
and heart (Russell, 2000). Human adenovirus serotypes 2 and 5 of subgroup C are the most 
extensively characterised and used as vectors (Hitt et al., 1997). The use of adenoviruses as 
vectors will be considered in more detail in Section 4.1.1,6,
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4.1.1.2. Structure and genome
The characteristic morphology the adenovirus is defined by an icosahedral capsid, 
surrounded by protruding knobbed fibre domains at each of the 12 vertices (Stewart et aL, 
1993). The capsid, of diameter 80-90 mn, encloses the viral genome and is assembled from 
three major proteins, the hexon, penton base and knobbed fibre, along with a number of 
other minor proteins (Stewart et al., 1993) (Figure 4.1). 240 hexons make up the faces of 
the icosahedron, with a penton base residing at each of the 12 vertices. A fibre protein, 
ending in a globular tip known as the knob domain, extends fi-om each penton base 
(Stewart et al., 1993). The adenovirus genome consists of a linear, double-stranded DNA 
molecule, which varies in size between groups from 30- 40 kb. The genome of the most 
commonly used human adenovirus (serotype 5) comprises a linear, 36 kb, double stranded 
DNA molecule (Cluoboczek et al., 1992). Both strands are transcribed and nearly all 
transcripts are extensively spliced. Conventionally, viral transcription units are divided into 
regions that are expressed at an early (El, E2, E3 and E4) (Section 4.1.1.4) or late stage of 
the infectious cycle.
Kirsty M. Proctor, 2006 Chapter 4, 133
m
( apsid nmtcims ( cmcnt pn-itciit( ofc proteins
Hexon
u MuBase
Figure 4.1 Structure of adenovirus (taken from (Russell, 2000))
The characteristic icosahedral morphology of the adenovirus, along with its main 
structural components. The positions of the capsid proteins (the hexon, fibre and 
penton base), core proteins and hypothetical locations of the cement proteins are as 
indicated.
TP- terminal proteins, containing the inverted terminal repeats at the 5’ end of the virus 
DNA, the hypothetical arrangement of which is depicted in black.
Kirsty M. Proctor, 2006 Chapter 4,134
4.1.1.3. Infectious cycle of the adenovirus
The infectious cycle of the adenovirus can be clearly divided into an “early” and a “late” 
phase, which occur before and after virus replication, respectively. The early phase in a 
permissive cell takes about 6-8 hours and involves the entry of the virus into the host cell 
and subsequent transport of the virus into the nucleus, where the selective transcription and 
translation of the early genes can occur (Russell, 2000). These early events serve to modify 
the host cell functions to create favourable conditions for replication of the virus DNA and 
the resultant transcription and translation of the late genes. The late phase can yield virus in 
a fiirther 4-6 hours (Russell, 2000).
4.1.1.4. Cell receptors for the adenovirus
The entry of the adenovirus into cells is mediated by interactions with two distinct cell- 
surface receptors (Figure 4.2). The initial contact of the adenovirus with the host cell is via 
the knobbed fibre domain. In the case of the human subgroup C adenoviruses, the knobbed 
fibre domain binds to the coxsackie / adenovirus receptor (CAR), so called because it is 
identical to the receptor for the coxsackie B virus (Bergelson et al., 1997). The next step 
involves an interaction of the vims with the cellular integrins, which normally react with 
the extracellular matrix to facilitate adhesion, differentiation and other cell-cell phenomena 
(Meredith, Jr. et al., 1996). The vims interacts with the cellular av(33 or avps integrins (Bai 
et al., 1993; Takayama et al., 1998; Wickham et al., 1993) through an exposed ROD 
(arginine-glycine-aspartate) motif on the penton base (Stewart et al., 1993) and entry of the 
virus proceeds via clathi'in-mediated endocytosis. Both avp3 and avP5 support adenovims 
internalisation (Bai et al., 1993; Takayama et al., 1998; Wickliam et al., 1993) and 
interestingly, avpS is expressed on human bronchial epithelial cells, a major site of 
adenovims infection in vivo (Mette et al., 1993).
Following endocytosis, the virus escapes into the cytosol by lysis of the endosomal 
membrane, induced by the penton base. The viron is then disassembled stepwise during the 
process of internalisation and import to the nucleus, where transcription, replication and 
viral packaging take place (Russell, 2000).
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Figure 4.2 Binding and internaiisation of the adenovirus (taken from AdenoVator 
Applications Manual, Version 1.1, QBIOgene)
A) The virus attaches to the target cell by binding of the knobbed fibre to the CAR 
proteins on the cell surface. B) The exposed ROD motif on the penton base interacts 
with the av integrins and mediates endocytosis of the virus into the host cell.
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4.1.1.5. Use of adenoviral vectors to confer gene transfer 
into mammalian cells
The ability of adenovims to infect a wide variety of cell types and tissues in both dividing 
and non-dividing cells, combined with their relative ease of preparation and purification, 
has led to their extensive use as gene vectors. Recombinant adenovimses can transfer 
genes to a broad spectmm of cell types with the major advantage that gene transfer is not 
dependent on active cell division. Additionally, high titres of viruses and high levels of 
transgene expression generally can be obtained.
The adenovirus can incorporate only about 2 kb of foreign DNA without significant affects 
on its stability or its infectivity. Adenoviral vectors have been designed to allow for the 
introduction of longer sequences by the removal of some or all of the vims genes. The 
various methods for the constmction of adenovirus vectors are reviewed in Hitt et. al., 
1997. In most recombinant vectors, transgenes are introduced in place of El and/or E3 
genes, allowing the introduction of up to 6.5 kb of foreign DNA. Deletion of the El gene 
removes the ability of the virus to replicate in target cells and therefore prevents 
propagation of infectious viral particles. The E3 region encodes proteins involved in 
evading host immunity and is not required for the replication of vims in tissue culture. A 
further generation of vectors have been developed, which involve the deletion of the E2 
genes, or in some cases, nearly all of the vims genes in so-called “gutless vectors” (see 
Russell, 2000 and references within).
4.1.1.6. HEK 293 cells
HEK 293 cells constitute a cell line that provides El genes in trans (Graham et al., 1977) 
and as such are used to allow the propagation of replication deficient viruses lacking the 
El genes. Human embryonic kidney cells were transformed by exposing the cells to 
sheared fragments of adenovims type 5 DNA (Graham et al., 1977). High titres of 
recombinant adenovirus lacking the El genes can be therefore be obtained by infection and 
propagation in HEK 293 cells.
Kirsty M. Proctor, 2006 Chapter 4,137
4.1.1.7. Construction recombinant adenoviruses
There is a range of techniques for the construction of recombinant adenovimses and these 
are described in detail elsewhere (Hitt et al., 1997; Tashiro et al., 1999; Zhang, 1999). 
Generally, the gene of interest is cloned into a suitable “shuttle” vector, which seiwes the 
standard purpose of “shuttling” cDNAs of interest from a plasmid vector to a viral 
constmct, followed by homologous recombination with a larger vector constituting the 
viral backbone. Homologous recombination can occur by co-transfection of the shuttle 
vector and the viral backbone into bacteria (He et al., 1998), followed by production of 
viral particles in HEK 293 cells, or co-transfection directly in HEK 293 cells. Finally, the 
vims can be amplified in HEK 293 cells (Graham et al., 1977) and the titre accurately 
determined by a range of methods such as plaque unit forming assay (AdEasy Adenoviral 
Vector System Instmction Manual, Stratagene, USA, www.stratagene.com).
Although rendered defective for replication as a result of deletion of the El genes, the 
potential exists for recombinant adenovimses to regain the ability to replicate in a non­
complimenting cell line. Replication competent adenovimses can emerge within a 
population of replication deficient adenovimses as a result of a double crossover event 
between the homologous overlapping sequences present in the recombinant adenovims and 
the HEK 293 genome (Lochmuller et al., 1994), resulting in the loss of the transgene and 
its replacement by the El region (Zhu et al., 1999). The method used to generate 
recombinant adenovimses in my study was the RAP Ad. I system, developed by Anderson 
and co-workers (Anderson et al., 2000). The system makes use of a novel adenovirus 
backbone devoid of the left-hand inverted tenninal repeat, the packaging signal and El 
sequences. The investigators reasoned that an adenoviral genome devoid of sequences 
necessary for packaging and replication would greatly reduce or eliminate production of 
wild-type vims. Thus the RAPAd.I system allowed for generation of a recombinant 
adenovims containing virtually no contaminating El sequences and no detectable wild- 
type vims contamination (Anderson et al., 2000).
4.1.1.8. Receptor availability may affect protein 
expression
Clearly the first step in achieving successfiil protein expression in target cells involves the 
ability of the adenovims to enter that particular cell. This relates to the availability of the 
cell-surface receptors discussed in Section 4.1.1.4. Although CAR and av integrins are
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widely distributed among most cell types, some tissues and cells, such as lymphocytes, 
express very little if any of these receptors, (Hitt et al., 1997; Leon et al., 1998). Evidently, 
the availability of these receptors is a crucial factor that must be taken into account when 
considering adenovims mediated gene transfer in a particular cell.
4.1.1.9. Why use adenovirus in this study?
My study into elucidating a role for STX16 in GLUT4 trafficking required the use of 
terminally differentiated 3T3-L1 adipocytes, a cell line which would allow native GLUT4 
trafficking to be studied. Gene transfer via standard transfection methods has been shown 
to be very inefficient in these highly differentiated cells (Gnudi et aL, 1997). Adenovirus 
vectors, on the other hand, are able to transfer genes even to highly differentiated cells and 
gene transfer is not dependent on active cell division (Russell, 2000). As such adenovims 
vectors have been successfully used to transfer genes into 3T3-L1 adipocytes (Bose et al., 
2001; Emoto et al., 2001; Sakaue et al., 1997).
4.2. Aims
My ultimate goal was to study the fimction of STX16 in 3T3-L1 adipocytes. Cmcial to my 
study, therefore, was the identification and design of the STX16 mutants that would 
provide ftmctional information and ultimately test the hypothesis described Section 1.9, 
Chapter 1. The second hurdle was to be able to express these proteins in 3T3-L1 
adipocytes, notoriously difficult to transfect using standard techniques (Gnudi et al., 1997). 
Therefore recombinant adenovimses were required to drive expression. Nevertheless, 
despite an efficient transfection system, the expression of STX16 in 3T3-L1 adipocytes 
was subject to limitations that had to be overcome to achieve optimum expression. 
Therefore the aims of this Chapter were as follows:
1. To design STXl 6 mutants to test the hypothesis in 3T3-L1 adipocytes
2. To clone these mutants into the adenoviral vector pShuttle-CMV for subsequent 
generation of recombinant adenovirus
3. To optimise adenovims-mediated expression of the STXl6 mutants in 3T3-L1 
adipoeytes
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4.3. Materials and Methods
4.3.1. G eneration o f  recom bin an t a d en o viru ses
4.3.1.1. ViraQuest
Homologous recombination and amplification were carried out by Ronald B. Haskell at 
ViraQuest Inc., 310 West Zeller, North Liberty, lA, USA. The RAPAd.I system (Section 
4.1.1.8.) was used as described in Anderson et al,, 2000. The general procedure is 
summarised briefly here and in Figure 4.3.
The “shuttle” vector, housing the gene of interest (Section 4.4.2.1), and the adenoviral 
backbone, RAP Ad™, were linearised by enzymatic digestion with P a d  and the mixture 
was transfected into HEK 293 cells using standard calcium phosphate methods. Viral foci 
were observed 6 days later, with more foci evident in the following days. The cells were 
haiwested 8 days after transfection, pelleted by low speed centrifugation, and the virus 
liberated by three cycles of freeze/thaw. The cell lysate (1 ml in 10 mM Tris, pH 8.1) 
containing the recombinant virus was amplified and purified. The infectious titre of the 
resultant purified virus particles was determined by HEK 293 plaque assay as described 
(Anderson et al., 2000). A549 cell overlay and PCR methods to detect potential El 
sequences were used as deseribed in Anderson et al., 2000 to ensure that no wild-type virus 
was detectable after amplification.
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Gene of interest cloned into “shuttle” vector
Linearization of “shuttle” vector and RAP Ad™ backbone with P ad
Co-transfection into HEK 293 cells
Homologous recombination and generation of virus particles
Liberation of virus by harvest and lysis of HEK 293 cells
Amplification and purification of virus
Figure 4.3 Generation of recombinant adenovirus using the RAPAd.1 system (adapted 
from Anderson et. al. 2000).
The gene of interest was cloned into the “shuttle” vector (Section 4.4.2.1). At 
ViraQuest Inc., this plasmid was linearised by digestion with P a d . The RAP Ad™ 
viral backbone (described in Anderson et. al. 2000) was also digested with P ad . The 
digested products were then co-transfected into HEK 293 cells, where homologous 
recombination occurred. Viral foci were observed six days later. Eight days after 
transfection, the cells were harvested and lysed by three cycles of freeze/thaw. The cell 
lysate, containing recombinant virus was amplified and purified. Large-scale 
amplification resulted in a high titre of virus capable of expressing the gene of interest.
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4.3.1.2. Amplification of pShuttle-CMV virus in HEK 293 
cells
5 pi of control vims (“empty” pShuttle-CMV), diluted in 10 ml of HEK 293 growth media, 
were used to infect one 75 cm flask of HEK 293 cells, which were -  90 % confluent. The 
cells were incubated at 37 ‘’C and 5 % CO2 for ~ 4 days. After this time, the cells were 
detached by gently tapping the flask, and harvested by centrifugation at 1000 ipm for 5 
min in a bench-top centrifuge. The viral growth medium was decanted and, after dilution in 
HEK 293 growth medium, was used to infect further flasks of HEK 293 cells (~ 90 % 
confluent). This process was repeated until there was enough viral media to infect thirty 
150 cm  ^ flasks of HEK 293 cells. The viral medium was mixed with nonnal HEK 293 
growth medium at a ratio of 1 : 5. 5 ml of this mixture were pipetted into each flask and 
allowed to completely cover the cells. The cells were incubated at 37 °C and 5 % CO2 for 1 ;î;h before the addition of an additional 20 ml HEK 293 growth medium. This was followed 
by incubation at 37 °C and 5 % CO2 for -  4 days or until the cells began to show the 
cytopathic effects of rounding up detaching from the flask. The flasks were gently tapped 
to remove all remaining attached cells, which were then harvested by centrifugation at 
1000 rpm for 5 min. The viral medium was carefully decanted and aliquots were stored at 
-80 °C until required for further infections of HEK 293 cells and virus preparations. The 
virus was extracted from the cell pellets as described in Section 4.3.1.4 below.
4.3.1.3. Purification of viral particles from HEK 293 cells
HEK 293 cells fi'om thirty 150 cm^ flasks were combined and resuspended in 10 ml PBS.
An equal volume of ARKeloneP was added to the cell suspension, which was mixed 
thoroughly and allowed to stand for 10 min until the layers separated. The mixture was 
then subjected to centrifugation at 1000 ipm for 5 min, after which time the top lysed layer 
was removed and gently pipetted onto the CsCE giadient prepared as follows. 3 ml 30 %
CsCb (Section 2.1.7) was added to a Beckman 14 x 95 mm tube and this was carefully 
under-layered with 1.5 ml 60 % CsCE (Section 2.1.7). The CsCE giadient was poured 
directly prior to use and after the addition of the top lysed layer it was immediately spun in 
an ultracentrifuge at 27 K, zero deceleration at 8 °C for 90 min in an SW40 swing-out 
rotor. The white viral band was identified and removed by piercing the tube with an 18 G 
needle and withdrawing the virus into a 5 ml syringe. The viral band was then dialysed
Kirsty M. Proctor. 2006 Chapter 4,142
against 1 L TE buffer (Section 2.1.7) at 4 °C overnight. The CsCb gradient and dialysis 
steps were repeated and the purified virus was stored in 50 pi aliquots in cryo-vials at — 80 
until required.
4.3.1.4. Calculation of virus titre for accurate infections
It was essential that the virus be accurately quantified following the preparation of each 
batch of control virus to ensure consistency between samples. The quantification of the 
viral stocks was determined using the Adeno-X™ Rapid Titre Kit as described in the f
Adeno-X™ Rapid Titre Kit Manual and described briefly here.
1 ml of healthy HEK 293 cells ( 5 x 1 0  cells/ml) in HEK 293 growth medium was added 
to each well of a 12-well plate. The number of cells was accurately determined using a
I 'haemocytometer. 10-fbld serial dilutions of the viral sample to be quantified were prepared 
in PBS from 10'  ^ to 10'  ^ml (10'^ 10'\ 10' ,^ 10 ^ 10'  ^ml). 100 pi of each dilution were 
added drop-wise to the appropriate wells. Duplicate infections were performed at each 
dilution to ensure accurate assay results. The cells were incubated at 37 '’C and 5 % CO2 
for 48 h, after which time the medium was aspirated and the cells were allowed to dry in 
the flow-hood for 5 min.
The cells were fixed by the addition of 1 ml ice-cold 100 % methanol to each well and 
incubation at -20 for 10 min. The methanol was then carefully aspirated and the wells 
were rinsed tliree times with 1 ml PBS + 1 % BSA. Anti-Hexon primary antibody 
(provided) was diluted 1:1000 in PBS + 1 % BSA and when the final rinse had been 
aspirated from the cells, 0.5 ml of the antibody dilution were added per well. After 
incubation for 1 h at 37 °C on an orbital shaker, the antibody was aspirated and the cells 
were gently rinsed three times with 1 ml PBS + 1 % BSA. HRP conjugated secondary 
antibody (provided) was then diluted 1:500 in PBS + 1 % BSA and 0.5 ml of this dilution 
were added to each well, followed by incubation at 37 for 1 h on an orbital shaker. 
During this incubation, the DAB working solution was prepared by diluting 10 x DAB 
substrate (provided) 1:10 with 1 x Stable Peroxidase Buffer (provided) and the DAB 
working solution was allowed to come to room temperature. The secondary antibody was 
removed and each well was gently rinsed three times with PBS + 1 % BSA. 500 pi of the 
DAB working solution was added to each well and incubated at room temperature for 10 
min, after which time the DAB was aspirated and 1 ml PBS was added to each well. The 
DAB solution caused the labelled cells to be stained brown/black. The cells were then 
viewed on a microscope with a 20 x objective lens. Four fields were selected at random
..Svïii
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and the numbers of brown/black positive cells were counted per field. Dilutions with 10 % 
or fewer positive cells were eounted and ideal fields contained 5 to 50 positive cells. The 
mean number of positive cells in each well were calculated.
The number of infectious units (ifu)/ ml were calculated as follows:
Ifu = (infected cells/fieldl x (fields / well) 
Volume virus (ml) x dilution factor
4.3.1.5. Multiplicity of infection (MOI)
The titre of the resulting adenovirus is expressed as infectious units or plaque fonning units 
per ml (pfu/ml). The amount of virus used in infections in cell culture is often expressed as 
the ratio of cells to pfu, known as the multiplicity of infection (MOI). Therefore, an MOI 
of 1:100 is equivalent to 100 pfii per cell.
To calculate the volume of a particular virus to add to each well of a 12-well plate, the 
following formula was used:
Number of virus particles ___^  pi virus per well
pfu per pi
Where:
Number of vims particles is calculated fi'om the MOI used, assuming 2 x 10“^ 3T3-L1 
adipocytes per well of a 12- well plate, in a confluent monolayer.
4.3 .2Jnfection  o f  3T3-L1 a d ip o c y te s  with aden oviru s
3T3-L1 adipocytes, differentiated as described in Section 2.3.4.2 were infected on day 6 
post-differentiation unless otherwise stated and the assay was carried out on day 8. On the 
day of infection, the growth medium was aspirated and the cells were gently rinsed twice 
in semm-fiee DMEM. After removal of the final wash, 350 pi semm-ffee DMEM (to 
maximise contact of the vims with the cells) was added to each well. The desired amount 
of vims was then added directly to each well and the plate was swirled gently to induce 
mixing. This was then incubated for 24 hours, after which time the vims was removed and 
replaced with normal 3T3-L1 adipocyte giowth medium. This was then incubated for a 
further 24 h at 37 °C and 5 % CO2 prior to assay.
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4.3.3.Infection o f  HeLa ce lls  with aden ovirus
Î
4.3.5. A den oviru s u se  and sa fe ty  con sidera tion s
Adenovimses are stable at room temperature for a number of days and should never be 
stored at 4 °C. For long-term storage vims stocks were stored in aliquots at -  80 in 
designated, clearly labelled areas. Prior to use, vimses were defrosted at room temperature 
and were maintained at room temperature during use. If an experiment was earned out 
over a number of days (such as day 4 and 6 infections, Section 4.4.4.6), vimses were stored 
at room temperature during this period. As a rule, vimses should not be subjected to more 
than two freeze / thaw cycles to maintain optimum infectivity.
All infections were carried out in a Type II Cell Culture facility designated for adenoviral 
work. Double latex gloves and designated laboratory coats were worn when handling vims 
stocks. Vials containing viral stocks were opened only inside a designated flow hood and 
vims was added directly from the vial to cells to be infected using a sterile pipette tip. All 
virally contaminated plasticware was steeped in Vircon for 30 min before disposal in 
designated waste bags for subsequent autoclaving procedures. Virally infected cells were 
incubated in designated incubators.
Infection of HeLa cells was carried out as for 3T3-L1 adipocytes (Section 4.3.2) except the 
infection was carried out entirely in HeLa growth medium.
4.3.4. Treatm ent o f  in fec ted  3T3-L1 a d ip o cy te s  with MG132
A  10 mM stock solution was prepared by dissolving MG132 in DMSO. 3T3-L1 
adipocytes were infected on day 6 post-differentiation as described in Section 4.3.2. The 
vims was removed 24 h after infection (day 7) and replaced with 500 pi normal 3T3-L1 
adipocyte growth medium per well. 8 h later, 2.5 pi of MG132 were added directly to each 
well (final concentration 50 pM) and the plate was swirled gently to induce mixing. The 
cells were incubated with MG 132 at 37 °C and 5 % CO2 for times from 4 - 1 6  hours. The 
16-hour treatment began on the evening of day 7 and proceeded until the morning of day 8.
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4.4. Results
4.4.1. Design of STXl 6 mutants
The STXl 6 proteins described below were either full-length or truncated versions of the 
STXl6A sequence given in Chapter 3 (Figure 3.2), obtained by direct sequencing of the 
cDNA used in this study (Section 3.5.2). The proteins are described in detail in Sections 
4.4.1.1- 4.4.1.3 and summarised in Figure 4.4.
4.4.1.1. The cytosolic domain (STXIGcyt)
In order to define the role of STXl 6 in GLUT4 trafficking in 3T3-L1 adipocytes, it was 
sought to study the effects of inhibition of STXl6 function. SNARE protein function can 
be inhibited by means of expressing only the cytosolic domain of the SNARE protein in 
question. A protein lacking the transmembrane domain competes with the endogenous 
protein for binding to its SNARE partners thus reducing their interactions with the 
membrane-bound endogenous protein. Other SNAREs have been studied using these so- 
called “poison proteins” to inliibit endogenous protein function, for example the plasma 
membrane localised STXla and STX4 (Olson et al., 1997; Tellam et al., 1997; Volchuk et 
al., 1996). In particular, previous work in our laboratory involved the study of STX6 by 
expressing the cytosolic domain of the protein (Perera et al., 2003). Therefore a constmct 
expressing only the cytosolic domain of STXl 6 (denoted STX16cyt) was generated.
DNA strider (www.cellbiol.com) was utilised to generate a Kyte/Doolittle hydropathy plot 
in order to locate the residues comprising the transmembrane domain (Figure 4.5). The 
full-length STXl 6 sequence was analysed. The plot predicted that the transmembrane 
domain begins approximately at residue M280. It was therefore decided to tmncate the 
protein after residue R278 to ensure that no hydrophobic residues remained and all 
membrane associations had been abolished. Therefore the STX16cyt mutant comprised 
residues 1-278 of the full-length STX16A sequence (Figure 4.4), plus an N-tenninal myc- 
tag.
4.4.1.2. N-terminal deletion mutant (STXl6T)
It was hypothesised that, like STXla (Dulubova et al., 1999; Misura et aL, 2001) (Section 
1.5.2), STXl6 could adopt an active and inactive confonnation in which the N-tenninal
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Habc domain may self-associate with the functional SNARE domain, preventing SNARE 
complex assembly with other SNAREs. Figure 4.6 demonstrates how these so-called open 
and closed conformations, if adopted by STXl 6, could be regulated either by 
phosphorylation or mVps45 binding. In order to test this model, and to determine whether 
each conformation exerts a different effeet on GLUT4 trafficking, an N-terminal truncation 
mutant of STXl 6 lacking the Habc domain, denoted STX16T, was constructed (Figures 4.4 
and Figure 4.6).
Previous work has shown that deletion of the N-terminal Habc domain of either STXla or 
Ssolp significantly increases the rate of SNARE complex formation and / or membrane 
fusion compared to the full-length proteins (Nicholson et. al., 1998; Parlati et. al., 1999). It 
is assumed that in the absence of the inhibitory action of the Habc helices, the SNARE 
motif is more readily available for binding to other SNAREs.
Similarly, it was hypothesised that removal of the STXl 6 Habc domain would prevent 
formation of the closed confoimation (if indeed a closed conformation exists) rendering 
STX16T a constitutively active version of wild-type STXl 6. Removal of the Habc domain 
would also have the effect of removing the mVps45 binding site (Dulubova et al., 2002) 
and the hypothesised sites of phosphorylation (Chapter 3). This construct was therefore 
anticipated to mimic the open active confoimation with the SNARE motif available for 
binding at all times.
A similar mutant was made previously in the yeast homolog, Tlg2p, (Bryant and James, 
2001) in which the N-terminal 230 residues (constituting the Habc domain) were removed. 
This mutant was shown to bypass the requirement for Vps45p in SNARE complex 
assembly in yeast. Binding to Vps45p was abolished but the truncated Tlg2p was still able 
to form complexes with its cognate SNAREs Tlglp and Vtilp in cells lacking the SM 
protein (Bryant and James, 2001). The sequence alignment of STXl 6 with Tlg2p generated 
in Chapter 3 (Figure 3.2) was utilised to compare the position of the domains. Figure 4.7 
highlights the first residue of the Tlg2p N-terminal truncated mutant (residue T231). The 
corresponding STXl6 threonine residue in the homology plot is T197. Figure 3.4B (in 
Chapter 3), demonstrates that this residue is predicted to occur within the linker region 
between the Habc and SNARE domains. Therefore STX16T was truncated before residue 
T197, and so constitutes residues 197 -  303 of wild-type STX16A (Figure 4.4). This 
mutant was cloned bearing an N-teiminal HA tag.
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4.4.1.3. Full-length STX16 (STX16F)
It has been shown that expression of full-length Syntaxins can amplify the effects of these 
Syntaxins (Pagan et al., 2003; Thurmond et al., 1998). Therefore, it was decided to 
compare the effects of expressing truncated STX16 (STX16T) with those of expressing 
full-length STX16 and so an adenovirus construct expressing full-length STX16 was 
prepared (denoted STX16F) to provide a control in experiments involving the expression 
of STX16T. The sequence of STX16F was identical to the sequence of STX16A (Figure 
3.2, Chapter 3), constituting all 303 residues (Figure 4.4), and an N-terminal myc-tag.
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A) STX16F
N H abc 303SNARE TM C
B) STX16cyt
N H abc 278SNARE C
C) STX16T
N 197 303SN ARE TM C
Figure 4.4 Comparison of domain structures of STX16F, STX16cyt and STX16T
Schem atic diagram o f  full-length ST X 16 and the ST X 16 mutants, ST X 16 mutants 
were designed to a llow  the effec ts  o f  G LUT4 trafficking to be studied in 3T3-L1 
adipocytes. The N - and C-term ini are indicated, including the residue num bers. 
Coloured boxes correspond to different structural elem ents in STX 16. A) STX 16F, full 
length STX 16, com prising all 303 residues. B) S T X 16cyt, cytosolic domain o f  STX 16, 
com prising residues 1-278, and consisting o f  the N-term inal m V ps45 binding m otif, 
the intact Habc and SN A R E  dom ains but lacking the transmembrane dom ain. C) 
STX 16T, truncation mutant lacking the N-term inal Habc domain and m Vps45 binding 
m otif, and com prising residues 197-303.
N-terminal - N-term inal 55 residues predicted to bind to m V ps45 (D ulubova et.
m otif (green) al., 2002)
Habc (blue) -Syntaxin  hom ology  or autoinhibitory dom ain, characteristic o f
syntaxins
SNARE (pink) -SN A R E  hom ology dom ain, the defining feature o f  SN A R E s and
facilitative o f  their assem bly into SNARE com plexes 
TM (purple) -C -term inal transm em brane dom ain, w hich  con fers m em brane
attachment
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Figure 4.5 STX16 Kyte-Dooiittle Plot, indicating the position of the 
transmembrane domain
DNA Strider (www.cellbiol.com) was used to generate a Kyte/Doolittle 
hydropathy plot. Hydrophobic domains are plotted as positive numbers, 
indicated by peaks above the black line. A red arrow indicates the 
predicted location of the transmembrane domain at residue M280. 
STXlôcyt was therefore truncated after R278.
A hydropathy plot is an approximate method to determine the higher order 
structure of a protein. It is based on the principle that 20-30 consistently 
hydrophobic residues are required to constitute a membrane-spanning a- 
helix. For each amino acid residue, a weighted average of the 
hydrophobicity of the residue and its immediate neighbours are calculated. 
Hydrophobic domains are plotted as positive numbers (Lackie and Dow, 
2003).
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STX 16
B
“Active” Phosphorylated? Active
± mVps45?
< ------------------------------
Dephosphorylated?
STX16T
Figure 4.6 Comparative models of wild-type STX16 and STX16T
A) STX 16 may exist in a closed “inactive” or an open “active” confirmation, in which 
the availability of the SNARE domain (pink) for binding to other SNAREs is regulated 
by mVps45 binding and /or phosphorylation. B) Removal of the Habc domain (blue) 
prevents the formation of a closed confirmation. The mVps45 binding site (Dulubova 
et al., 2002) and hypothesised sites of phosphorylation (Chapter 3) will also be absent 
in this mutant, therefore bypassing the requirement for a regulated shift to the active 
state, mediated either by mVps45 or phosphorylation. This construct is anticipated to 
mimic the active “open” conformation with the SNARE motif available for binding at 
all times.
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STX 16 T lg2p
STX 16 T lg2p
STX16T lg2p
STX16T lg2p
STX 16 T lg2p
STX16T lg2p
STX 16 T lg2p
MATRRLTDAFLLLRNNSIQNRQLLA--EQLADDR MALVSGISLDPEAAIGVTKRP-- 53-MFRDRTNLFLSYRRTFPHNITFSSGKAPLGDDQDIEMGTYPMMNMSHDISARLTDERKN 59
•A- - A «  *  +  *  « A -  • •  *  A 4 »  A  • •  »  A
---------------- PPKWVDGVDEIQYDVGRIKQKMKESASLHDKHLNRPTLDDSSEEEHAIEIT104KHENHSDALPPIFIDIAQDVDDYLLEVRRLSEQLAKVYRKNS-LPGFEDKSHDEALIEDL118
A A- . « A  • • • •  • • • •  • • A .  .  A .  A .  .  A A .  A A A
TQEITQLFHRCQRAVQPCRAGP---------- GPAPSRRGGCLGT--WCLVAQALQELSTSFRH156SFKVIQMLQKCYAVMKRLKTIYNSQFVDGKQLSREELIILDNLQKIYAEKIQTESNKFRV178
. .  . A . .  .  A • •  • •  A A A • » A » . A  A A A
#  #  AAQSGYLKRMKNREER - - SQHFFDTSVPLMDDGDD----------------------NTLYHRGFTEDQLV2 0 2LQNNYLKFLNKDDLKPIRNKASAENTLLLDDEEEEAAREKREGLDIEDYSKRTLQRQQQL238
A A A A  . . .  .  .  ■ ■  A » A A » , * « A »  « A  «
LVEQNTLMVEEREREIRQMVQSISDLNEIFRDLGAMIVEQGTVLDRIDYNVEQSCIKTED262HDTSAEAYLRERDEEITQLARGVLEVSTIFREMQDLWDQGTIVDRIDYNLENTWELKS298
.  A A . A  A A .  .  .  .  .  A A A . .  .  . A .  A A A .  . A A A A A A . A .  .  .  .  .
GLKQLHKAEQYQKKNRKMLVILILFVIIIVLIWLVGVKSR----------------------------------- 303ADKELNKATHYQKRTQKCKVILLLTLCVIALFFFVMLKPHGGGSGGRNNGSNKYNNDDNK3 5 8
A  .  A .  A A . A A A .  .  A A A A .  A  .  .  A A .  . .
TVNNSHDDGSNTHINDEESNLPSIVEVTESENDALDDLL 3 97
AVFPMILW RED Small (small+ hydrophobic (incl.aromatic -Y))
DE BLUE Acidic
RHK MAGENTA Basic
STYHCNGQ GREEN Hydroxyl + Amine + Basic - Q
Others Gray
Figure 4.7 Sequence alignment of STX16 with Tlg2p
Sequence alignment of STX16A and yeast Tlg2p, generated using ClustalW and used here 
to design STX16T. Identical residues are indicated by an asterisk, conserved residues by 
double dots and semi-conserved residues by a single dot. A red dot indicates the beginning 
of the Tlg2p N-terminal truncation mutant (Bryant and James, 2001) at residue T231, 
which occurs within the linker region between the Habc domain and the SNARE domain. 
According to Figure 3.4 (Chapter 3) the STX 16 Habc domain ends ~ at residue SI59 and 
the SNARE domain begins ~ at residue R214, each denoted by purple dots. Therefore, the 
corresponding threonine residue in STX 16, T197 (denoted by a blue star), also occurs 
within the linker region between the Habc and SNARE domains. Therefore STX16T was 
truncated before residue T197. The transmembrane domains of both proteins are 
highlighted with a red arrow.
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4.4.2. Construction of recombinant adenoviruses to express 
STX16cyt, STX16T and STX16F in 3T3-L1 adipocytes
4.4.2.1. Cloning of STX16cyt, STX16T and STX16F into 
pShuttle-CMV
The first step involved the cloning of the genes of interest into the “shuttle” vector 
pShuttle-CMV (See Appendix) (He et al, 1998), which makes use of the heterologous 
cytomegalovirus (CMV) promoter.
The c-DNAs encoding STXlôcyt (834 bp), STX16T (318 bp) and STX16F (915 bp) were 
PCR amplified using the conditions and cycling parameters described in Section 2.2.1. The 
full-length STX 16 open reading frame including the N-teiminal myc-tag, housed in 
pCR3.1 (Section 3.5.2.1) was used as the template DNA for each PCR at a concentration 
of 0.5 mg/ml. Primers were designed to each domain appropriately, including an N- 
tenninal myc (63 bp) or HA (27 bp) tag and restriction sites compatible with pShuttle- 
CMV {Bglll at the N-terminus and Hindlll at the C-terminus).
The forward primer for both STXlôcyt and STX16F was simply the first 18 bp encoding 
the N-terminal myc-tag. Since STXl 6T contained an N-teraiinai truncation, the myc-tag 
could not be amplified directly from STXl6 pCR3.1. Therefore an N-terminal HA-tag was 
included in the forward primer, followed by a start codon inserted before base 197 
(corresponding to the start of the SNARE domain). The HA-tag was chosen due to it 
having a short recognition sequence, in keeping with an appropriate primer length.
The reverse primer for both STX16F and STX16T was simply the bases encoding the C- 
terminal 21 residues of STXl 6, including the stop codon. In the reverse primer for 
STXlôcyt, a stop codon was inserted after residue 278 (corresponding to the end of the 
cytosolic domain).
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Therefore, the primers were as follows (restriction sites underlined; start and stop codons 
in bold):
STXlôcyt
Fwd: 5’-AAAGATÇTATGGCCCATATGGAACAAAAA-3’
Rev: 5 ’-GGAAGCTTTTACCGATTCTTCTTTTGA-3 '
STX16T
The sequence of the HA tag is indicated.
Fwd:
HA tag
5’- AGATCTATGTACCCTTACGATGTGCCTGATTACGCAACAGAGGACCAGTTA - 3’ 
Rev: 5’-GGAAGCTTTTATCGAGACTTCACGCCAAC -3’
STX16F
Fwd: 5’-AAAGATÇTATGGCCCATATGGAACAAAAA-3 ’
Rev: 5’-GGAAGCTTTTATCGAGACTTCACGCCAAC -3’
The resulting PCR products were gel purified as described in Sections 2.2.3 and 2.2.4 
(Figure 4.8A and Figure 4.9A), Taq-treated (Section 2.2.5) and TA cloned into pCR2.1 as 
described in Section 2.2.6. White colonies, positive for the introduction of the insert were 
selected and propagated as in Section 2.2.10. The pCR2.1 plasmids were sequenced fully 
on both strands before proceeding. The inserts were freed from pCR2.1 by enzymatic 
digestion with Bglll and Hindlll (Section 2.2.7), gel purified and ligated (Section 2.2.8) 
into pShuttle-CMV which had been digested with the same enzymes (Figure 4.9B). 
Ligation products were then transfoiined into TOP-10 cells and colonies were selected in 
the presence of Kanamycin (Section 2.2.9). Plasmid DNA was isolated as described in 
Section 2.2.11 and successfhl transformants were identified by restriction digest with Bglll 
and Hindlll (Figure 4.8B and Figure 4.9C). These were ethanol precipitated (Section 
2.2.15) and fully sequenced on both strands (Section 2.2.16) to confinn that no unwanted 
point mutations had been introduced by the PCR.
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4.4.2.2. ViraQuest
100 pi of each plasmid, at a concentration of 1 mg / ml was required for recombination. 
Large-scale DNA preparations (Section 2.2.12) were therefore carried out to generate large 
amounts of the desired plasmids, after which the plasmid DNA was resuspended in TE 
buffer pH 8.0 (Section 2.1.7). Recombination and amplification were then earned out at 
ViraQuest Inc. as described in Section 4.3.1.1 (Figure 4.3). The titre of the resulting 
recombinant adenoviruses was 3.0 x 10^  ^PFU/ml.
4.4.3. Control virus
A recombinant adenovirus generated previously in our laboratory by H.K.I. Perera (Perera 
et al., 2003) was used as the control for my functional studies. This adenovims was 
generated using “empty” pShuttle-CMV vector i.e. no insert was cloned into the vector 
prior to recombination. Amplification, purification and quantification of this virus were 
carried out routinely in this study as required as described in Sections 4.3.1.3 to 4.3.1.5.
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Cl 02
1 kb
-4—  STXlôcyt (897 bp)
B L Cl C2
\<—  pShuttle-CMV 
(~ 7.4 kb)
1 kb — H
\<—  STXlôcyt (897 bp)
Figure 4.8 Construction of STX16cyt pShuttle-CMV plasmid
A) Products of two independent PCRs (Cl and C2) resolved on a 1 % agarose gel. 
The strongly stained bands at ~ 0.9 kb correspond to STXlôcyt cDNA. This was 
then TA cloned into pCR2.1 for propagation in bacterial cells, and the STXlôcyt 
insert was freed by restriction digests with Bglll and Hindlll (not shown). pShuttle- 
CMV vector was also digested (not shown). B) Restriction digests with Bglll and 
Hindlll of two potential ligation products (Lanes Cl and C2) following ligation of 
STXlôcyt into pShuttle-CMV. The bands at ~ 7.4 kb can be attributed to pShuttle- 
CMV; the insert, freed by the restriction digest, is observed in sample C2.
L; 1 kb DNA ladder. The 1 kb mark is indicated.
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L T1 T2 FI F2
0.5 kb
STX 16F (978 bp) 
STX16T (318 bp)
B 5 fil 3 i^l
1 r  1L T1 FI P T2 F2
0.5 kb
0.25 kb
pShuttle-CMV (7.4 kb) 
2.7 kb 
1.2 kb
pCR2.1
STX 16F (978 bp) 
STX16T (381 bp)
0.5 kb
0.25 kb
pShuttle-CMV (~ 7.4 kb)
STXl6F (978 bp) 
STX16T (318 bp)
Figure 4.9 Construction of STX16T and STX16F pShuttle-CMV plasmid
A) STX16T (Lanes T1 and T2) and STX 16F (Lanes FI and F2) were PCR amplified 
and the resulting products were resolved on a 1 % agarose gel. Lane F2 contains a 1 
kb band corresponding to STX16F and lanes T1 and T2 contain bands at 0.3 kb 
corresponding to STX16T cDNA. B) Restriction digests with Bglll and Hindlll of 5 
pi and 3 pi respectively of STX16T (T1 and T2) and STX16F (FI and F2) TA- 
cloned into pCR2.1. pCR2.1 contains an internal Bglll site and as such is observed as 
two bands at 2.7 and 1.2 kb. STX16T can be observed at 0.3 kb in T1 and STX16F at 
1 kb in F2. pShuttle-CMV vector (P) was also digested with the same enzymes. C) 
Restriction digests with Bglll and Hindlll of ligation products following ligation of 
STX16F (F) and STX16T (T) into pShuttle-CMV. pShuttle-CMV can be observed at 
~ 7.4 kb and STX16T and STX16F at 0.3 and 1 kb respectively.
L: 1 kb DNA ladder. The 3, 1, 0.5 and 0.25 kb marks are indicated.
:
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4.4.4. Optimisation of infection of STX16cyt in 3T3-L1 
adipocytes
4.4.4.1. Trial infection of HeLas
As HeLas are easier to infect, expression of STXlôcyt was verified in these cells first. 
HeLa cells, grown to ~ 70 % confluence in 12-well plates, were infected with increasing 
amounts of STXlôcyt adenovirus as described in Section 4.3.3 at MOIs (Section 4.3.1.6) 
of 1:3, 1:9, 1:33, 1:99 and 1:300 (Figure 4.10). 48 h after infection, lysates were prepared 
(Section 2.3.4.3) and separated on a 12 % SDS-PAGE gel. This was transferred to 
nitrocellulose and immunoblotted with anti- myc (Sections 2.4.4 and 2.4.5). It appeared 
that optimum expression was reached with an MOI of 1:99, An MOl of 1:300 perhaps 
resulted in cytopathic effects, resulting in less efficient expression. This experiment 
verified that the virus was capable of expressing myc-tagged STXl 6cyt.
4 4.4.2. Infection of 3T3-L1 adipocytes
3T3-L1 adipocytes were infected similarly with increasing amounts of STXlôcyt 
adenovirus from MOIs of 1:150 to 1:300 (Figure 4.11). The infections were earned out in 
serum-free DMEM as described in Section 4.3.2. The optimum MOI for infection of 3T3- 
L1 adipocytes was found to be 1:225. This experiment verified that the virus was able to 
confer expression of STXlôcyt in 3T3-L1 adipocytes and that this protein was successfully 
labelled with anti-STXl 6. Although myc-tagged STXlôcyt has a predicted molecular 
weight of 34.48 kDa, it was observed to run faster thi'ough the SDS-PAGE gel than 
endogenous STXl6 (predicted molecular weight 34.78 kDa).
4.4.4.3. Infection in 3T3-L1 adipocytes +/- 0.5 % BSA
Infection of 3T3-L1 adipocytes with adenovirus is generally earned out in the presence of 
0.5 % BSA. However, previous work in our laboratory suggested that the presence of BSA 
during infection miglit interfere with GLUT4 trafficking, increasing the basal level of 
glucose uptake (unpublished data). Therefore, infection was earned out using the optimum 
MOI of STXlôcyt adenovirus, (1:225) both in the presence and absence of 0.5 % BSA. 
Lysates were prepared (Section 2.3.4.3) and probed for the presence of STXlôcyt by
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immunoblotting with anti-STX16 (Sections 2.4.4 and 2.4.5). STXlôcyt was expressed at 
similar levels in cells infected in media ± 0.5% BSA, indicating that infections could be 
carried out successfully in serum-free media. This was advantageous for my study, as the 
infected cells were to ultimately be used to investigate GLUT4 trafficking.
However, this experiment higlilighted another important point. It showed that STXlôcyt 
was expressed to a level less than that of endogenous STXl 6. In order to produce effective 
inhibition the endogenous protein, it was considered that it may be necessary to increase 
this level of expression.
4.4.4.4. avp5 integrins
I therefore set out to investigate why the levels of STXlôcyt expressed were lower than 
anticipated. Section 4.1.1.5 describes the process of internalisation of the adenovirus into 
target cells, mediated by the CAR and cellular integrins. Both av(33 and avp5 integiins 
support adenovirus internalisation (Wickham et al. 1993). It was suggested that the levels 
of these integrins can vary considerably between cell-types and that the quantification of 
the avp5 integi ins may be a good way of predicting the susceptibility of cells to adenovirus 
vectors (Takayama et al., 1998). It was also reported that the expression level of integiins 
and the efficiency of adenovirus-mediated gene transfer varied during differentiation of a 
skeletal muscle cell line (Acsadi et al., 1994). Therefore, I set out to determine the most 
favourable time post-differentiation to infect the cells with regard to the availability of the 
avp3 and avp5 integrins.
The relative quantities of avP5 and avp3 were measured from day 2 to day 10 post­
differentiation. Therefore, 3T3-L1 fibroblasts were differentiated as described in Section 
2.3.4.2 and lysates were prepared (Section 2.3.4.3) from day 2 to day 10 post- 
differentiation. These lysates were analysed by immunoblotting with appropriate 
antibodies (Figure 4.12). The bands were quantified using Scion Image software.
When exposed to heat and SDS, the integrins denature into the individual subunits, av (150 
kDa), P3 (90-110 kDa) and P5 (80 kDa) and so the lysates were probed with antibodies 
specific to each individual subunit. The av subunit (150 kDa) further dissociates into two 
subunits (125 kDa and 25 kDa). The lysates were probed using anti-p5 (80 kDa), anti-av 
(125 kDa), anti-av (25 kDa) and anti-p3 (90-110 kDa). The antibody to the 25 kDa subunit 
of av did not produce a clear result, therefore this protein was quantified by means of the
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antibody specific to its 125 kDa subunit. Similarly, the p3 subunit could not be studied, as 
the quality of the antibody binding was poor.
This experiment highlighted, importantly, that the av and pS subunits are indeed expressed 
in 3T3-L1 adipocytes. It also demonstrated that the levels of both subunits do in fact 
change during differentiation. Figure 4.12 demonstrates an increase in the levels of each 
subunit, particularly the P5 subunit, from day 2 to day 5 followed by a decrease from day 5 
to day 10. Since a peak in integrin expression was reached at day 5 post-differentiation 
(with a 3.5-fold increase in p5 expression over expression on day 2), infection on this day 
was attempted, however, the levels of STXl 6cyt produced were identical to those observed 
from day 6 infection (not shown). Maximum expression of each subunit was observed 
between days 4 and 6, indicating that it was indeed advantageous to can-y out infections at 
this time (as in Section 4.4.6). Therefore, it was concluded that it was not possible to 
improve the expression levels of STXlôcyt by changing the time of infection.
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MOI
1:0 1:3 1:9 1:33 1:99 1:300
34 kDa a-myc
STXlôcyt
Figure 4.10 Expression of STXIScyt in HeLa cells
HeLa cells were infected with STXlôcyt adenovirus as described in Section 4.3.3. 
Increasing MOIs were used as indicated, from no virus (1:0) to MOI 1:300. Lysates 
were resolved on a 12 % SDS-PAGE gel. Myc-tagged STXlôcyt was visualised by 
Western Blotting with anti-myc.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
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34 kDa STX 16 
STXlôcyt
B SF 0.5 % BSA 
  ►
0 1:225 0 1:225
34 kDa STX 16 STXlôcyt
Figure 4.11 Infection of 3T3-L1 adipocytes with STXIBcyt in the presence and absence of 
0.5 % BSA
A) 3T3-L1 adipocytes were infected in serum-free DMEM (SF) on day 6 post- 
differentiation as described in Section 4.3.2 with MOIs of 1:150 to 1:300 STXlôcyt 
adenovirus per well of a 12-well plate. Lysates were analysed by electrophoresis 
through a 12 % SDS-PAGE gel followed by Western Blotting with anti STXlô. Both 
endogenous STXlô and STXlôcyt can be observed. B) 3T3-L1 adipocytes were 
infected on day ô post-differentiation with MOI 1:225 of adenovirus per well (1:225) or 
no virus (0), in either serum free DMEM (SF) or DMEM supplemented with 0.5 % BSA 
(0.5 % BSA). The lysates from this experiment were probed with anti-STX16 as above. 
STXlôcyt is observed at similar levels when cells are infected either with or without 0.5 
% BSA, indicating that infection can be carried out in serum-free medium thus avoiding 
the complications associated with infection in the presence of exogenous serum. 
Endogenous STXlô is observed in all lysates in (A) and (B) at ~ 34 kDa as indicated. 
This highlights that the level of expression of STXlôcyt is < 50 % of that of the 
endogenous protein.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
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Figure 4.12 Expression of the av and p5 subunits In 3T3-L1 adipocytes from day 2 to day 10 post-dlfferentlatlon
3T3-L1 fibroblasts were differentiated as in Section 2.3.4.2. A) Lysates were prepared 
from 3T3-L1 adipocytes from day 2 to day 10 post-differentiation. These were 
separated by electrophoresis through a 12 % SDS-PAGE gel and probed for the pS and 
the 125 kDa av integrin subunits by immunoblotting. The lysate loaded in each well 
corresponds to 2 % of the total lysate obtained from one well of a 12-well plate.
B) Quantification of the data in (A) generated using Scion Image software. This 
highlights an increase in the expression level of av and (35 from day 2 to day 5, 
followed by a decrease from day 5 to 10. Although the quantification of each receptor 
can be compared from day to day, the levels of the av should not be compared to that of 
the P5 due to differences in the binding affinities of the antibodies.
This experiment was repeated three times with similar results. Data from a
representative experiment is shown.
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4.4.4.5. Why such low expression?
After confirming that the integrin mediated endocytosis of the virus was maximal, it was 
anticipated that the reason for poor expression of STXl 6cyt could relate to its cognate SM 
protein, mVps45 (Section 1.6.5). It has been shown that SM proteins and their t-SNAREs 
are expressed at 1:1 stoichiometry (Hickson et al., 2000) and that deletion of Vps45p, the 
yeast homologue of mVps45, results in rapid proteasomal degradation of its cognate t- 
SNARE, STXl6 homologue Tlg2p (Bryant and James, 2001). As STXl6 is upregulated 
post-differentiation (Shewan et al., 2003), it was speculated that perhaps the additional 
protein expressed by the vims exceeded the level of mVps45 and was subsequently 
degraded by the proteasome.
Two methods were employed to address this possibility. The first involved canying out 
multiple infections earlier in the differentiation process and the second involved inliibition 
of proteasome function. These methods are detailed in sections 4.4.4.6 and 4.4.4.V below.
4.4.4.6. Expression of STX16cyt is increased by infection 
of 3T3-L1 adipocytes on days 4 and 6 post­
differentiation
As mentioned previously, infections were generally carried out on day 6 post- 
differentiation to allow for 48 h incubation time before the assay on day 8 when the cells 
should be fully differentiated. Previous work indicated that STXl 6 was upregulated by 4.6 
±2.1 fold (n=4 ±SEM) upon differentiation of 3T3-L1 fibroblasts into adipocytes, by day 8 
post-differentiation (Shewan et al., 2003). It was reasoned that if the cells were infected 
before or during the upregulation of STX 16, perhaps more STXlôcyt would be expressed 
by the vims at the expense of endogenous STXl 6. Therefore, cells were subjected to 
multiple, duplicate or single infections, 48 h apart, on days 2, 4, and 6, days 4 and 6 or day 
6 only post-differentiation. Each infection was earned out using an MOI of 1:225 per well 
of a 12-well plate as described in Section 4.3.2.
Figure 4.13 shows that infection on days 2, 4 and 6 post-differentiation increased the 
expression of STXlôcyt most dramatically with ~ 2.75-fbld increase in protein produced, 
compared to infection on day 6 alone. However, these multiple infections, beginning only
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one day after differentiation was induced, appeared to interfere with the differentiation 
process. Assessment of these cells under a 2 0  x objective lens indicated that they possessed 
fibroblast-like morphology, even at day 10 post-differentiation (not shown). However, 
cells infected on days 4 and 6  post-differentiation differentiated well and produced more 
STXlôcyt (~ 1.5-fold increase) compared to those infected on day 6 only. Therefore this 
was the chosen method to carry out the functional assays detailed in Chapter 5. 
Surprisingly, the anticipated reduction in the level of endogenous protein with the 
corresponding increase in STXlôcyt was not observed. This will be discussed below in 
Section 4.5.
4.4.4.7. Expression of STX16cyt is increased when 3T3- 
L1 adipocytes are treated with Proteasome inhibitors 
(IVIG132) following infection on day 6 post­
differentiation
The proteasome is the second major cellular compartment for proteolysis. Located 
abundantly in both the cytoplasm and nucleoplasm, often accounting for up to 1 % of total 
cellular protein, proteasomes are large, cylindrical structures composed of multiple protein 
subunits. There are several proteolytic active sites in the stmcture, which combine to 
degrade proteins to small peptides (Bochtler et al., 1999). The best-characterised targeting 
mechanism to the proteasome involves the reversible, covalent linkage of a small protein, 
ubiquitin, onto the target protein (Bonifacino and Weissman, 1998). Tlg2p could be 
stabilised in cells lacking Vps45p by inhibition of proteasome function. (Bryant and James, 
2001).
Therefore, in the second method employed to increase expression of STXlôcyt in 3T3-L1 
adipocytes, the cells were treated with proteasome inhibitors. MG132 (Z-Leu-Leu-Leu- 
CHO, C26H41N3O5) is a potent, cell permeable and selective proteasome inhibitor 
(BIOMOL International, product data). MG132 was prepared as described in Section 4.3.4 
by dissolving in DMSO.
3T3-L1 adipocytes were infected with MOI 1:225 STXlôcyt adenovirus on day 6  post­
differentiation (Section 4.3.2.). Treatment with 50 pM MG132 on day 7 post­
differentiation was earned out as described in Section 4.3.4 for 4 to lô h as indicated in 
Figure 4.14. The cells remained healthy throughout the treatment as judged by 
moiphological analysis under a 2 0  x objective lens (not shown). Lysates were prepared 48
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h after infection and analysed by gel electrophoresis and immunoblotting with anti- STX 16 
(Figure 4.14). The level of STXlôcyt expressed was dramatically increased with MG132 
treatment. Treatment of the cells with MG132 for 16 h was capable of increasing the level 
of STXlôcyt produced by almost 10-fold. The level of endogenous STXlô remained 
constant during the treatment. STXlôcyt was not observed in cells treated with 50 pM 
MG132 only or DMSO only (the solvent for MG132) in the absence of virus and no 
change in the level of endogenous STXlô was obseiwed. This indicates that the additional 
STXlôcyt obseiwed in infected cells treated with MG132 was indeed expressed by the 
virus and was not a product of any other treatment.
4.4.4.8. Levels of I RAP, mVps45, STX4, Vti1a, VAMP2 and 
endogenous STX16 remain constant with MG132 
treatment
Figure 4.14 demonstrates that the level of endogenous STXlô was not affected when cells 
were exposed to MG 132 proteasome inhibitors. It was decided to investigate if the 
treatment altered expression of a range of representative proteins relevant to my study or if 
the effect was indeed specific to STXlôcyt. Therefore the lysates prepared in Section 
4.4.4.7 were analysed by Western Blotting for the presence of IRAP, mVps45, STX4, 
Vtila and VAMP2 by probing with appropriate antibodies. Figure 4.15 shows that the 
levels of all these proteins remained constant with MG 132 treatment.
As mentioned above, the level of endogenous protein remained constant, suggesting that 
STX1Ô is not normally subject to proteasomal degradation, as inhibiting proteasome 
function did not result in an increase in this protein. Similarly, the levels of Vtila, a t- 
SNARE known to interact with STXl 6 in a functional SNARE complex (Bose et al., 2005; 
Mallard et al., 2002) (this study, Chapter 3) and VAMP2 and STX4, chosen as 
representative examples of v- and t-SNAREs known to be involved in GLUT4 trafficking 
(Foster and Klip, 2000), were unchanged.
It has been reported that inhibition of proteasome function, mediated by MG 132, decreased 
the level of GLUT4 in the cell (Cooke and Patel, 2005), a finding that could potentially be 
detrimental to my functional studies. The lysates were therefore probed with antibodies to 
GLUT4; however, the results were unclear due to poor quality of antibody binding at this 
time. IRAP is known to traffic similarly to GLUT4 (Garza and Birnbaum, 2000) and as
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such the levels of this protein were analysed and found to remain uniform in the absence of 
proteasome flmction.
Given that t- SNAREs and their SM proteins were shown to be expressed at a 1:1 ratio 
(Hickson et al., 2000), it was deemed necessary to investigate how the levels of mVps45 
were affected. Surprisingly, the level of mVps45 remained constant although the level of 
its cognate t-SNARE increases significantly. This will be discussed in more detail in 
Section 4.5.
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Figure 4.13 Expression of STXlôcyt In 3T3-L1 adipocytes Is Increased when cells are 
infected on days 4 and 6 post-dlfferentlatlon
3T3-L1 adipocytes, differentiated as described in Section 2.3.4.2, were subjected to 
infection with MOI 1:225 STXlôcyt adenovirus (Section 4.3.2) on days 2, 4 and ô, 
days 4 and 6 or day 6 only, as indicated. Cells treated in the same way but without 
virus provided a control (no virus). A) Immunoblot of the cell lysates with anti-STXlô. 
B) Quantification of data in (A). Although cells infected on days 2, 4 and ô post- 
differentiation displayed the most dramatic increase in the expression of STXlôcyt 
compared to infecting on day 6 only (>2.5 fold increase), the morphology of these 
cells remained fibroblastic during the differentiation process, suggesting that infection 
early in the differentiation process interferes with the process. Infections on days 4 and 
Ô post-differentiation increased the level of expression of STXlôcyt, compared to 
infecting on day 6 only (~ 1.5 fold). Cells treated in this way were observed to 
differentiate normally and expression of STXlôcyt was approximately equal to that of 
endogenous STXlô. The level of endogenous protein (indicated at 34 kDa) was not 
significantly altered by multiple infections.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
This experiment was repeated multiple times with similar results. Data from a 
representative experiment is shown.
Kirsty M. Proctor, 2006 Chapter 4,168
Virus day 6 
+ MG132
MG132 DMSO 
only only
34 kDa
STXl 6
STXlôcyt
B
Expression of STX16cyt in 3T3-L1 Adipocytes
h
W T3
i l
1 
§
2 0) 
V
10
8
6
4
2
0 Æ L
Condition
Figure 4.14 Stabilisation of STXIBcyt expression with MG132
Lysates prepared from 3T3-L1 adipocytes treated as indicated were resolved on a 12 % 
SDS-PAGE gel and analysed by Western Blotting with anti- STXl6. A) 3T3-L1 
adipocytes were infected with MOI 1:225 STXlôcyt adenovirus on day ô post- 
differentiation as described in Section 4.3.2. 50 pM MG 132 was then added for 0, 4, ô 
or lôh (lanes 2 - 5). Control cells were untreated (Lane 1), treated with 50 pM MG 132 
only (Lanes ô and 7) or DMSO only (Lanes 8 and 9) for ô or 1 ô h. B) Quantification of 
the levels of STXlôcyt produced in cells treated as in (A). The numbers on the x-axis 
correspond to the numbers below each lane in (A). This indicates that treatment with 
MG132 for lô h increases the expression of STXlôcyt by ~10-fold compared to 
infection on day ô alone.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
This experiment was repeated three times with similar results. Data from a 
representative experiment is shown.
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Figure 4.15 Levels of IRAP, mVps45, STX4, V tila, VAMP2 and endogenous S TX l6 remain 
constant following treatment with MG132 proteasome inhibitors
Lysates prepared from 3T3-L1 adipoeytes treated as indicated were resolved on a 12 % 
SDS-PAGE gel and the levels of IRAP, mVps45, STX4, Vtila, VAMP2 and STXl6 
were analysed by immunoblotting with relevant antibodies. 3T3-L1 adipocytes were 
infected with MOI 1:225 STXlôcyt adenovirus on day ô post-differentiation as 
described in Section 4.3.2. 50 pM MG132 was then added for 0, 4, ô or lôh (lanes 2 - 
5). Control cells were untreated (Lane 1), treated with 50 pM MG 132 only for lôh 
(Lane ô) or DMSO only for lô h  (Lane 7).
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
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4.4 4.9. Optimisation of STX16F in 3T3-L1 adipocytes
Expression of STX16F was optimised based on the findings for STXlôcyt above (Section
4.4.4), It was anticipated that expression of STXlôF might be subject to the same 
limitations experienced when expressing STXlôcyt, requiring stabilisation by mVps45. In 
support of this notion, Bryant and James (Bryant and James, 2001) were unable to 
overproduce Tlg2p significantly in wild-type cells, presumably because levels of Vps45p 
became rate limiting.
STX1ÔF expression was optimised in 3T3-L1 adipocytes, using the conditions indicated in 
Figure 4.1Ô. Lysates were analysed for the presence of STXlôF by immunoblotting with 
anti-STXlô (Figure 4.1Ô). Although myc-tagged-STXlôF (predicted molecular weight 
37.25) is effectively heavier than endogenous STXlô (predicted molecular weight 34.78) it 
was observed to resolve at a lower molecular weight on a 12 % SDS-PAGE gel. This could 
indicate that the confirmation of STXlôF is different from that of endogenous STXlô, 
perhaps caused by the presence of the myc-tag. A similar phenomenon was obseiwed for 
STXlôcyt (Section 4.4.4.2) and the cytosolic domain of STX6, which also resolved at 
lower molecular weights than anticipated (Perera et al., 2003).
In contrast to STXlôcyt, infection with an MOI of only 1:90 STXlôF adenovims on day ô 
post-differentiation was capable of producing levels of STXlôF almost equalling that of 
the endogenous protein. However, as for the cytosolic domain, it appeared that the 
maximum protein expressed during one infection was reached with an MOI of 1:225, with 
no significant increase in protein expression observed with an MOI of 1:300.
As anticipated, double infection of the cells on days 4 and 6 with MOI 1:225 increased the 
level of STX1ÔF produced, compared to infection on day ô alone, and appears to be 
accompanied by a small decrease in endogenous STXlô. This finding perhaps supports the 
theory that infection before or during the upregulation of STXlô, induced by 
differentiation (Shewan et al., 2003), results in more STXlôF expressed by the vims at the 
expense of endogenous STXlô.
Expression of STXlôF was dramatically enhanced by treatment with MG132 following 
infection. Cells infected with MOI 1:225 STXlôF vims per well on day ô (Section 4.3.2.) 
were exposed to 50 pM MG132 overnight from the evening of day 7 to day 8 (Section
■'
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4.3.4). As for STXlôcyt, this large increase in STXlôF observed with the inhibition of 
proteasome activity, supports the hypothesis that t-SNARE in excess of and therefore not 
stabilised by its cognate SM protein is subject to proteasomal degradation. Intriguingly, in 
these cells a significant decrease in the level of endogenous STXlô is also observed. The 
reason for this is at present unclear but will be discussed in more detail in Section 4.5.
4.4.4.10. Optimisation of STX16T in 3T3-L1 
adipocytes
It was anticipated that the expression of STX16T would not present the same problems 
encountered with STXlôcyt or STXlôF. It was hypothesised that removal of the potential 
autoinhibitory Habc domain, including the mVps45 binding-site (Dulubova et al., 2002) and 
the hypothesised phosphorylation site (Chapter 3) would remove any need for regulation or 
stabilisation (Figure 4.6). Bryant and James found that expression of the similarly 
truncated Tlg2p, bypassed the need for stabilisation by Vps45p (Bryant and James, 2001).
Once again the methods used to optimise the expression of STXlôcyt (Section 4.4.4) were 
utilised here. 3T3-L1 adipocytes were subjected to the conditions indicated in Figure 4.17. 
Lysates were analysed for the presence of STX16T by immunoblotting with anti-STXlô 
(Figure 4.17). Importantly, Figure 4.17 shows that the heavily truncated STX1ÔT is 
recognised by anti-STXlô, an extremely important feature in my study to allow detection 
of both STX16T and endogenous STXlô. However, it should be noted that the binding 
affinity of the antibody for STX1ÔT is unknown. HA-tagged STX16T is a small 14.8 kDa 
protein that resolves at ~ 15 kDa on an SDS-PAGE gel and therefore was too small to be 
observed on a 12 % gel. As such, a 15 % gel was used to visualise this protein, and 
although full length STXlô (-34 kDa) is best resolved on a 12 % gel, it is, nonetheless, 
still observed.
Figure 4.17 shows that infection on day ô alone with MOI 1:225 of virus could not be 
detected compared to the level of endogenous protein in the cell lysate. Double infection 
with an MOI of 1:225 on days 4 and 6 increased this to detectable levels, therefore, this 
method was used to optimise the expression, with increasing MOI in each infection. 
Intriguingly, the expression of STX1ÔT, unlike STXlôcyt or STX16F (Figures 4.11 and 
4.1Ô), was dose dependent, with a steady increase in protein produced from MOI 1:225 to 
1:900 on days 4 and 6 post-differentiation. An MOI higher than 1:900 was not attempted, 
due to the potential adverse effects that could be experienced by the cells with such a high
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dose of virus. However, it is highly probable that the level of STX16T would have 
continued to rise with higher MOL
Unexpectedly, treatment with MG132 following infection (Section 4.3.4) also increased 
the level of STX16T expressed compared to infection in the absence of proteasome 
inhibitors (Figure 4.17), but with no obvious decrease in the level of endogenous STX16 as 
noted for STX16F in the same experiment.
These intriguing effects will be discussed in Section 4.5.
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Figure 4.16 Optimisation of expression of STX16F in 3T3-L1 adipocytes
3T3-L1 adipocytes were infected as described in Section 4.3.2 with MOIs of 1:0, 1: 90, 
1:225 or 1:300 STX16F adenovirus per well as indicated on day 6 post-differentiation 
(lanes 1-4), MOI 1:225 per well on both days 4 and 6 post-differentiation (lane 5) or 
MOI 1:225 day 6, followed by treatment with 50 pM MG132 for 16 h overnight from 
day 7 to day 8 post-differentiation (lane 6). Lysates prepared from these cells on day 8, 
48 h after infection, were subjected to SDS-PAGE electrophoresis and analysed for the 
presence of STX16F by immunoblotting with anti-STX16. Endogenous STX16 can be 
observed at 34 kDa as indicated. Although STX16F is heavier than endogenous 
STX16, due to the presence of the N-terminal myc tag, it was found to resolve at a 
lower molecular weight on the 12 % SDS-PAGE gel.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
Kirsty M. Proctor, 2006 Chapter 4,174
MOI 
day 6 +
MOI day 6 MG 132 MOI days 4 & 6
0 1:225 1:225 1:225 1:450 1:900
34 kDa
15 kDa
SIX  16
STX16T
Figure 4.17 Optimisation of STX16T expression in 3T3-L1 adipocytes
3T3-L1 adipocytes were infected as described in Section 4.3.2 with MOIs of 1:0 or 
1:225 day 6 (Lanes 1 and 2), MOI 1:225 day 6, followed by treatment with 50 pM 
MG 132 proteasome inhibitors for 16 h overnight on day 7 to day 8 post-differentiation 
(lane 3), or MOIs of 1:225, 1: 450 or 1:900 STX16T adenovirus per well on both days 
4 and 6 post-differentiation (Lanes 4-6). Lysates prepared from these cells on day 8, 
48 h after infection, were subjected to SDS-PAGE electrophoresis on a 15 % gel and 
analysed for the presence of STX16T by immunoblotting with anti-STX16. 
Endogenous STX16 (upper panel) is better resolved on a 12 % gel; however, a 15 % 
gel was used to allow successful detection of STX16T (lower panel). Both panels are 
from the same gel, however, they should not be directly compared, as the affinity of the 
STX16 antibody to STX16T is unknown.
The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
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4.5. Discussion
Previous work suggested a possible role for STX16 in GLUT4 trafficking in 3T3-L1 
adipocytes (Perera et al., 2003; Shewan et al., 2003) (Section 1.8, Chapter 1). I set out to 
investigate its precise function by analysing the effects of expressing STX16 mutants in 
3T3-L1 adipocytes. Transfection of 3T3-L1 adipocytes by standard transfection methods is 
poor (Gnudi et al., 1997) and would not produce the required levels of protein for my 
study. Adenovirus vectors, on the other hand, are known to be highly efficient in their 
ability to transfer genes into even highly differentiated cells and the efficiency is not 
limited in non-dividing cells (Russell, 2000). As such this method has been used for the 
successful introduction of transgenes into 3T3-L1 adipocytes (Bose et al., 2001; Emoto et 
al., 2001; Sakaue et al., 1997). This Chapter describes the generation of recombinant 
adenoviruses capable of expressing STX16 mutants and the optimisation of their 
expression in 3T3-L1 adipocytes.
Of course, adenovims-mediated gene transfer is subject to limitations such as the 
availability of the CAR proteins and av(35 integrins, which allow the internalisation of the 
vims, on the cell type in question (Takayama et al., 1998; Wickham et al., 1993). 
FurtheiTnore, much overlooked during the development of adenovims technology was the 
immune response provided by the host (Russell, 2000). Nonetheless, the adenovims 
remains a pivotal tool in the transfer of genes to cells that would be otherwise inaccessible. 
Homologous recombination and production of the adenovims es used in this study was 
carried out at ViraQuest Inc., because their patented teclinology (Anderson et al., 2000) 
allows for the production of adenovimses considerably quicker than the standard current 
methods available for laboratory use and have little to no wild-type contamination or 
unwanted complicating El sequences.
Recombinant adenovimses were generated to express full length STX16 (STX16F), the 
cytosolic domain (STX16cyt) and an N-terminal tmncation mutant (STX16T) (Figure 4.4). 
STX16cyt was required to inhibit the effects of the endogenous protein (Olson et al., 1997; 
Perera et al., 2003; Tellam et al., 1997; Volchuk et al., 1996); STX16T, lacking the 
putative Habc domain, was anticipated to act as a constitutively active version of the wild 
type protein (Bryant and James, 2001), by mimicking a hypothetical open conformation; 
and STX16F, with its ability to amplify the effects of the endogenous protein (Pagan et al..
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2003; Thurmond et al., 1998) was generated to provide a control for experiments involving 
STX16T. The effects of these proteins on GLUT4 trafficking are described in Chapter 5. 
However, I found that the expression capabilities of STX16cyt, STX16T and STX16F 
were very informative in tei*ms of the properties of those particular STX16 domains, the 
associated proteins and their environment.
The study began by looking at the infection capabilities of the adenovims in 3T3-L1 
adipocytes. Infection of the cells in serum free media produced levels of STX16cyt almost 
identical to those produced by standard infection conditions in the presence of exogenous 
semm (Figure 4.11). Infection in semm free media limited any potentially detrimental 
effects on GLUT4 trafficking, which may occur in cells infected in exogenous semm. In |  
addition, it was shown that 3T3-L1 adipocytes are in possession of the avps integrins, 
required for internalisation of the vims, and that the levels of these proteins are elevated 
between days 4 and 6 post-differentiation (Figure 4.12), corresponding to the time 
infections were carried out. It is likely that a number of additional factors could be 
responsible for the low expression levels, as discussed below.
After exhausting the possibilities regarding limitations of the vims and the expression 
system, it was decided to look at the properties of STXl 6 with regard to its ability to be 
overproduced in adipocytes. As mentioned previously, it has been shown that SM proteins 
and their t-SNAREs are expressed at 1:1 stoichiometry (Hickson et al., 2000), a finding 
that could suggest that, at steady state, STXl 6 and mVps45 are present at an equal level. It 
has not yet been shown that mVps45 is directly related to / required for STXl 6 stability, 
however, 1 think that this possibility is highly likely with regard to my vims studies 
(discussed below). The results suggest that STX16F and STX16cyt require stabilisation 
from mVps45. STXl 6 is upregulated post-differentiation, however, it is not currently 
known if this is also the case for mVps45. Further experiments will be required to test this %
possibility. Nonetheless, it is probable that the upregulation of STXl 6, combined with 
protein produced by the virus (STX16F or STXlôcyt), eventually exceeds the level of 
mVps45. Deletion of Vps45p in yeast resulted in the rapid proteasomal degradation of its 
cognate t-SNARE, Tlg2p (Bryant and James, 2001). This could imply that the excess 
STX16F or STXlôcyt would be targeted for proteasomal degradation. STX16T, on the 
other hand was not anticipated to be subject to such limitations. Tmncation of the N- 
terminal 230 residues of Tlg2p abolished binding to Vps45p and was found to bypass the 5
requirement for Vps45p stabilisation (Bryant and James, 2001). As such, it was anticipated 
that the similarly tmncated STX16T, devoid of the mVps45 binding site (Dulubova et al.,
2002) and inhibitory Habc domain (Figure 4.6) would be capable of overexpression.
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Recombinant adenovimses were used previously in our laboratory to express the cytosolic 
domains of STX6, STX8 and STX12 in 3T3-L1 adipocytes (Perera et ah, 2003). The 
expression level of each SNARE protein was found to vary but the reasons for these 
differences were not fully explored in terms of the individual properties of the target 
proteins. STXlôcyt could not be expressed to a similar level as that of the cytosolic 
domain of its partner SNARE, STX6 (Perera et ah, 2003), using the same method of 
adenoviral mediated gene transfer. Both proteins are known to be upregulated during 
differentiation (Shewan et ah, 2003), yet STX6 overexpression is not limited because of 
this. I anticipate that the main difference in expression capability of these two proteins is 
due to the fact that STXl6, but not STX6, interacts directly with mVps45 (Dulubova et ah, 
2002) and correlate this to a requirement for stabilisation, not required by STX6. The 
requirement for a 1:1 stoichiometry of the t-SNARE and SM protein (Hickson et ah, 2000) 
will become rate limiting for STXl 6. Interestingly, Bryant and James were unable to 
overproduce Tlg2p significantly in wild-type cells, presumably because levels of Vps45p 
become rate limiting (Bryant and James, 2001).
Expression of STXlôcyt and STX16F could be increased by infecting the cells on days 4 
and 6 post-differentiation, compared to day 6 alone (Figures 4.13 and 4.16). It was 
hypothesised that infection of the cells earlier in the differentiation process would allow 
greater expression of STXlôcyt or STX16F by the virus at the expense of endogenous 
STXl 6. In favour of this hypothesis, a small corresponding decrease in the level of 
endogenous STXl6 was observed in cells producing STX16F. However, this effect was 
not observed when STXlôcyt was overproduced. The difference could be due to the fact 
that STX16F requires membrane insertion and is therefore in more direct competition with 
the endogenous protein.
Similarly, the expression levels of STXlôcyt and STX16F were increased dramatically 
when proteasome function was inhibited using MG132 (Figures 4.14 and 4.16). This is in 
agreement with the suggestion that any t-SNARE (Qa-SNARE) in excess of its SM protein 
is subject to proteasomal degiadation (Bryant and James, 2001). Very intriguing is the fact 
that the level of endogenous STXl 6 decreased significantly with proteasome inhibitor 
treatment in cells expressing STX16F (Figure 4.16). The reason for this is at present 
unclear. However, it could suggest that the endogenous STXl 6 must somehow be disposed 
of to support the large increase in STX16F. Clearly, this route of disposal is not via the 
proteasome but perhaps another pathway for the degradation of this unstabilised protein 
exists. It is particularly important to notice here that the level of mVps45 remained 
constant with proteasome inhibitor treatment (Figure 4.15), adding weight to the theory
. . i i
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that endogenous STXl 6 in excess of mVps45 had to be degraded. The absence of this 
effect in STXl 6cyt could once again be due to its cytosolic nature.
Although it was anticipated that expression of STX16T would not be subject to such 
limitations, the levels produced were unexpectedly poor in cells infected on day 6 alone. 
Equally surprising was the fact that expression could be increased using the same methods 
as STXlôcyt and STX16F, by infection on days 4 and 6 or by treatment with MG132 
(Figure 4.17). Some possible explanations for these effects will be discussed below. It is 
important to note, however, that the increase in STX16T expression using these methods 
could not be quantified, as the level of STX16T produced fiom infection on day 6 alone 
could not be detected by the antibody. It is not therefore possible to determine if the 
increases in expression of STX16T occur to the same extent as for STXlôcyt and STX16F, 
and as such, it is possible that additional factors, such as those described above, are 
responsible for the increases obseiwed for these proteins.
The increase in STX16T observed after double infection on days 4 and 6 may be simply 
due to the additive effects of protein produced Jfrom two infections, which, of course, could 
also be responsible for the increase observed in STXlôcyt and STX16F, However, the 
decrease in endogenous STXl 6 with increasing expression of STXlôF (Figure 4.1Ô) is 
perhaps more indicative of the need for stabilisation described above. Most significant with 
regard to this theory is that, unlike STXlôcyt and STXlôF, the expression of STXlôT was 
dose dependent and increased with increasing (MOI) virus (Figure 4.17). Expression of 
STXlôcyt and STXlôF appealed to reach a plateau, which could not be increased by the 
addition of more virus in a single infection (Figures 4.11 and 4.1Ô). This plateau was not 
due to cytopathic effects because this would also have been apparent for STXlôT, which 
was infected with a higher MOI. Although this notion is based on the comparison of single 
infections for STXlôcyt and STXlôF, and double infections for STXlôT, 1 reasoned that 
expression of STXlôcyt and STXlôF would similarly reach a plateau with increasing 
levels of virus in a double infection. In fact this was shown to be the case for STXlôF later 
in the study when double infection with an MOI greater than 1:225 in each infection did 
not increase the level of STXlôF produced (Figure 5.5, Chapter 5). This could support the 
notion that STXl 6 in possession of an N-terminal domain requires stabilisation by mVps45 
and the truncated form, lacking this domain and the mVps45 binding site bypasses the 
requirement for this stabilisation, a finding supported by the yeast homolog, Tlg2p (Bryant 
and James, 2001).
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Surprisingly, proteasome inhibitor treatment also increased the level of STX16T produced 
(Figure 4.17). It was anticipated that STX16T would not be subject to proteasomal 
degradation as it was not dependent on mVps45 stabilisation. This liighlights the possible 
alternative explanation that all adenoviral products are subject to proteasomal degradation, 
especially considering the levels of native proteins, such as mVps45, VAMP2, Vtila, 
IRAP and STX4 are unaffected by the treatment (Figure 4.15). Perhaps the introduction of 
foreign genes into 3T3-L1 adipocytes results in their products being subject to degradation 
by the proteasome. However, this was not the case for the cytosolic domains of STX6 and 
STXl2 (Perera et al., 2003), which could be expressed to 16-fold the level of the 
endogenous protein with one single infection. Perhaps there is a property inherent in 
STXl6, which makes overexpression of even the truncated domain subject to limitations 
not observed for other Syntaxins such as STX6, STX8 or STXl2 (Perera et ah, 2003). So 
far, I have based my model of STXl 6 function on Tlg2p but have not addressed the 
possibility that STXl 6 may in fact be different from Tlg2p and that perhaps even STX16T 
requires stabilisation. Half-life studies could be very informative here, to compare the half- 
life of the STXl 6 mutants and other syntaxins expressed by the adenovirus.
In general, I feel that the differences in expression capabilities of the STXl 6 mutants 
provide the first shi'eds of evidence towards proving the existence of STXl 6 active and 
inactive confonnations. I hypothesise that these conformations are stabilised by mVps45, 
which may also be required to facilitate its transition to an active state. Whether these 
conformations resemble the open and closed confonnations described for STXl a with the 
SM binding to the closed conformation, or are more like those observed for other 
intracellular SNARE complexes (Dulubova et al., 1999; Rizo and Sudhof, 2002)(Section 
1.5.6) is yet to be discovered, although my immunoprécipitation studies suggest that 
mVps45 does not bind to the intact SNARE complex (Section 3.5.2.5, Chapter 3). Further 
studies, for example NMR or protein crystallography will be required to fully test these 
possibilities. NMR studies of the N-terminal region of Tlg2p predicted that, although it 
shared little homology with the conesponding domains of other syntaxins known to be in 
possession of an Habc domain, it adopted a structure characteristic of a tlrree helical domain 
(Dulubova et ah, 2002). Based on the homology between STXl 6 and Tlg2p, I predict that 
STXl6 does also. However, the study also concluded that Tlg2p did not adopt a closed 
conformation (Dulubova et al., 2002). In the case of STXl a, the three a-helical N-terminal 
domain is believed to mimic the three helices provided by their cognate SNAREs in a 
functional SNARE complex (Dulubova et ah, 1999; Misura et ah, 2001). If Tlg2p, and 
correspondingly STXl6, do not adopt a closed conformation, what then could be the
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function of this three helical N-terminal domain? This is an intriguing question, which will 
require careful further studies.
The implications of expression of the STXl 6 domains on GLUT4 trafficking will be 
presented in Chapter 5.
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Chapter 5
The role of STX16 in the intracellular trafficking
of GLUT4
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5. The role of STX16 in the intracellular trafficking 
of GLUT4
5.1. Introduction
In an effort to resolve the function of STXl 6 in GLUT4 trafficking, recombinant 
adenovimses were prepared to express wild-type STXl6, STX16F, and STXl 6 mutants, 
STXlôcyt and STX16T, in 3T3-L1 adipocytes (Chapter 4). This Chapter details the effects 
of these proteins on GLUT4 trafficking in 3T3-L1 adipocytes as well as the effect of 
expression of STXlôcyt on ACRP30 secretion from these cells. As a complimentary 
approach to measuring GLUT4 trafficking in cells overexpressing the dominant negative 
STXlôcyt, STX1Ô expression was knocked-down using a specific Morpholino Anti sense 
Oligonucleotide and the consequences for insulin-stimulated 2-Deoxy-D-glucose (deGlc) 
uptake were evaluated.
5.1.1,Morpholino Antisense Oiigonucieotides (MAOs)
Moipholino Antisense Oligonucleotides (MAOs) are advanced tools for blocking sites on 
RNA to obstruct protein expression. With properties including stability, nuclease- 
resistance, efficacy, long-tenn activity, water solubility, low toxicity and high specificity, 
they have become widely used as gene knockdown reagents. MAOs are manufactured 
exclusively by GeneTools Inc. and are described in detail on the website (www.gene- 
tools.com). MAOs are short chains of Morpholino subunits (Figure 5.1) comprised of a 
nucleic acid base, a moipholine ring and a non-ionic phosphorodiamidate. The moipholino 
backbone differs fi'om that of DNA and RNA in that moipholine rings replace ribose or 
deoxyribose sugar moieties, and non-ionic phosphorodiamidate linkages replace anionic 
phosphates. MAOs act via a steric block mechanism (RNAse H-independent) with high 
mRNA binding affinity and specificity, either by blocking the translation initiation 
complex (by targeting 5’ UTR through first 25 bases of coding sequence) or nuclear 
splicing machinery (by targeting splice junctions in pre-mRNA). These antisense reagents 
bind to the complementary strand of the RNA via Watson-Crick pairing. As the backbone 
is not recognised by cellular enzymes or signalling proteins, MAOs are stable to nucleases 
and do not trigger an immune response.
I
'
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Figure 5.1 Structure of a Morpholino subunit
M A O s are short chains o f  M orpholino subunits, com prised o f  a nucleic acid base (B, 
black), a m orpholinc ring (b lue) and a non-ion ic phosphorodiam idate (red). The 
resulting m orpholino backbone differs from that o f  D N A  and R N A  in that the 
m orpholinc rings replace ribose or deoxyribose sugar m oieties, and the non-ionic  
phosphorodiamidate linkages replace anionic phosphates.
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5.1.2.GLUT4 trafficking
Gliit4 has a complex intracellular itinerary in adipocytes, which is described in detail in 
Section 1.7 (Chapter 1). Recent studies support a model in which the intracellular GLUT4 
itinerary involves two intracellular cycles (Figure 1.9, Chapter 1). In the first cycle GLUT4 
recycles tlirough the fast cycling endosomal system. From there, unique sequences within 
GLUT4 direct it into a slowly recycling pathway, involving the tmns-Golgi network 
(TGN) and GSVs. The selective routing of GLUT4 into this slowly recycling pathway 
results in the effective sequestration of GLUT4 away from the cell surface, in a population 
of vesicles available for rapid mobilisation upon insulin binding. The intracellular 
components that regulate the GLUT4 intracellular trafficking pathway remain largely 
unknown.
There is much evidence to implicate the TGN-localised t-SNARE, STXl 6 in the 
intracellular trafficking and/or translocation of GLUT4 to the cell surface in adipocytes 
(described in detail in Section 1.8, Chapter 1), which led to the development of my 
hypothesis and model for this thesis (Section 1.9, Chapter 1). STXl6 was therefore 
directly tested for its involvement in GLUT4 trafficking in this Chapter.
5.1.3.Secretion ofACRPSO from adipocytes
ACRP30 (adipocyte complement-related protein of 30 kDa) is a protein secreted 
exclusively by adipocytes (Scherer et al., 1995) (Section 1.3.5) and its mRNA is induced 
over 100-fold during adipocyte differentiation (Scherer et al., 1995). ACRP30 is a 
relatively abundant serum protein and, paradoxically, circulating levels were found to 
decrease in parallel with increasing obesity and the progression of insulin resistance (Yang 
et al., 2001). Previous work suggests that ACRP30 is secreted from a distinct secretory 
compartment to GLUT4 (Bogan and Lodish, 1999), and that Vtila, known to bind to 
STXl6 (Mallard et al., 2002), may regulate a step common to both GLUT4 and ACRP30 
trafficking in 3T3-L1 adipocytes (Bose et al., 2005). For this reason, ACRP30 secretion 
was chosen for investigation as another index of STXl 6 function.
/î
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5.2. Aims
The main aim of this Chapter was to study the effects of inliibition of STXl 6 function on 
GLUT4 trafficking in 3T3-L1 adipocytes. Inhibition was achieved both by overexpression 
of the dominant negative STXlôcyt (Section 4.4.1.1) and MAO knockdown of endogenous 
STXl6 in 3T3-L1 adipocytes. To assess GLUT4 trafficking, deGlc uptake was assayed in 
basal and insulin-stimulated cells and following insulin withdrawal from the cell receptors.
Additionally, I sought to study the effects of STX16T and STXlôF (Sections 4.4.1.2 and
4.4.1.3) on GLUT4 trafficking in 3T3-L1 adipocytes and the effect of STXlôcyt on 
ACRP30 secretion from these cells.
Therefore, the aims of this Chapter were as follows:
• To achieve knock down of STXlô in 3T3-L1 adipocytes via a Morpholino 
Antisense Oligonucleotide
• To determine the effect of perturbation of STXlô on basal and insulin-stimulated 
deGlc transport
• To detennine the effect of perturbation of STXlô on the cells ability to return 
glucose transport to basal levels after the withdrawal of insulin (reversal of GLUT4 
translocation)
• To determine the effect of perturbation of STXlô on secretion of ACRP30 in 3T3- 
L1 adipocytes
• To detennine the effect of expression of STXlôT and STXlôF on basal and 
insulin-stimulated deGlc transport
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buffer pH 7.4 pre-warmed to 37 ”C. After aspiration of the final KRP wash, 500 pi KRP 
was added to each well then removed and transfeiTed to an eppendorf tube after 0, 5, 10 
and 20 min. The experiment was then repeated, this time adding KRP containing 1 pM 
insulin. The samples were then TCA precipitated as described in Section 2.4.2 and stored 
at -  80 °C prior to analysis by SDS-PAGE (Section 2.4.3). ACRP30 secretion was assayed 
by immunoblotting with an anti-peptide antibody raised against the C-tenninal 15 amino 
acids of the murine protein (Ewart et al., 2005).
5.3.1.2. Glucose Transport Assay
Cells were rinsed three times in KRP buffer pre-warmed to 37 °C and then covered with 
475 pi KRP ±10  pM Cytochalasin B, ± 100 nM insulin as appropriate, and incubated for 
30 min. Transport was then initiated by the addition of 25 pi of deGlc such that the final 
concentration was 50 pM, with 0.25 pCi per well. Transport was assayed for 5 min, after 
which time, the contents of the wells were flipped out and the plates were rapidly washed 
by dipping in three consecutive beakers of ice-cold PBS. Cells were air-dried for 
approximately 1 h, and then solubilised in 500 pi 1% Triton X-100 for at least 2 h. The 
solubilised samples were then transfen'ed to scintillation vials containing 5 ml scintillation
5.3. Materials and Methods
5.3.1.Assays
All assays were carried out in 12-well plates of 3T3-L1 adipocytes on day 8 post- 
differentiation. All measurements and controls were conducted in triplicate. Cells were 
incubated in serum-free DMEM for 2 h prior to each assay at 37 °C and 5 % CO2, and 
transferred to 37 °C hot-plates where the assays were carried out.
For assays measuring 2-Deoxy-D-glucose (deGlc) uptake, the classic inliibitor of glucose 
transport, Cytochalasin B (CB), was added to control wells to measure non-specific 
association of deGlc with the cells, which was subsequently subtracted from the 
appropriate measurements.
5.3.1.1. ACRP30 Secretion Assay
Cells were washed three times with 1 ml Krebs-Ringer-Phosphate (KRP, Section 2.1.7)
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fluid and mixed thoroughly. The radioactivity associated with the cells was then 
detennined by liquid scintillation spectrophotometry.
5.3.1.3. Reversal of GLUT4 translocation after insulin 
withdrawal
Cells were rinsed three times in KRP buffer pre-waimed to 37 '’C. Control plates 
(measuring basal and insulin-stimulated glucose transport) were covered with 475 pi KRP 
± 1 0  pM Cytochalasin B, ± 100 nM insulin as appropriate, incubated for 30 min and 
assayed straight away exactly as described in Section 5.4.1.2. For the insulin reversal 
experiments, cells were incubated in 475 pi KRP, ± 100 nM insulin for 30 min. After this 
incubation, the cells were then rapidly washed into KRM buffer at pH 6.0 (as KRP except 
MES replaced the sodium phosphate) to cause dissociation of insulin from its receptor and 
the subsequent re-intemalisation of GLUT4. Cells were gently washed in KRM pH 6.0 
every 5 min for different times (from 5 to 40 min, as indicated) before a final wash in KRP 
pH 7.4 and subsequent assay in 475 pi KRP pH 7.4 ± 10 pM Cytochalasin B as outlined 
above (Section 5.4.1.2).
5.3.1.4. Statistical analysis
Data from glucose transport assays and quantified immunoblots were analysed using Excel 
software. Results are shown as mean ± SE (standard error). An unpaired Student’s t test 
was carried out as a determination of statistical significance. Values of p < 0.05 were 
considered to be statistically significant for comparisons.
5.3.2.Electroporation of3T3-L1 adipocytes with MAO
Morpholino Antisense Oligonucleotides (MAOs) designed to deplete cells of STXl6 were 
generated by GeneTools Inc. (Philomath, OR) and introduced into 3T3-L1 adipocytes by 
electroporation as described in Jiang et al., 2003 and summarised here. Briefly, 3T3-L1 
adipocytes were cultured in 10 cm  ^ dishes as described in Section 2.3.4.1 and 
electroporation was earned out on day 6 post-differentiation. Cells were washed twice with 
Dulbecco’s-PBS at room temperature then incubated at 37 °C in 2ml 1 x Trypsin-EDTA 
and 3ml 1 mg/ml Collagenase. After 10 min, the cells were gently shaken off the plate, 10 
ml of 3T3-L1 adipocyte growth medium (Section 2.1.6) added and the cells centrifuged for 
5 min. Cells were washed twice in D-PBS, then resuspended in 650 pi of the same and 
transfen'ed to an electroporation cuvette prior to electroporation. 20 or 40 nmoles MAO
Kirsty M. Proctor, 2006 Chapter 6,188
was added directly to the cells and the electroporation performed in a Bio-Rad GenePulser 
II at 0.18 kV, 950 pF. Cells were then added to 15 ml of 3T3-LI adipocyte growth medium 
(Section 2.1.6) and plated into 12-well plates. The cells were then incubated at 37 ‘’C and 5 
% CO2 for 48 h prior to the assay on day 8 post-differentiation.
5 .4 . Results
5.4.1.Effect of STXlôcyt, STX16T and STX16F on GLUT4 
trafficking
5.4.1.1. Overview
STXl 6 mutants were designed to provide functional information about GLUT4 trafficking 
when expressed in 3T3-L1 adipocytes (Chapter 4). The cytosolic domain, STXl 6cyt, was 
anticipated to act as an inhibitor of the endogenous protein (Volchuk et al., 1996; Tellam et 
al., 1997b; Olson et al., 1997), whereas an N-terminal truncation, STX16T, was designed 
to mimic the hypothesised open conformation of STXl 6 (Bryant and James, 2001) and 
therefore to represent a constitutively active version of the wild-type protein. The effects of 
STX16T were compared to those of expressing the fiill-length protein STX16F, anticipated 
to amplify the effects the endogenous protein (Pagan et al., 2003; Thurmond et al., 1998).
The adenovirus-mediated expression of STX16cyt, STX16T and STX16F in 3T3-L1 
adipocytes was optimised in Chapter 4. Two methods were used to increase the expression 
of these mutants: infection of the cells on days 4 and 6 post-differentiation, and infection 
on day 6 alone followed by treatment with MG132 proteasome inliibitors (Sections 4.3.2 
and 4.3.4). Cells treated in each way were used to carry out functional assays in which the 
effects of these mutants on GLUT4 trafficking could be measured.
Glucose transport and insulin withdrawal assays were carried out on day 8 post­
differentiation as described in Section 5.4.1 (5.4.1.2 and 5.4.1.3).
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5.4.1.2. Effect of MG132 Proteasome Inhibitors on basal 
and insulin-stimulated deGlc transport
MG132 proteasome inhibitors could be used to increase the expression of STXlôcyt, 
STXlôT and STXlôF in 3T3-L1 adipocytes (Chapter 4). To check the compatibility of this 
method with deGlc transport assays, the effects of MG 132 on basal and insulin-stimulated 
deGlc uptake were measured. 3T3-L1 adipocytes were treated with MG132 as described in 
Section 4.3.4 for 16 h overnight from day 7 to day 8 post-differentiation. Control cells 
were untreated. The results from a representative experiment are displayed in Figure 5.2.
Unexpectedly, this experiment highlighted that treatment of the cells with MG 132 
significantly decreased both basal and insulin-stimulated glucose uptake in 3T3-L1 
adipocytes (Figure 5.2). It was previously reported that GLUT4 expression in 3T3-L1 
adipocytes was repressed by proteasome inhibition by MG132 (Cooke and Patel, 2005). 
This loss of GLUT4 is likely to be responsible for reduced glucose transport into cells 
treated with MG132, however, this phenomenon will be discussed further in Section 5.7.
5.4.1.3. Effect of STX16cyt on deGlc transport in basal 
and Insulin-stimulated cells and following insulin 
withdrawal
Since treatment of the cells with MG 132 caused a decrease in the level of insulin- 
stimulated glucose uptake, the alternative method to achieve optimum expression of 
STXlôcyt was utilised and deGlc transport was measured in cells infected on days 4 and 6. 
Therefore, cells were infected on days 4 and 6 as described in Section 4.3.2 with MOI 
1:225 STXlôcyt or empty pShuttle-CMV virus.
Figure 5.3 demonstrates that expression of STXlôcyt did not perturb basal or insulin- 
stimulated deGlc transport rates significantly. However, expression of STXlôcyt 
significantly slowed the rate of deGlc transport reversal after insulin withdrawal. Whereas 
in control cells (infected with empty pShuttle-CMV virus) insulin-stimulated deGlc 
transport returned essentially to basal levels 40 min after insulin withdrawal, in cells 
expressing STXl 6cyt transport remained significantly elevated at this time point, often as 
high as -50% of the maximal insulin-stimulated rate.
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The levels of STXlôcyt and endogenous STXlô were compared to check if inliibition was 
achievable under these conditions. The expression levels were investigated thoroughly 
during the optimisation described in Chapter 4. However, to ensure that expression had 
been achieved, lysate was prepared (Section 2.3.4.3) just prior to the assay from cells 
treated in exactly the same way and at the same times as those to be assayed. The cell 
lysate was then subjected to SDS-PAGE electrophoresis (Section 2.4.3) and probed with 
anti-STXlô. Figure 5.4 shows that during the experiment, STXlôcyt and STXlô were 
present at approximately equal levels. In similar experiments involving STX6 (Perera et 
al., 2003), the STXô cytosolic domain was expressed to 12-1Ô fold that of the endogenous 
protein (the reasons for low STXlô expression are discussed in detail in Chapter 4). 
However, it was reasoned that a 1:1 ratio of endogenous STXlô to STXlôcyt may be 
sufficient to cause inhibition, at least during reversal conditions, when high levels of 
GLUT4 may be trafficking back into GSVs.
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Figure 5.2 Effect of MG132 on basal and insulin-stimulated deGlc transport
DeGlc transport was assayed in cells treated with 50 M MG 132 (Sections 4.3.2 and
4.3.4). Control cells were untreated. Basal and Insulin-stimulated deGlc transport was 
assayed in the presence or absence of 100 nM insulin (after stimulation for 30 min). 
Strikingly, MG 132 treatment significantly inhibits basal and insulin-stimulated deGlc 
transport.
The data shown is from a representative experiment, repeated three times with similar 
results. Each point is the mean of triplicate determinations and the error bars are ± 
standard error. The difference between control and MG132-treated cells is significant 
for basal (p=0.001) and insulin-stimulated (p=0.0001) deGlc transport.
Figure 5.3 Effect of STX16cyt on deGlc transport in basal and insulin-stimulated cells and 
following insulin withdrawal
DeGlc transport was assayed in cells infected with MOI 1:225 STXlôcyt or empty 
pShuttle-CMV adenovirus on days 4 and 6 post-differentiation (Section 4.3.2). Cells 
were incubated in the presence or absence of 100 nM insulin for 30 min, after which 
time basal and insulin-stimulated deGlc transport were assayed over 5 min. Insulin- 
stimulation was reversed by low pH washes in parallel experiments, and the rate of 
reversal of insulin-stimulated deGlc transport assayed at 10 (RIO) and 40 (R40) min 
after reversal. A) Expression of STXlôcyt does not affect basal or insulin-stimulated 
glucose transport compared to control cells but significantly slows the reversal of 
insulin-stimulated deGlc transport during the 10 to 40 min period. B) Rate of reversal 
of insulin-stimulated glucose transport. The values in (A) are expressed as a percentage 
of the maximal insulin-stimulated value in each case and demonstrate that STXlôcyt 
expression slows reversal of insulin-stimulated deGlc transport.
The data shown is from a representative experiment, repeated three times with similar 
results. Each point is the mean of triplicate determinations. The error bars are ± standard 
eiTor. The difference between control and STXlôcyt expressing cells is significant at 
RIO (p~0.01) and R40 (p=0.005), but not significant under basal or insulin-stimulated 
conditions.
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DeGlc Transport in cells expressing STX16cyt
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Figure 5.4 Quantification of STX16cyt produced by cells infected day 4 and 6
Cells were infected on days 4 and 6 post-differentiation with MOI 1:225 S T X lôcyt  
adenovirus. C ells to be assayed were treated in exactly the sam e way at the same 
times. Just prior to the assay on day 8 post-differentiation, cells were lysed (Section
2.3 .4 .3) and resolved on an SD S-PA G E gel and analysed by im m unoblotting with  
anti-STX16. A ) A  representative im m unoblot demonstrates that S T X l6 and S T X lôcyt  
are present in approxim ately equal quantities. B) Quantification o f  the im m unoblot in 
(A ), confirm ing that S T X lô  and S T X lô cy t are indeed present in approximately equal 
quantities.
The lysate loaded in the w ell corresponds to 2 % o f  the total lysate obtained from one 
w ell o f  a 12-well plate.
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5.4.1.4. Effect of STX16T and STX16F on basal and 
insulin-stimulated glucose transport
Cells were infected on days 4 and 6 as described in Section 4.3.2 with STX16T, STX16F 
or empty pShuttle-CMV adenovirus. The cells were infected at MOI 1:225 or 1:450. As for 
STXlôcyt, expression of STXlôT and STXlôF at each MOI of virus was assessed prior to 
each experiment. Lysates were prepared as described in Section 2.3.4.3 and analysed by 
SDS-PAGE electrophoresis and Western Blotting with anti-STXlô (Figure 5.5). The levels 
of STXl ÔT increased in a dose dependent manner from MOI 1:225 to MOI 1:450, whereas 
the levels of STXlôF at each MOI were similar. It therefore proved difficult to express 
STX1ÔT and STXlôF at equal levels. In addition, it was not possible to achieve both equal 
exposure to virus and equal levels of protein present because the proteins were not 
expressed to the same extent at each MOI. However, cells infected with each virus at MOI 
1:450 were used thereafter for the glucose transport assays, as it was advantageous to carry 
out the assay with optimum levels of STXlôT. It is, however, likely that the levels of 
STX1ÔT and STXlôF were not equal during the experiment; hence the effects of each 
protein cannot be directly compared. In addition, as STXlôT lacks a large part of the N- 
terminus, it is possible that a portion of the antibody-binding site is absent and as a result 
the binding affinity of anti-STXlô to STXlôT may be different to that of STXlôF or 
endogenous STXlô.
Figure 5.Ô demonstrates that expression of neither STXlôT nor STXlôF significantly 
affects basal or insulin stimulated glucose transport, with levels of glucose transport 
remaining essentially equal compared to control cells. A trend was observed, however, for 
modestly elevated levels of insulin-stimulated deGlc transport in cells expressing STXlôF 
and STX1ÔT, and decreased levels in basal cells expressing STXlôF. These possible 
effects will be discussed further in Section 5.7.
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Figure 5.5 Quantification of STX16T and STX16F produced by cells infected day 4 and 6
Cells were infected on day 4 and 6 post-differentiation with MOIs of 1:225 or 1:450 
STX16T or STX16F adenovirus as indicated, in parallel with cells to be assayed. 
Exactly prior to the assay on day 8, cells were lysed (Section 2.3.4.3). The lysates were 
then resolved on an SDS-PAGE gel and analysed by immunoblotting with anti-STX16. 
The level of STX16T produced increased in a dose dependent manner from MOI 1:225 
to 1:450. In contrast, STX16F expression remained constant at each MOI. As the 
ability of each protein to recognise the STXl 6 antibody is unknown, the relative levels 
of each cannot be directly compared.The lysate loaded in each well corresponds to 2 % of the total lysate obtained from one 
well of a 12-well plate.
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Figure 5.6 Effect of STX16T and STX16F on deGIc transport In 3T3-L1 adipocytes
DeGlc transport was assayed in cells infected with MOI 1:450 STX16T, STX16F or 
empty pShuttle-CMV adenovirus on days 4 and 6 post-differentiation (Section 4.3.2). 
Basal and insulin-stimulated deGIc transport was assayed in the presence or absence of 
100 nM insulin (after 30 min stimulation). Nether STX16T nor STX16F have a 
significant effect on basal or insulin-stimulated deGIc transport compared to control 
cells.
The data shown is from a representative experiment, repeated three times with similar 
results. Each point is the mean of triplicate determinations. The error bars are ± 
standard error.
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5.4.2.Effect of STX16cyt on the secretion ofACRP30 
5.4.2.1. Overview
Next, the effect of inhibition of STX16 function on ACRP30 secretion was examined. 
Secretion of ACRP30 from adipocytes is described in Section 5.1.2. ACRP30 secretion 
from 3T3-L1 adipocytes was measured as described by Kitagawa and co-workers 
(Kitagawa et al., 1989). Secretion assays were canied out on day 8 post-differentiation as 
described in Section 5.4.1 (5.4.1,1) in the presence or absence of 1 |iM insulin. Secretion 
samples, collected at various time points, from 0 to 20 min, were resolved by gel 
electrophoresis and immunoblotted with anti-ACRP30. Each time-point was perfonned in 
triplicate and each experiment was canied out tliree times with similar results. In each 
case, representative immunoblots are shown.
5.4.2.2. Effect of MG132 on ACRP30 secretion
As mentioned previously, expression of STX16cyt could be enhanced by treatment of the 
cells with MG132 proteasome inhibitors (Section 4.4.4.7, Chapter 4). As for glucose 
transport assays, the suitability of this method for the analysis of ACRP30 secretion was 
investigated.
3T3-L1 adipocytes were treated with 50 pM MG132 as described in Section 4.3.4 for 16 h 
overnight from day 7 to day 8 post-differentiation. Controls cells were differentiated in 
parallel but were not treated with MG132. Strikingly, Figure 5.7 shows that there is a 
dramatic reduction in ACRP30 secretion in both basal and insulin-stimulated cells treated 
with MG 132. The reasons for this intriguing effect are at present unclear* but will be 
discussed further in Section 5.7 below. ACRP30 secretion appears to be decreased to a 
greater extent by MG 132 treatment of basal cells. This could be due to the enhancement in 
ACRP30 secretion previously reported in response to insulin (Bogan and Lodish, 1999; 
Scherer et al., 1995).
5.4.2.3. Effect of STX16cyt on ACRP30 secretion
Due to the adverse effects of MG 132 on ACRP30 secretion, the alternative method to 
produce optimum STX16cyt expression was then utilised. Cells were therefore infected on
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days 4 and 6 post-differentiation as described in Section 4.3.2 with MOI 1:225 STX16cyt, 
empty pShuttle-CMV adenovims or no virus. No appreciable difference was observed in 
secretion of ACRP30 in cells expressing STX16cyt compared to cells infected with empty 
pShuttle-CMV (Figure 5.8A) or no virus control cells (not shown) after 0, 5, 10 or 20 min.
It was then decided to compare the secretion of ACRP30 from cells expressing STX16cyt 
to cells expressing the cytosolic domain of another Syntaxin, STX12 (Tang et al., 1998c), 
which was previously shown to have no effect on ACRP30 secretion in 3T3-L1 adipocytes 
(H.K.I. Perera, unpublished data). This was achieved by infecting cells with a recombinant 
adenovirus generated previously in our laboratory by H.K.I. Perera (Perera et al., 2003), 
capable of expressing the cytosolic domain of STX12 (STX12cyt). Once again, no 
appreciable difference was observed in the levels of ACRP30 secreted from cells 
expressing STX16cyt compared to STX12cyt after 10 min either in the presence or 
absence of insulin (Figure 5.8B).
These data suggest that that STX16cyt and therefore STX16 has no effect on the secretion 
of ACRP30 from 3T3-L1 adipocytes.
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Figure 5.7 Effect of MG132 treatment on ACRP30 secretion in 3T3-L1 adipocytes
3T3-L1 adipocytes were treated with 50 pM MG 132 (Section 4.3.3) for 16 h overnight 
from day 7 to day 8 post-differentiation. Control cells were differentiated in parallel but 
not treated with MG132. The secretion assay was carried out on day 8 post- 
differentiation as described in Section 5.4.1.1, in the presence or absence of 1 pM 
insulin and secretion samples were collected after 0 and 10 min. The samples were 
resolved by SDS-PAGE electrophoresis and analysed by immunoblotting with anti- 
ACRP30.
Upper Panel: Samples collected from basal cells after 0 and 10 min indicated that 
MG 132 treatment dramatically inhibited ACRP30 secretion from 3T3-L1 adipocytes. 
Lower panel: Secretion samples collected from insulin-stimulated cells after 0 and 10 
min also showed that MG 132 treatment decreases ACRP30 secretion.
The upper and lower panels are from different exposures of separate immunoblots and 
therefore should not be directly compared. The experiment was carried out three times 
with similar results. A representative immunoblot is shown. Each lane was loaded with 
2/5 of the secreted proteins from one well of a 12-well plate, collected after the times 
indicated.
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Figure 5.8 Effect of STXIBcyt on ACRP30 secretion in 3T3-L1 adipocytes
3T3-L1 adipocytes were infected on days 4 and 6 post-differentiation (Section 4.3.2) 
with MOI 1:225 STXlôcyt, empty pShuttle-CMV adenovirus or an adenovirus 
expressing the cytosolic domain of STX12 (STX12cyt). The secretion assay was carried 
out on day 8 post-differentiation as described in Section 5.4.1.1, and secretion samples 
were collected at the time points indicated. The samples were resolved by SDS-PAGE 
electrophoresis and analysed by immunoblotting with anti-ACRP30. A) Samples 
collected after 0 ,5 ,1 0  and 20 min indicated that STXlôcyt had no effect on ACRP30 
secretion compared to control cells (infected with empty pShuttle-CMV virus) in basal 
cells. B) Secretion samples collected after 0 and 10 min in cells expressing STXlôcyt or 
STX12cyt in the presence (Insulin, bottom panel) or absence (Basal, top panel) of 1 pM 
insulin were compared. No appreciable difference in ACRP30 secretion was observed in 
cells expressing STXlôcyt compared to STX12cyt, either in the presence or absence of 
insulin.
The experiments were carried out three times with similar results. Representative 
immunoblots are shown. Each lane was loaded with 2/5 of the secreted proteins from 
one well of a 12-well plate, collected after the times indicated.
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5.5. Knockdown of STX16 in 3T3-L1 adipocytes 
5.5.1. Overview
In Section 5.5.1, the effects of inhibiting STX16 function were studied by means of 
expressing the dominant negative cytosolic domain, STXlôcyt. As a complimentary 
approach to probe the function of STXlô in GLUT4 trafficking, Moipholino Antisense 
Oligonucleotides (MAGs) were employed to knockdown levels of this protein in 3T3-L1 
adipocytes. MAGs are described in Section 5.1.3.
5.5.2.STX16 specific MAO
5.5.2.1. Blast search and design of STX16 MAO
A Blast search was canied out to identify the murine STXlô sequence (not shown). The 
accession number was identified as NM_172ô75. The murine STXlô specific MAG was 
then designed according to this sequence and manufactured at GeneTools Inc. (Philomath, 
GR). The sequence of the STXlô MAG was as follows:
5’- GCCATGCGGTCATCAGCAAGCTCGT- 3’
5.5.3.internaiisation of fiuoresceinated MAO using Endo- 
Porter reagent
Although MAGs have a high success rate of knocking down target genes in various cell 
types, the limiting factor is their successful delivery into target cells. The Endo-Poiter 
delivery reagent (GeneTools Inc.) delivers substances into the cytosol of cultured cells via 
an endocytic pathway, avoiding toxicity due to disruption of the plasma membrane, and 
has been shown to suecessfully deliver MAGs into a number of cell types (www.gene- 
tools.com).
The Endo-Porter delivery reagent was therefore tested for its ability to internalise a 
standard control MAG with a fluorescent tag (3’-Carboxyfluorescein end modification) 
into 3T3-L1 adipocytes. 1, 5 or 10 pM fiuoresceinated MAG were added, along with 10
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pM Endo-Porter reagent per well of a 12 well plate, to 3T3-L1 adipocytes on day 6 post­
differentiation. Cells were viewed using an upright fluorescent microscope at various times 
for up to 48 h after treatment. 48 h after treatment, cells were imaged using AxioVision 4.3 
software and the results of representative fields are shown in Figure 5.9. Whereas diffuse 
fluorescence is indicative of successful delivery into the cytosol, it appeared that only 
punctate spots were observed at all concentrations of MAO. This suggests that the MAGs 
were trapped at the cell surface or in endosomes. 20 and 40 pM fiuoresceinated MAG were 
then tested for endocytosis with similar results (not shown).
In support of this finding, 3T3-L1 adipocytes treated with Endo-Porter reagent and STX16 
specific MAG displayed no change in the level of STX16 compared to control cells as 
shown by Western Blotting (not shown).
5.5.4. Electroporation of STS-LI adipocytes to achieve 
delivery of MAO
Electroporation was therefore employed to achieve delivery of the MAG into adipocytes. 
This method was used previously to successfully deliver RNAi into 3T3-L1 adipocytes and 
achieve successful gene knockdown (Jiang et al., 2003). However, the success of 
delivering uncharged MAGs, with different properties to RNA, was unknown. 
Electroporation was carried out as described Section 5.4.2 with 20 or 40 nmoles STX16 or 
control MAG on day 6 post-differentiation. 48 h later, the cells were either used for 
glucose transport assay (Section 5.6.4.2, below) or lysates were prepared as in Section 
2.3.4.3 and analysed by Western Blotting with anti- STX16 (Section 5.6,4.1, below).
5.5.4.1. STX16 is knocked down by > 90 % in 3T3-L1 
adipocytes using STX16 MAO
Lysates prepared from cells electroporated with 20 nmoles STX16 MAG (Section 5.4.2) 
were analysed by gel electrophoresis and Western Blotting with anti-STX16. Figure 5.10 
demonstrates that using 20 mnoles of MAG per 10cm plate of adipocytes was sufficient to 
reduce STX16 levels by > 90%. The lysates were also probed for the presence of other 
Syntaxin family members, STX4, STX8 and STX12, using appropriate specific antibodies. 
The levels of these Syntaxins were unchanged with MAG treatment (Figure 5.10), 
indicating that the effect was indeed specific to STX16.
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5.5.4.2. Knockdown of STX16 expression reduces 
insulin-stimulated deGIc transport
3T3-L1 adipocytes, electroporated as described above were then used to carry out a 
glucose transport assay. 20 or 40 nmoles of MAO were used per 10 cm  ^ dish to 
knockdown levels of STX16. The higher concentration was used in this case to maximise 
knockdown, since the sensitivity of the anti-STX16 antibody is unknown. The glucose 
transport assay was carried out as described in Section 5.4.1 (5.4.1.2), except insulin- 
stimulation was achieved using 1, 10 and 100 nM insulin. This was to assay insulin- 
stimulated deGIc transport at both maximal and sub-maximal insulin concentrations. As 
shown in Figure 5.11, knockdown of STX16 resulted in decreased rates of insulin- 
stimulated deGIc transport, evident at both maximal and sub-maximal doses of insulin.
5.5.4.3. Knockdown of STX16 expression reduces total 
cell GLUT4 levels
It was thought that this reduction in insulin-stimulated deGIc uptake in cells depleted of 
STX16 could correlate with depleted levels of GLUT4, and as such, the levels of GLUT4 
in cells depleted of STX16 were examined. 48 h after electroporation with STX16 MAO or 
control, on day 8 post-differentiation, cell lysates were probed with anti-GLUT4 (Figure 
5.12). It was found that depletion of STX16 indeed resulted in a 30.6 + 7.2% reduction in 
total cell GLUT4 levels. The possible reasons for this decrease will be discussed in Section 
5.7.
Figure 5.9 Delivery of a fiuoresceinated MAO at various concentrations into 3T3-L1 
adipocytes
Endo-Porter delivery reagent was tested for its ability to internalise a standard control 
MAO with a fluorescent tag into 3T3-L1 adipocytes. 3T3-L1 adipocytes were 
exposed to 0, 1, 5 or 10 pM fiuoresceinated MAO (as indicated), along with 10 pM 
Endo-Porter reagent per well of a 12 well plate, on day 6 post-differentiation. 48 h 
after treatment, cells were viewed using an upright fluorescent microscope and imaged 
using AxioVision 4.3 Software. Representative fields are shown. Bright field images 
(left hand panels) are displayed along with their corresponding fluorescent images 
(right hand panels). Punctuate spots of fluorescence at all concentrations of MAO were 
indicative that the MAOs were trapped at the cell surface or in endosomes.
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Figure 5.10 MAO-depletion of STX16 expression in 3T3-L1 adipocytes.
3T3-L1 adipocytes were electroporated (Section 5.4.2) in the presence of 20 nmoles of 
STXl6-MAO or control per 10 cm  ^dish. 48h later, cell lysates were prepared (Section
2.3.4.3) and immunoblotted with antibodies to STXl6, STX4, STX8 and STXl2. 
STXl6 levels were reduced by >90% with 20 nmoles MAO per plate, whereas the 
levels of STX4, STX8 and STXl2 were unchanged.
This experiment was repeated three times with similar results. Representative 
immunoblots are shown.
Fractions loaded: 1.0 is equivalent to 4 x 
loaded as indicated.
10 cells. 0.25 X and 1.0 x samples were
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Figure 5.11 Insulin-stimulated deGIc transport is inhibited by MAO-depletion of STX16 
in 3T3-L1 adipocytes
3T3-L1 adipocytes were electroporated with 20 or 40 nmoles of STXl 6-MAO or 
control per 10 cm  ^dish (Section 5.4.2) on day 6 post-differentiation. 48h later, basal 
and insulin-stimulated deGIc transport was assayed (Section 5.4.1.2) in triplicate at the 
concentrations of insulin shown (1 nM, 10 nM, 100 nM), following 30 min 
stimulation. Depletion of STXl 6 had no effect on basal deGIc uptake but significantly 
inhibited insulin-stimulated deGIc transport at each concentration of insulin.
Data shown is from a typical experiment of this type, repeated three times with similar 
results. MAO’s specific for STXl6 resulted in a statistically significant inhibition of 
deGIc uptake at all insulin concentrations tested (p<0.05 for all comparisons).
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Figure 5.12 GLUT4 levels are decreased in 3T3-L1 adipocytes depleted of S TX l6 
in 3T3-L1 adipocytes
3T3-L1 adipocytes were electroporated with 40 nmoles STXl 6 MAO or control 
on day 6 post-differentiation. Lysates were prepared 48 h later and 
immunoblotted for GLUT4. This demonstrates that levels of GLUT4 are ~ 30.6 
+ 7.2% depleted in cells lacking STXl6 compared to control cells. 0.3 and 1.0 
equivalents of lysates were added (as indicated) to demonstrate the linearity of 
the immunoblot.
This experiment was repeated three times with similar results. A representative 
immunoblot is shown.
Fractions loaded: 1.0 is equivalent to 4 x lo"^  cells. 0.3 x and 1.0 x samples 
were loaded as indicated.
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5.6. Discussion
GLUT4 trafficking is described in detail in Section 1.7 and my discussion of the results 
obtained in this Chapter is based upon the model shown in Chapter 1 (Figure 1.9), taken 
fi'om (Bryant et al., 2002), which highlights the existence of two GLUT4 trafficking 
pathways in 3T3-L1 adipocytes: a fast recycling pathway between the cell surface and 
endosomes and a slowly recycling pool, which sequesters GLUT4 away fi'om the general 
endosomal traffic and may involve the TGN and insulin-responsive GSVs.
To address the function of STXl 6 in GLUT4 trafficking directly, two complementary 
approaches were used, each of which involved the inliibition of endogenous STXl6 
function. The first method involved the construction of a recombinant adenovirus to 
express a mutant form of STXl6, STXlôcyt, lacking its transmembrane domain (Section 
4.4.1.1). Previous studies of SNARE protein function have shown that endogenous 
SNARE protein function can be effectively inliibited by expression of the corresponding 
cytosolic domain (Olson et al., 1997; Tellam et al., 1997b; Volchuk et al., 1996). 
Expression of STXlôcyt in fully differentiated 3T3-L1 adipocytes was found to have little 
or no significant effect on either basal or insulin-stimulated deGIc uptake (Figure 5.3). 
However, STXlôcyt expression significantly slowed the rate of reversal of insulin- 
stimulated deGIc transport (Figure 5.3). Insulin-stimulated deGIc transport was reversed by 
rinsing cells with a low pH buffer, which causes insulin to dissociate with its receptor 
resulting in the re-sequestration of GLUT4 into intracellular compartments. In control 
cells, insulin-stimulated deGIc transport returned essentially to basal levels 40 min after 
insulin withdrawal. On the other hand, in cells expressing STXlôcyt, deGIc transport 
remained significantly elevated during the 10-40 minute withdrawal period time point, 
often as high as ~50% of the maximal insulin-stimulated rate after 40 min (Figure 5.3), 
This could suggest that inhibition of STXl 6 function results in defects in either the 
endocytosis of GLUT4 from the cell surface or the intracellular sorting of GLUT4 from the 
endosomal system into the slowly recycling intracellular pool. Although it is not possible 
to formally distinguish between these possibilities, I hypothesise that, as previously 
reported for STX6, this corresponds with an inability of GLUT4 to be sequestered from the 
fast recycling endosomal system into the slow cycling intracellular compartment involving 
the TGN and the GSVs. This therefore implies a role for STXl 6 in the intracellular
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sequestration of GLUT4 from the endosomal recycling pathway, contributing to its 
exclusion from the cell surface in the absence of insulin.
In order to consolidate this data, a second method to inhibit endogenous STXl 6 function 
was employed. A specific Morpholino Anti sense Oligonucleotide (MAO) was used to 
knockdown STXl 6 in 3T3-L1 adipocytes. Using this method, cellular levels of STXl6 
were reduced by more than 90 % (Figure 5.10). In 3T3-L1 adipocytes depleted of STXl6 
in this way, a marked decrease in the magnitude of insulin-stimulated deGIc uptake was 
observed (Figure 5.11). This finding adds further support to the model described above in 
which STXl6 functions to control sorting of GLUT4 from the recycling endosomal 
pathway into the slowly recycling aim housing the insulin-responsive GSVs. It was 
thought that cells depleted of STXl 6 may be unable to sequester GLUT4 into this 
compartment, resulting in reduced levels of GLUT4 in the insulin-responsive vesicles. In 
an attempt to resolve where the miss-sorted GLUT4 then resided in the cell, cell lysates 
treated with STXl6 specific MAO were probed with antibodies to GLUT4. Strikingly, the 
levels of GLUT4 in cells depleted of STXl6 were reduced by ~ 30% (Figure 5.12). This 
suggests that when sorting into the slowly recycling compartment is blocked, GLUT4 may 
be diverted into a degradative pathway. Interestingly, insulin resistance in adipose tissue 
was shown to con'elate most strongly with reduced GLUT4 expression and decreased 
GLUT4 mRNA (Shepherd and Kahn, 1999).
A decrease in insulin-stimulated deGIc transport was not observed upon over-expression of 
STXlôcyt perhaps because the levels produced were not high enough to produce complete 
inhibition of the endogenous molecule. STXlôcyt was expressed to a level equal to that of 
endogenous STXl 6, whereas in similar experiments, the cytosolic domain of STX6 was 
expressed to levels of 12-16 fold that of the endogenous protein (Perera et al., 2003). As a 
result of this relatively low expression, GLUT4 could presumably still be sorted into the 
slowly recycling compartment, avoiding degi-adation, due to the active presence of 
endogenous STXl6. A significant inliibitory effect was perhaps only observed after insulin 
withdrawal because this step would require the re-sequestration of a large proportion of 
GLUT4 from the cell surface into intracellular compartments.
Nonetheless, I suggest that these two complementary approaches both argue that STXl6 is 
involved in sorting of GLUT4 from the general endosomal traffic into the slowly recycling 
pathway. This model would be consistent with a role for STXl 6 in EE to TGN trafficking 
as reported in HeLas (Mallard et al., 2002) and correlates well with its description as a 
TGN localised t-SNARE (Simonsen et al., 1998; Tang et al., 1998a). Perhaps STXl6 is
' %»
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involved in a general trafficking step at this location, accepting incoming traffic from the 
EE arriving at the TGN or perhaps its role becomes more specific to GLUT4 trafficking in 
3T3-L1 adipocytes. This will be considered further in Chapter 6.
Secretion of ACRP30 (Section 5.1.2) from 3T3-L1 adipocytes is enhanced by insulin 
(Scherer et ah, 1995; Bogan and Lodish, 1999). Despite initial results suggesting the 
existence of a common insulin-regulated secretory pathway in adipocytes (Scherer et al.,
1995), more recent work suggested the existence of at least two distinct compartments that 
undergo insulin-stimulated exocytosis in adipocytes: one for ACRP30 and one for GLUT4 
(Bogan and Lodish, 1999). However, Bose et. a l demonstrated that Vtila is involved in 
insulin-stimulated glucose transport as well as ACRP30 secretion, and offer the hypothesis 
that it is involved in the regulation of a common step between the two pathways (Bose et 
ah, 2005). Vtila was previously shown to bind to STXl6 (Mallard et ah, 2002) in a 
complex that controls trafficking between the EE and the TGN. My study was therefore 
extended by determining if STXl 6 was involved in the intracellular trafficking or the 
sorting of this molecule into a secretory compartment.
Once again, STXlôcyt was expressed in 3T3-L1 adipocytes and ACRP30 secretion was 
measured at various time points. Experiments showed that expression of STXlôcyt had no 
effect on ACRP30 secretion in either basal or insulin-stimulated cells (Figure 5.8). I 
therefore concluded that, like STXô (Perera et ah, 2003), STXlô is not involved in the 
intracellular trafficking or secretion of ACRP30. This is consistent with a model that 
suggests both STXô and STXlô operate in the same SNARE complex, which is involved 
in GLUT4 trafficking but not ACRP30 secretion in 3T3-L1 adipocytes.
The role of STXlô was further investigated with a study into how the molecule may 
stmcturally act to regulate GLUT4 trafficking. A recombinant adenovims was constructed 
to express another mutant protein, STX1ÔT (Section 4.4.1.2), which lacked the potential 
autoinhibitory Habc domain. A similar mutant in Tlg2p was shown to bypass the 
requirement for Vps45p in SNARE complex assembly in yeast (Bryant and James, 2001).
The effects of STXlôT were compared to those of expressing the full-length protein, 
STX1ÔF (Section 4.4.1.3), in an attempt to identify if STXlôT represented a constitutively 
active version of the wild-type protein by accelerating the effects of expressing the full- 
length protein. However, expression of STXlôT or STXlôF did not alter basal or insulin- 
stimulated deGIc uptake significantly (Figure 5.5). Although this could suggest that neither 
STX1ÔT nor STXlôF have any effect GLUT4 trafficking, the effects of STXlôcyt 
expression were similarly not observed on basal or insulin-stimulated deGIc uptake but on
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the endocytic retrieval following insulin withdrawal. Future work will be required to 
address whether these proteins affect GLUT4 trafficking following insulin withdrawal. 
Before future work can proceed, however, it will be necessary to equalise the levels of 
STX16T and STX16F produced. The proteins are not expressed to the same level at the 
same MOI virus (Figure 5.6), and given that the recognition of STX16T to the STXl6 
antibody is unknown, it would, with hindsight, have been prudent to express the proteins 
bearing the same N-teiminal tag (Section 4.4.1).
However, it is worth noting that, consistently, the levels of insulin-stimulated glucose 
transport were modestly elevated in cells expressing STX16F and STX16T compared to 
control cells, with those expressing STX16T exhibiting higher levels still (Figure 5.5). This 
may correlate with increased sequestration of GLUT4 into the insulin-responsive GSV 
compartment resulting in a larger fraction being mobilised to the PM in response to insulin. 
The elevated response of STX16T compared to STX16F may be indicative of a lack of 
regulation. Whereas STX16F may be subject to regulation by dephosphorylation in 
response to insulin and /or the autoinhibitory Habc domain, STX16T, lacking this domain 
and potential sites of phosphorylation (Chapter 3), may not. Also worth noting is the 
modest decrease in deGIc transport consistently observed in basal cells expressing STX16F 
(Figure 5.5). Again, this would correlate with increased levels of GLUT4 being 
sequestered from the endosomal pool and subsequently away horn the cell surface in the 
basal state. It would be anticipated that STX16T would also exhibit decreased basal deGIc 
uptake; however, the absence of this effect could once again be due to a lack of regulation. 
Once again, further studies will be required to explore these possibilities, and it should be 
clearly noted that despite this trend, the data do not reach statistical significance.
MG132 functions as a competitive inhibitor of proteasome function. Since MG132 
proteasome inhibitors could be used to increase adenoviral-mediated expression of the 
STXl 6 mutants, the effects of these inliibitors on deGIc transport and ACRP30 secretion 
were assessed. Intriguingly and unexpectedly, cells treated with MG132 displayed both 
inhibition of deGIc transport and ACRP30 secretion (Figures 5.2 and 5.7). Most intriguing 
is the fact that both effects are observed in type II diabetes.
Insulin-stimulated glucose uptake in adipocytes is highly coiTelated with the expression 
level of GLUT4, and it has been suggested that altered expression of GLUT4 in adipocytes 
may play a role in the insulin resistance of type II diabetes (Shepherd and Kahn, 1999). 
Indeed, GLUT4 protein and mRNA levels are decreased in adipocytes in most cases of
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insulin resistance, including that present in human obesity and type II diabetes (Shepherd 
and Kahn, 1999).
A recent study reported that the treatment of cells with proteasome inhibitors, including 
MG132, results in a decrease in the cellular levels of GLUT4 (Cooke and Patel, 2005), a 
finding that most likely explains the reduced dcGlc uptake observed in response to insulin 
in my study. The direct effect of inhibition of proteasome function might be expected to 
increase protein levels. The authors hypothesise that proteasome inhibition stabilized an 
inhibitor of GLUT4 expression and implicate a number of potential transcription factors 
including PPARy and its coactivator PGC-la, which have been shown to inhibit GLUT4 
expression (Aimoni et ah, 2003; Miura et ah, 2003), as likely candidates of factors that 
mediated the repression of GLUT4 expression with proteasome inliibition. In my study, 
MG132 samples were not tested for GLUT4 levels to verify this theory, however, future 
work should address this important issue.
ACRP30 is an abundant protein in human plasma (Maeda et ah, 1996), and circulating 
levels decrease in parallel with increasing obesity and the progi'ession of insulin resistance 
(Yang et ah, 2001). The expression of ACRP30 mRNA is significantly reduced in the 
adipose tissue of obese humans (Hu et ah, 1996) and fat loss in obese patients causes 
ACRP30 levels to increase (Yang et ah, 2001). Insulin resistant patients also display lower 
levels of ACRP30 (Hotta et ah, 2000; Maeda et ah, 2001) and when these patients are 
administered thiazolidinediones (TZD), an insulin-sensitising drug, ACRP30 levels 
increase (Maeda et ah, 2001). Most intriguing, then, is the decrease observed in ACRP30 
secretion in my study after MG132 treatment (Figure 5.7). I hypothesise that this decrease 
in secreted protein correlates with a decrease of protein expression in a manner similar to 
that observed for GLUT4 (Cooke and Patel, 2005), however, it is plausible that the 
ACRP30 secretion pathway is peitnrbed by proteasome inhibition. This could be resolved 
by immunoblotting cell lysates for total levels of ACRP30.
So could the decreases obseiwed in insulin-stimulated glucose transport and ACRP30 
secretion be related? As mentioned above, circulating ACRP30 levels were found to 
decrease in parallel with increasing obesity and the progression of insulin resistance (Yang 
et ah, 2001). However, it is not cuiTently known whether decreased levels of ACRP30 
secretion are a cause or effect of the insulin resistance. My results could suggest that there 
may be factors that regulate a connecting step in the two pathways, which are degraded by 
the proteasome. Although to discuss this further would be beyond the scope of this thesis.
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it nonetheless remains intriguing that inhibition of proteasome function leads to both of 
these significant effects.
In conclusion, I suggest that the data presented in this Chapter, paricularly that from the 
experiments involving STXlôcyt expression and MAO STXl6 knockdown, provides 
evidence that STXl 6 is involved in the intracellular sorting of GLUT4. I suggest that 
STXl6 plays a key role in deliverering GLUT4 from the general endosomal system to a 
slowly recycling intracellular trafficking pathway, which may involve the TGN and GSVs, 
thus sequestering GLUT4 away fi'om the cell surface in the absence of insulin. These 
findings are summarised in Figure 5.13. Wliether STXl6 has a further role to play in 
GLUT4 trafficking, such as in the biogenesis of GSVs or translocation to the PM will 
require careful fiiriher study, an issue which will be addressed in Chapter 6.
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Figure 5.13 A model depicting the involvement of STX16 in GLUT4 trafficking in 
adipocytes (adapted from (Bryant et al., 2002))
In this model, GLUT4 occupies two main intracellular recycling pathways. Cycle 1: 
GLUT4 recycles between the cell surface and endosomes, showing co-localisation 
with molecules such as the TfR. Cycle 2; GLUT4 is sequestered away from the 
endosomal system and recycles more slowly between the TGN and endosomes. 
Insulin-responsive GSVs, enriched with VAMP2 may bud from the TGN.
A red arrow depicts the step that I anticipate to be regulated by STX16, possibly in 
concert with STX6. It is likely that STX 16 would be involved in a SNARE complex 
that would allow the fusion of GLUT4-containing vesicles from the endosomal system 
with the TGN.
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6. Conclusions and future directions
Insulin promotes glucose uptake in muscle and adipose tissue by stimulating the 
translocation of the glucose transporter GLUT4 from an intracellular location to the plasma 
membrane (Bryant et ah, 2002; Watson et ah, 2004). Recent studies support a model in 
which the intracellular GLUT4 itinerary involves two intracellular cycles (Figure 1.9,
Chapter 1). In the basal state, GLUT4 recycles between the PM and endosomes in the fast 
recycling endosomal system. However, a large population of GLUT4 is sorted away fr om 
the endosomal system, into a slowly recycling intracellular pathway between endosomes 
and the TGN. This pathway involves the sorting of GLUT4 into unique storage vesicles,
GSVs, which are mobilised in response to insulin, and are responsible for the majority of 
GLUT4 that is delivered to the cell surface upon insulin-stimulation. The intracellular 
sorting of GLUT4 is therefore essential for the maintenance of blood glucose homeostasis, 
both to direct GLUT4 into the insulin-responsive compartment and to effectively sequester 
GLUT4 from the cell surface in the basal state. However, the molecules responsible for 
regulating this intracellular sorting remain largely unknown.
There is a substantial pool of evidence to suggest a role for the TGN localised t-SNARE 
STXl6 in the regulated trafficking of GLUT4 in 3T3-L1 adipocytes (Perera et al, 2003; '
Shewan et al, 2003) (Section 1.8, Chapter 1). In this thesis, I aimed to elucidate the role of 
STXl 6 in GLUT4 trafficking and to determine whether STXl 6 phosphorylation played a 
role in the regulation of this process. The experiments described in Chapters 3-5 are 
discussed in detail at the end of these Chapters. This Chapter aims to summarise the main 
conclusions drawn and suggest the future direction of the project.
6.1. Phosphorylation of STXl 6
STXl 6 is a phosphoprotein in 3T3-L1 adipocytes and this phosphorylation is decreased by 
~ 50 % following acute insulin-stimulation (Perera et al, 2003). It was decided that 
identification of the exact site of insulin-regulated phosphorylation in STX 16 would be the 
first step towards the elucidation of its function. Three potential sites were identified 
(based on the putative PKA site in the yeast homolog, Tlg2p), mutated to alanine residues 
and tested for phosphorylation in HEK 293 cells. These initial studies were carried out in 
HER 293 cells because they are easier to transfect than fully differentiated adipocytes. It 
was thought that the generation of recombinant adenoviruses (Chapter 4) at this stage 
would be much too time consuming and cost inefficient, and electroporation had not yet
..iiï 'Z ïS î
Kirsty M. Proctor, 2006 Chapter 6,219
been optimised as a method to deliver the plasmids into adipocytes. However, labelling 
suggested that neither these mutants nor wild type STXl6 (expressed in the same way as 
the mutants) were phosphorylated in these cells. It was concluded that STXl 6 
phosphorylation might be specific to adipocytes.
Clearly then, the next step will be to test these mutants for expression and phosphorylation 
directly in 3T3-L1 adipocytes. Electroporation can now be used to deliver the mutant 
plasmids into adipocytes and phosphorylation can be assessed by ^^ P labelling as before. If 
this approach is unsuccessful, or if the hypothesised phosphorylation sites prove to be 
incorrect, an alternative method could be utilised to identify the site of phosphorylation in 
STXl6. For example, STXl6 could be immunoprecipitated from 3T3-L1 adipocytes and 
analysed for phosphorylation by tryptic digest and mass spectrometry analysis. Initially, it 
was anticipated that the phosphorylation site was likely to coinespond directly to that in 
Tlg2p and therefore that it would be a simple matter to test this possibility using the 
phosphorylation mutants. However, with hindsight, it may have been more prudent to 
screen the STXl 6 sequence for phosphorylation sites in this way from the beginning. 
Nonetheless, once the site(s) has been identified, both phosphorylation-null (phospho-site 
to alanine) and phosphorylation-mock (phospho-site to aspartate) mutants could be 
generated, expressed in adipocytes and glucose transport assays (Chapter 5) perfonned to 
detennine their effects on GLUT4 trafficking. Expression of these mutants in adipocytes 
could be achieved either by electroporation of expression vectors or adenoviral mediated 
gene-transfer (Chapter 4). The ability to achieve < 90 % knockdown of endogenous 
STXl 6 in adipocytes using a specific MAO (Chapter 5) provides the additional possibility 
to express these mutants in cells depleted of endogenous STXl 6.
In order to detennine whether STXl 6 phosphorylation played a role in regulating the 
fonnation of a SNARE complex that may be involved in GLUT4 trafficking, it was 
deemed necessary to identify STX 16 binding partners, and whether binding was affected 
by insulin-stimulation. These studies revealed the existence of a STXl 6/STX6/Vti 1 a 
SNARE complex in 3T3-L1 adipocytes, the formation of which was not altered in response 
to insulin and, intuitively, neither by STXl6 phosphorylation. STXl6 did not appear to 
bind to mVps45 when part of this complex, either in the presence or absence of insulin.
Due to a lack of a STXl 6 specific antibody at this time, these binding studies were carried 
out by immunoprécipitation of STX6, and not STXl 6, from 3T3-L1 adipocytes. SNARE 
pairing is known to be promiscuous, particularly in the case of STX6 (Wendler and Tooze, 
2001), and it is highly plausible that the population of STXl6 present in the STX6
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immunoprecipitate does not correspond to that in the insulin-regulated complex. Future 
studies could immunoprecipitate STXl 6 directly, and as well as looking for potential 
SNARE partners, should perhaps be extended to looking at non-SNARE proteins, to allow 
for the possibility that STXl 6 phosphorylation serves another function other than to 
regulate SNARE complex formation. Once generated, the phosphorylation-null and 
phosphorylation-mock mutants described above could also be used to look for binding 
partners in adipocytes by means of immunoprécipitation with N-terminal tags.
In conclusion, I anticipate that STX6, STXl6 and Vtila certainly do form a complex in 
3T3-L1 adipocytes but, since binding is not altered by insulin-stimulation, this does not 
represent the insulin-regulated complex involved in GLUT4 trafficking. It is possible that 
this in fact represents the complex responsible for accepting incoming traffic to the TGN 
fi-om the EE as described by Mallard et. al (Mallard et al., 2002), which would of course 
suggest that STXl 6 is involved in a general trafficking step at this location. This could be 
investigated by testing STXl 6 for its involvement in the trafficking of other molecules 
known to follow this route in 3T3-L1 adipocytes. However, due to the promiscuous nature 
of SNARE proteins, it is highly plausible that STXl 6 may be involved in a separate 
SNARE complex at another stage of GLUT4 trafficking (discussed in Chapter 3). This 
insulin-regulated complex may still involve STX6 and STX 16 and perhaps even Vtila, but 
with a different v-SNARE on the incoming vesicle. The identity of these v-SNAREs and 
the possible nature of this complex are discussed in Chapter 3.
6.2. Effect of STX16 on GLUT4 trafficking in 3T3-L1 
adipocytes
STXl 6 mutants (STX16cyt and STX16T, described in detail in Chapter 4) were designed 
to test the function of STX16 in GLUT4 trafficking in 3T3-L1 adipocytes. Adenoviral 
vectors have been used in previous studies to successfully introduce genes into 3T3-L1 
adipocytes (Bose et al, 2001; Emoto et al, 2001; Sakaue et al, 1997), a cell line which is 
only poorly transfected using standard transfection methods (Gnudi et al, 1997). 
Recombinant adenoviruses were therefore prepared to express these STXl 6 mutants and 
full-length STXl6, STX16F. The cytosolic domain, STXlôcyt, was anticipated to act as an 
inhibitor of the endogenous protein (Olson et al, 1997; Perera et al, 2003; Tellam et al, 
1997; Volchuk et al, 1996), whereas an N-terminal truncation, STXlôT, was designed to 
mimic the hypothesised open conformation of STXl6 and therefore to represent a 
constitutively active version of the wild-type protein (Bryant and James, 2001). The effects
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of STXlôT were compared to those of expressing the full-length protein STX16F, 
anticipated to amplify the effects the endogenous protein (Pagan et al., 2003; Thurmond et 
al., 1998).
Expression of these proteins in 3T3-L1 adipocytes proved to be problematic, but perhaps 
informative in tenns of the properties of STXl 6 (discussed in detail in Chapter 4). In the 
case of STXlôcyt, which consisted of the SNARE domain and the Habc domain, an 
apparent need for stabilisation by its cognate SM protein, mVps45, was identified. It 
appeared that STXl 6 expressed in excess of mVps45 was subject to proteasomal 
degradation, as expression could be increased dramatically by inhibition of proteasome 
function. This method of expression, however, could not be used to carry out functional 
assays, as treatment of cells with proteasome inhibitors dramatically decreased both 
insulin-stimulated glucose transport and ACRP30 secretion (discussed in detail in Chapter 
5). An alternative method, involving double infection of the cells was utilised to achieve 
optimum expression.
When each of the proteins was expressed in 3T3-L1 adipocytes, neither basal nor insulin- 
stimulated glucose transport was significantly affected. Since depletion of STXl 6 in these 
cells proved that STXl 6 does in fact play a role in GLUT4 trafficking, it seems likely that 
the absence of an effect in cells expressing STXlôcyt, STXlôF and STXlôT was due to 
inefficient levels of protein produced. The proteins were expressed to approximately one­
fold of the level of the endogenous protein, compared to 12-1Ô fold for STXô expressed in 
the same way (Perera et al., 2003). In the case of STXlôcyt, which was designed to perturb 
endogenous STXlô function, the level was perhaps inefficient to achieve complete 
inhibition of the endogenous protein. In the case of STXlôT and STXlôF, the effects of 
these proteins on glucose transport were perhaps not observed over those of the 
endogenous molecule, which was still able to function correctly.
As mentioned above, the reasons for poor levels of expression appear to be due the 
properties of STXlô, rather than a problem with the adenovirus method of expression. A 
complementary approach to inhibition of STXlô function via STXlôcyt expression was 
achieved by knockdown of endogenous STXlô using a specific MAO (Chapter 5). An 
alternative method could have involved the generation of a recombinant adenovirus to co­
express mVps45 with STXlôcyt to provide the necessary stabilisation. However, the future 
of this study relies on the development of alternative methods to answer the questions 
posed by STXlôT and STXlôF. Expression of STXlôT and STXlôF attempted to address 
whether STXlô could adopt an open and closed conformation and, indeed, whether these
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conformations could influence GLUT4 trafficking. As a starting point, homology 
comparisons with other Syntaxins known to adopt these conformations could be 
informative. These studies could lead to further structural investigations by NMR or 
crystallisation studies. As mentioned previously, electi'oporation of adipocytes was not 
optimised until very late this study, however this may now provide the opportunity to 
eliminate endogenous STX16 function when expressing STX16T and STX16F using 
adenovims. Perhaps the absence of the endogenous protein will allow these mutants to be 
expressed to a higher level or at least will remove the interfering effects of endogenous 
STX16.
Finally, as the expressed mutant proteins do not run at the expected molecular weight on an 
SDS-PAGE gel, this could suggest that the conformations are different than that of the 
wild-type protein. Future work should perhaps address the exact localisation and 
functionality of the expressed STX16 mutants in 3T3-L1 adipocytes. To check if they are 
functional, the domains could be tested for their ability to interact with wild-type STX16 
SNARE partners, STX6 and Vtila, and mVps45 (Mallard et ah, 2002; Perera et ah, 2003; 
Shewan et ah, 2003)(Chapter 3). This could be achieved by immunoprécipitation using 
antibodies specific to the HA- or myc-tags present on N-teiminus of each mutant. In 
addition, fractionation / compartmentalisation studies could be carried out to ensure that 
the proteins are accurately targeted to the correct compartment in 3T3-L1 adipocytes. 
Preliminary results suggest that STXlbcyt is present in both a cytosolic and a membrane 
fraction (not shown) in adipocytes, in keeping with its cytosolic nature and ability to bind 
to membrane-bound SNAREs. This could be repeated to ensure that STX16T and STX16F 
are inserted into membranes. Immunofluorescence studies would allow the comparison of 
the localisation of the mutants in 3T3-L1 adipocytes with endogenous STX16.
Despite the low levels of protein produced, expression of STXlôcyt significantly slowed 
the reversal of GLUT4 trafficking after insulin withdrawal but did not affect ACRP30 
secretion. In the complementary method, depletion of STX16 significantly reduced insulin- 
stimulated deGlc transport, coiTcsponding to a decrease in GLUT4 expression in these 
cells. These results are discussed in detail in Chapter 5 but in summary, they were 
explained within a model in which STX16 plays an important role in the intracellular 
sorting of GLUT4 but not ACRP30. It was hypothesised that STX16 functions to sequester 
GLUT4 away from the fast recycling endosomal system into a slowly recycling 
intracellular loop involving the TGN and GSVs. When STX16 is depleted, GLUT4 is no 
longer sorted into this pathway and appears to be rerouted to a degradative pathway.
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6.3. Model of STX16 in GLUT4 trafficking
A model is described in Chapter 5 (Section 5.7, Figure 5.13), which suggests that the 
intracellular GLUT4 sorting step involving STX16 may involve the sorting of GLUT4 
away from the endosomal system to the TGN. To expand on this model, this trafficking 
step may constitute a general trafficking step at this location, as described by Mallard et. 
al (Mallard et al., 2002) or perhaps a more specific route taken exclusively by GLUT4 to 
the TGN subdomain enriched in STX16 and STX6 described by Shewan et. a l (Shewan et 
al., 2003). Vtila has also been reported to colocalise with GLUT4 in such a TGN 
subdomain (Bose et ah, 2005), suggesting this could indeed be the third t-SNARE involved 
in this complex. Of course, the presence of STX16 in GSVs and its apparent translocation 
to the cell surface upon insulin-stimulation (Bose et al., 2005; Perera et ah, 2003) must also 
be addressed. I offer the hypothesis that since STX16 is involved in the sorting of GLUT4 
to the TGN or a TGN subdomain, perhaps from which GSVs bud, then STX16 might 
become incoiporated into these vesicles during the budding of GSVs from this 
compartment in a manner similar to the inclusion of umiecessary cargo molecules, such as 
MPRs, during the budding of immature secretory granules from the TGN (Tooze et ah, 
2001). The nature of GSVs remains controversial (Section 1.7.4) (Bryant et ah, 2002), 
however, supposing GSVs do not undergo a process of maturation similar to secretory 
granules during which umiecessary molecules are removed, then this could explain the 
translocation of STX16 to the cell surface in these vesicles. This theory may also apply to 
STX6 and Vtila, which also appear to demonstrate insulin-stimulated translocation to the 
cell surface (Bose et ah, 2005; Perera et ah, 2003).
I also offer a hypothesis for the phosphorylation of STX16, given the trafficking step that I 
predict it to be involved in, from which future studies can build. I hypothesise that in the 
basal state, when STX16 is phosphorylated, it forms a SNARE complex which functions to 
sort GLUT4 from the fast recycling endosomal system into the slowly recycling 
intracellular pathway, thus sequestering GLUT4 away from the cell surface. Then in 
response to insulin, when STX16 becomes dephosphorylated, assembly of this SNARE 
complex is inhibited, blocking traffic into this slowly recycling compartment. This could 
either cause GLUT4 to re-enter the endosomal system and increase its delivery to the cell 
surface in this way or perhaps this is responsible for the modest slowing of GLUT4 
endocytosis obseiwed in insulin-stimulated cells (Jhun et al., 1992; Yang and Holman, 
1993). In fact, this slowing down of the endocytic retrieval of GLUT4 was obseiwed when 
STX16 function was partially inhibited using STXlôcyt. On the other hand, when STX16
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was almost completely depleted in fat cells, insulin-stimulated glucose transport was 
reduced, apparently owing to the rerouting of GLUT4 to a degradative pathway. This is 
perhaps why only a 50 % reduction in phosphorylation is observed upon insulin- 
stimulation (Perera et ah, 2003). This would be sufficient to slow the intracellular 
sequestration of GLUT4 without completely inhibiting the pathway.
To conclude my thesis, I  would like to present a model in which I  have put together both 
the data from my own experiments, along with the current literature, to suggest a possible 
role for STX16 in GLUT4 trafficking (Figures 6.1 and 6.2). The full testing of these 
models will require careful future study.
Figure 6.1 A possible model depicting the involvement of STX16 in GLUT4 trafficking 
in adipocytes (adapted from Bryant et al., 2002)
In this model, GLUT4 occupies two main intracellular recycling pathways. In the 
basal state, GLUT4 recycles between the PM and endosomes in the fast recycling 
endosomal system and shows co-localisation with recycling molecules such as the TfR 
(Cycle 1). A large population of GLUT4 is sequestered away from the endosomal 
system into a slowly recycling pathway between endosomes and the TGN (Cycle 2). 
This pathway involves the sorting of GLUT4 into unique storage vesicles (GSVs) 
enriched in VAMP2, which are mobilised in response to insulin and are responsible 
for the majority of GLUT4 that is delivered to the cell surface in response to insulin.
A red arrow depicts the step that I anticipate to be regulated by STX16. I hypothesise 
that STX16 would be involved in a SNARE complex, perhaps involving STX6 and 
Vtila, which would allow the fusion of sequestered GLUT4-containing vesicles from 
the endosomal system with a region of the TGN. This may constitute the TGN 
subdomain enriched in STX6 and STX16 previously described (Shewan et ah, 2003). 
GSVs may bud from this region, thus incorporating STX16 and STX6 into these 
vesicles and explaining their translocation to the PM upon insulin-stimulation (Perera 
et ah, 2003).
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Figure 6.2 Model depicting the possible role of STX16 phosphorylation in regulation of 
GLUT4 trafficking
In the basal state STX16 is phosphorylated and able to bind to its SNARE partner, 
STX6. This SNARE complex may be involved in the intracellular sorting of GLUT4 
into the slowly recycling compartment as described in Figure 6.1. Upon insulin- 
stimulation, phosphorylation of STX16 is decreased by ~ 50 % and SNARE complex 
formation is inhibited. Blockade of this trafficking step may slow the intracellular 
sorting of GLUT4 into slowly recycling compartment, thus increasing its presence at 
the cell surface during insulin-stimulation.
Previous work has suggested that (de)phosphorylation of t-SNAREs could regulate the 
formation of functional SNARE complexes (Gerst, 2003). This model is based on my 
assumption that phosphorylation of STX16 will promote SNARE complex assembly.
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AGCCG AATTCTGCAG ATATCCAGCA TTCOGC TTAAGAC6TC TATAGGTCGT
BGH reverso priming
CAGTCQCGGC CGCTCGAGTC TAGAGGGCCC GtTTAAACCC G OT^A TCA dFcTCG A CTG TG 'CCTTCTA  
GTCACCGCCG GCGAGCTCAG ATCTCCCGGG CAAATTTGGG CGACTAGTCG GAGCTGACAC GGAAGAX
pCR
PCR3.1 vector for expression in mammalian cells
pCR3.1 is a 5 kb cloning vector containing Ampicillin and Neomycin/Kanamycin 
resistance genes for selection. The gene of interest is inserted in the multiple cloning 
region (bases 670-801), follo^ving the CMV promoter (bases 1-596).
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LITR
pShuttle-CM .V
7462 bp
right arm
fôft arm
BgHI 955pnl 961 Sali 967 Notl 974 CXhol 982 ^Hîndlll 988 996 EcoRV 1002
XBamHI 4549 
Pacl 4541 /-Pm el 3521 
EcoRI 3527
pShuttle-CMV vector is described by He et, al (He et. al., 1998). This vector contains 
a multiple cloning site for insertion of exogenous transgenes between the 
cytomegalovims (CMV) promoter and a polyadenylation site. It contains a polylinker 
for the expression of transgenes, surrounded by adenoviral sequences (“arms”) that 
allow homologous recombination with the adenovims backbone. Artificially created 
P a d  sites surround both arms. The pShuttle plasmid also contains a Kanamycin 
resistance gene and the origin of replication from pBR322.
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pCR2.1 for TA cloning
pCR2.1 is a 3.9 kb vector containing Ampicillin and Kanamycin resistance genes for 
selection. The gene of interest is TA cloned into this vector as described in Section 
2.2.6. pCR2.1 contains the lacZ-alpha complememtation fragment for blue-white 
colour screening.
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